Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
Sennoside B | 128-57-4 | C42H38O20 | 862.74 | 5,5-Bis(b-D-glucopyranosyloxy)-9,9,10,10-tetrahydro-4,4-dihydroxy-10,10-dioxo-(9R,9S)-[9,9-bianthracene]-2,2-dicarboxylic acid |
Sennoside A | 81-27-6 | C42H38O20 | 862.74 | 5,5-Bis(b-D-glucopyranosyloxy)-9,9,10,10-tetrahydro-4,4-dihydroxy-10,10-dioxo-,(9R,9S)-[9,9-bianthracene]-2,2-dicarboxylic acid |
SENNIDINE B | 517-44-2 | C30H18O10 | 538.46 | SENNIDINE B; (R*,S*)-9,9',10,10'-tetrahydro-4,4',5,5'-tetrahydroxy-10,10'-dioxo[9,9'-bianthracene]-2,2'-dicarboxylic acid; 9-(2-carboxy-4,5-dihydroxy-10-oxo-9H-anthracen-9-yl)-4,5-dihydroxy-10-oxo-9H-anthracene-2-carboxylic acid; Sennidin B; SENNIDINE B h |
SENNIDINE A | 641-12-3 | C30H18O10 | 538.46 | SENNIDINE A; (R*,R*)-(+)-9,9',10,10'-tetrahydro-4,4',5,5'-tetrahydroxy-10,10'-dioxo[9,9'-bianthracene]-2,2'-dicarboxylic acid; EINECS 211-371-5; dihydroxydianthrone; SENNIDINE A: TECH.; SENNIDINE A hplc; (R*,R*)-(+)-9,9',10,10'-Tetrahydro-4,4',5,5'-tetrah |
Senna Leaf Extract | 85085-71-8 | |||
Senkyunolide S | 172723-28-3 | C12H16O5 | 240.255 | 3-[(2R)-2-Hydroxybutylidene]-6beta,7alpha-dihydroxy-4,5,6,7-tetrahydroisobenzofuran-1(3H)-one |
Senkyunolide R | 172549-37-0 | C12H16O5 | 240.255 | 3-[(2R)-2-Hydroxybutylidene]-6alpha,7beta-dihydroxy-4,5,6,7-tetrahydroisobenzofuran-1(3H)-one; (3Z,6S,7S)-6,7-dihydroxy-3-[(2R)-2-hydroxybutylidene]-4,5,6,7-tetrahydro-2-benzofuran-1-one |
Senkyunolide H | 94596-27-7 | C12H16O4 | 224.3 | (3Z,6R,7S)-rel-3-Butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone; Dimethyl 3-oxo-3H-pyrrolo[2,1,5-de]quinolizine-1,2-dicarboxylate |
Senkyunolide G | 94530-85-5 | C12H16O3 | 208.25 | 3-Butyl-4,5-dihydro-3-hydroxy-1(3H)-isobenzofuranone |
Senkyunolide E | 94530-83-3 | C12H12O3 | 204.225 | (3Z)-3-(2-hydroxybutylidene)-2-benzofuran-1-one; (Z)-3-(2-Hydroxybutylidene)isobenzofuran-1(3H)-one |
Senkyunolide C | 91652-78-7 | C12H12O3 | 204.22 | (3Z)-3-Butylidene-5-hydroxy-1(3H)-isobenzofuranone |
Senkyunolide A | 62006-39-7 | C12H16O2 | 192.25 | 3-N-butyl-4,5-dihydrophthalide; 3-butyl-4,5-dihydro-3H-isobenzofuran-1-one; Senkyunolide A (=3-butyl-4,5-dihydro-3H-2-benzofuran-1-one) |
Senkyunolide A | 63038-10-8 | C12H16O2 | 192.25 | (3S)-3-Butyl-4,5-dihydro-1(3H)-isobenzofuranone; (-)-Sedanenolide; (S)-Sedanenolide; 3-n-Butyl-4,5-dihydrophthalide; Senkyunolide; Sedanenolide |
Senktide | 106128-89-6 | C40H55N7O11S | 841.97 | Succinyl-6-asp-8-Me-phe-substance P (6-11) |
SENKIRKIN | 2318-18-5 | C19H27NO6 | 365.42 | RENARIDINE; SENKIKIN; SENKIRKIN; (4Z)-4-Ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione; 11,16-trione,12-hydroxy-4-methyl-8-secosenecionan-8; 2,12-Dihydroxy-4-methyl-11,16-dioxosenecionanium; 4,8-Secosenec |
Senicapoc | 289656-45-7 | C20H15F2NO | 323.34 | 2,2-bis(4-fluorophenyl)-2-phenylacetamide bis(4-fluorophenyl)phenylacetamide ICA 17043 ICA-17043 ICA17043 senicapoc |
Senexin A | 1366002-50-7 | C17H14N4 | 274.33 | 4-[(2-Phenylethyl)amino]-6-quinazolinecarbonitril; |
Seneganolide | 301530-12-1 | C26H30O8 | 470.5 | (1S,2R,6R,7R,10R,11S,16S,20R)-6-(3-Furyl)-20-hydroxy-7,17,17-trimethyl-5,13,21-trioxahexacyclo[17.2.1.01,10.02,7.011,16.011,20]docosane-4,14,18-trione |
Seneciphyllinine | 90341-45-0 | C20H25NO6 | 375.421 | 12-Acetylseneciphylline; Acetylseneciphylline; O-acetylseneciphylline; Seneciphylline acetate |
Seneciphylline N-oxide | 38710-26-8 | C18H23NO6 | 349.4 | (3Z,6R,14aR,14bR)-3-Ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-6-methyl-5-methylene-[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione 12-Oxide; 13,19-Didehydro-12-hydroxysenecionan-11,16-dione 4-Oxide |
Senecionine N-Oxide | 13268-67-2 | C18H25NO6 | 351.17 | Senecionine oxide; 12-Hydroxysenecionan-11,16-dione 4-oxide |
Senecionine | 130-01-8 | C18H25NO5 | 335.4 | Aureine; Senecionin; 12-Hydroxysenecionan-11,16-dione |
Sendran | 114-26-1 | C11H15NO3 | 209.24 | 2-ISO-PROPOXYPHENYL METHYLCARBAMATE;2-ISOPROPOXYPHENYL-N-METHYL-CARBAMATE;2-(1-Methylethoxy)phenol methylcarbamate;2-(1-Methylethoxy)phenyl methylcarbamate;BAYGON;BAYGON (TM);BAYER 39007;BLATTANEX(R) |
SEN 1269 | 956128-01-1 | C18H18N4O2 | 322.36 | 956128-01-1; 3-(5-(3-(dimethylamino)phenoxy)pyrimidin-2-ylamino)phenol; 3-({5-[3-(dimethylamino)phenoxy]pyrimidin-2-yl}amino)phenol; 3-((5-(3-(Dimethylamino)phenoxy)pyrimidin-2-yl)amino)phenol; SCHEMBL3602388; CHEMBL2386874; CTK5H7888; DTXSID40676566; 435 |
SEN 12333 | 874450-44-9 | C20H25N3O2 | 339.43 | WAY 317538; N-[4-(3-pyridinyl)phenyl]-4-morpholinepentanamide; 5-morpholin-4-yl-N-(4-pyridin-3-ylphenyl)pentanamide |
SEMPERVIRINE NITRATE WITH HPLC | 549-92-8 | C19H19N3O4 | 353.37 | |
Sempervirine | 6882-99-1 | C19H16N2 | 272.4 | 1,2,3,4-tetrahydroindolo[2',3':3,4]pyrido[1,2-b]isoquinoline |
Semorphone | 88939-40-6 | C19H23NO5 | 345.393 | |
Semilicoisoflavone B | 129280-33-7 | C20H16O6 | 352.342 | 5,7,8'-Trihydroxy-2',2'-dimethyl-2'H-(3,6')bi(1-benzopyranyl)-4-one; 4H-1-Benzopyran-4-one,5,7-dihydroxy-3-(8-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)- |
Semduramicin,30-hydroxy-5-(tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl)- (9CI) | 98824-17-0 | C52H88 O19 | ||
Semaxanib | 194413-58-6 | C15H14N2O | 238.28 | SU5416 |
Sematilide hydrochloride | 101526-62-9 | C14H24ClN3O3S | 349.87 | Benzamide, N-(2-(diethylamino)ethyl)-4-((methylsulfonyl)amino)-, monohydrochloride; Sematilide hydrochloride; Sematilide HCl; Sematilide hydrochloride; Sematilide; CK-1752A; CK1752A; CK 1752A; CK-1752; CK1752; CK 1752. |
Semapimod hydrochloride | 164301-51-3 | C34H56Cl4N18O2 | 890.746 | CNI-1493; CNI 1493; CNI1493; AXD455; AXD 455; AXD-455; AIDS121302; AIDS-121302; AIDS 121302 |
Semapimod | 352513-83-8 | C34H52N18O2 | 744.91 | CNI-1493; CNI 1493; CNI1493; N,N'-bis[3,5-bis[(E)-N-(diaminomethylideneamino)-C-methylcarbonimidoyl]phenyl]decanediamide |
Semaglutide | 910463-68-2 | C187H291N45O59 | 4113.641 | UNII-53AXN4NNHX; NNC 0113-0217; 53AXN4NNHX |
Semagacestat | 425386-60-3 | C19H27N3O4 | 361.44 | LY-450139; LY450139; (2S)-2-hydroxy-3-methyl-N-[(2S)-1-[[(5S)-3-methyl-4-oxo-2,5-dihydro-1H-3-benzazepin-5-yl]amino]-1-oxopropan-2-yl]butanamide |
Selumetinib | 606143-52-6 | C17H15BrClFN4O3 | 457.684 | ARRY-142886; ARRY 142886; ARRY142886; AZD6244; AZD-6244; AZD 6244; ARRY-886; ARRY886; ARRY 886 |
Selonsertib | 1448428-04-3 | C24H24FN7O | 445.5 | 5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide; GS-4997; GS4997; GS 4997 |
Selinidin | 19427-82-8 | C19H20O5 | 328.36 | (Z)-2-Methyl-2-butenoic acid [(S)-9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b']dipyran-9-yl] ester;Jatamansin;Secryptotaenin A |
Selinexor | 1393477-72-9 | C17H11F6N7O | 443.313 | KPT-330; KPT 330; (Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyrazin-2-ylprop-2-enehydrazide |
Seliciclib | 186692-46-6 | C19H26N6O | 354.44 | R-roscovitine. CYC202. CYC 202; R-Roscovitine; Roscovitin; Roscovitine |
Seletracetam | 357336-74-4 | C10H14F2N2O2 | 232.227166;g/mol | (2S)-2-[(4S)-4-(2,2-difluoroethenyl)-2-oxopyrrolidin-1-yl]butanamide; Seletracetam; UNII-RFR2CH3QZK; UCB44212; 357336-74-4; UCB-44212 |
Seletalisib | 1362850-20-1 | C23H14ClF3N6O | 482.85 | UCB-5857; UCB 5857; UCB5857; (R)-3-(8-chloro-3-(2,2,2-trifluoro-1-(pyrido[3,2-d]pyrimidin-4-ylamino)ethyl)quinolin-2-yl)pyridine 1-oxide |
Secnidazole | 3366-95-8 | C7H11N3O3 | 185.18 | SYM-1219; SYM1219; SYM 1219; PM 185184, RP 14539; PM185184, RP14539; PM-185184, RP-14539 |
SecinH3 | 853625-60-2 | C24H20N4O4S | 460.5 | |
sec-butyl 3-methylheptanoate | 16253-72-8 | C12H24O2 | 200.318 g/mol | |
SECBUMETON | 26259-45-0 | C10H19N5O | 225.29 | 1,3,5-Triazine-2,4-diamine, N-ethyl-6-methoxy-N'-(1-methylpropyl)-; 2-(sec-butylamino)-4-(ethylamino)-6-methoxy-s-triazin; 2-methoxy-4-sec-butylamino-6-aethylamino-s-triazin; 2-sec-butylamino-4-ethylamino-6-methoxy-s-triazine; 5-triazine-2,4-diamine,n-eth |
Secaubrytriol | 925932-10-1 | C30H50O5 | 490.725 | |
Secaubryenol | 925932-08-7 | C30H48O3 | 456.7 | 3-[(1R,3aS,3bS,6R,6aR,7aS,9aR)-6-(3-Hydroxy-1-propen-2-yl)-3a,9a- dimethyl-1-[(2R)-6-methyl-5-hepten-2-yl]decahydro-1H-cyclopenta[a ]cyclopropa[e]naphthalen-6a(7H)-yl]propanoic acid |
SEC-AMYL IODIDE | 637-97-8 | C5H11I | 198.05 | 2-IODOPENTANE; SEC-AMYL IODIDE; 2-iodo-pentan; Pentane,2-iodo-; Pentane,2-iodo(DL); Pentane,2-iodo-,(±)-; s-Amyliodide; 1-Methylbutyl iodide |
Secalciferol | 55721-11-4 | C27H44O3 | 416.64 | (24R)-24,25-Dihydroxyvitamin D3 |
SEBUTHYLAZINE-2-HYDROXY | 33124-61-7 | C9H17N5O | 211.26 | SEBUTHYLAZINE-2-HYDROXY |
Sebiferenic acid | 94390-09-7 | C30H48O4 | 472.71 | 2,3-Dihydroxy-14-taraxeren-28-oic acid |
SEA0400 | 223104-29-8 | C21H19F2NO3 | 371.38 | 2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline 2-(4-((2,5-difluorophenyl)methoxy)phenoxy)-5-ethoxyaniline SEA 0400 SEA-0400 SEA0400 |
4'-Nitrobenzoyl-6-selenoinosine | 40144-12-5 | C17H17N5O6Se | 466.31 | 2-(hydroxymethyl)-5-[6-[(4-nitrophenyl)methylselanyl]purin-9-yl]oxolane-3,4-diol; p-nitrobenzyl-6-selenopurine riboside; Se-(p-Nitrobenzyl)-6-selenoinosine; 6-(p-Nitrobenzyl)selenopurine riboside; (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[(4-nitrophenyl)methy |
Se-(Methyl)selenocysteine hydrochloride | 863394-07-4 | C4H10ClNO2Se | 182.08096 | |
SDZ285-428 | 174262-13-6 | C24H20ClN3O | 401,894 | 4-(4-chlorophenyl)-N-(2-imidazol-1-yl-2-phenylethyl)benzamide; NVP-VID-400 |
Sarracenin | 59653-37-1 | C11H14O5 | 226.22 | Sarrancenia flava Extract |
Sarpogrelate Related Compound II (3-Dimethylamino-1-[o-[2-(m-methoxyphenyl)-1-Hydroxyethyl]phenoxy]-2-propyl Hydrogen Su | 1659311-44-0 | C24H31NO7 | 445.52 | 4-((1-(dimethylamino)-3-(2-(1-hydroxy-2-(3-methoxyphenyl)ethyl)phenoxy)propan-2-yl)oxy)-4-oxobutanoc cid. - See more at: https://www.clearsynth.com/cn/CSO13417.html#sthash.KzPsLa9J.dpuf |
Sarpogrelate Metabolite M1 HCl | 135261-74-4 | C20H27NO3. HCl | 365.9 | 1-(Dimethylamino)-3-(2-(3-methoxyphenethyl)phenoxy)propan-2-ol Hydrochloride |
Sarpogrelate Hydrochloride | 135159-51-2 | C24H31NO6.HCl | 466.02 | Sarpogrelate hydrochloride |
Sarpogrelate | 125926-17-2 | C24H31NO6 | 429.51 | |
Sarpagine | 482-68-8 | C19H22N2O2 | 310.4 | Sarpagan-10,17-diol;Raupine;Sarpagane-10,17-diol |
Saropyrone | 159650-12-1 | C16H16O5 | 288.299 | 6-(3,4-dihydroxyphenyl)-2,3-dihydro-2,3,3-trimethyl-4h-furo[3,2-c]pyran-4-one |
S-2-Bromopropionic acid | 32644-15-8 | C3H5BrO2 | 152.97 | (S)-(-)-2-BROMOPROPIONIC ACID; (S)-2-BROMOPROPIONIC ACID; PROPANOIC ACID, 2-BROMO-, (2S)-; (S)-()-2-Bromopropionic acid; (S)-(-)-2-Bromopropionic acid, >85% ee, 98%; (S)-(-)-2-Bromopropionic acid, GC 99% |
S-2--bromobutyricacid | 32659-49-7 | C4H7BrO2 | 167.00118;g/mol | S-2--bromobutyricacid; (S)-2-Bromobutanoicacid; 32659-49-7; S-2-Bromobutyricacid; UNII-XK125R6KHN; (2S)-2-bromobutanoicacid |
S-2--Bromo Glutaric acid | 51528-22-4 | C5H7 Br O4 | 211.01 | |
Ricinoleic acid | 141-22-0 | C18H34O3 | 298.46 | Ricinolic acid; (R,Z)-12-Hydroxyoctadec-9-enoic acid |
Ricinelaidic acid | 540-12-5 | C18H34O3 | 298.5 | 12-D-Hydroxy-9-trans-octadecenoic acid; (E,12R)-12-hydroxyoctadec-9-enoic acid |
Resveratrol Impurity C | 678149-02-5 | C21H18O3 | 318.38 | (E)-3-(Benzyloxy)-5-(4-hydroxystyryl)phenol; Resveratrol Impurity C; 3-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-5-(phenylmethoxy)-phenol |
Resveratrol Impurity B | 1610531-11-7 | C21H18O3 | 318.38 | 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-2-(phenylmethyl)-1,3-benzenediol; (E)-2-Benzyl-5-(4-hydroxystyryl)benzene-1,3-diol; Resveratrol Impurity B |
Resveratrol | 501-36-0 | C14H12O3 | 228.247 | trans-Resveratrol; SRT-501; SRT 501; SRT501; RM1812; RM1812; RM 1812; RM-1812; CA1201; CA 1201; CA-1201; Resvida; Vineatrol 20M; trans-Resveratrol; Trans-resveratrol; 3,4',5-Trihydroxystilbene; 3,4',5-Stilbenetriol; 3,5,4'-Trihydroxystilbene |
Quinapril-d5 Hydrochloride | 1356020-03-5 | C25H26D5ClN2O5 | 480.01 | CI-906-d5, PD-109452-2-d5, Accupril-d5, Accuprin-d5, Accupro-d5; Korec-d5; Korectic-d5; |
Quinaprilat-d5 | 1279034-23-9 | C23H21D5N2O5 | 415.5 | (3S)-2-[(2S)-2-[[(1S)-1-Carboxy-(3-phenyl-d5)propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid; Accuprin-d5; CI-928-d5 |
Quinaprilat | 82768-85-2 | C23H26N2O5 | 410.47 | (3S)-2-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid; Accuprin; CI-928; USP Quinapril Related Compound B; Quinapril EP Impurity C; |
Quinapril N-Oxide | 82586-55-8 | C25H31ClN2O5 | 474.98 | (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid Hydrochloride; CI-906; PD-109452-2; Accupril; Accuprin; Accupro; Korec; Korectic; |
Quinapril Impurity G HCl | 103775-06-0 | C25H30N2O5. HCl | 474.99 | |
Quinapril Impurity D | 103733-49-9 | C25H28N2O4 | 420.50 | (aS,3S,11aS)-1,3,4,6,11,11a-Hexahydro-3-methyl-1,4-dioxo-a-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetic Acid;2H-Pyrazino(1,2-B)isoquinoline-2-acetic acid, 1,3,4,6,11,11A-hexahydro-3-methyl-1,4-dioxo-alpha-(2-phenylethyl)-, ethyl ester, (3S-(2(R |
S-Doxazosin | 104874-86-4 | C23H25N5O5 | 451.48 | (S)-1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]-piperazine; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]carbonyl]piperazine |
SDMA | 30344-00-4 | C8H18N4O2 | 202.25 | (2S)-2-amino-5-[(N,N'-dimethylcarbamimidoyl)amino]pentanoic acid; guanidino-N(1),N(2)-dimethylarginine; N(G1),N(G2)-dimethylarginine; N,N'-dimethylarginine; NG,N'G-dimethyl-L-arginine; omega-N(G),N'(G)-dimethylarginine; sDMA arginine; symmetric dimethylar |
SDM25N hydrochloride | 342884-71-3 | C26H26N2O3·HCl | 450.96 | SDM25N HCl; (4bS,8R,8aS,14bR)-5,6,7,8,14,14b-Hexahydro-7-(2-methyl-2-propenyl)-4,8-methanobenzofuro[2,3-a]pyrido[4,3-b]carbazole-1,8a(9H)-diol hydrochloride |
S-DIPHENYLCARBAZONE | 10329-15-4 | C26H26N8O2 | 482.537 | PHENYLAZOFORMIC ACID 2-PHENYLHYDRAZIDE COMPOUND 1,5-DIPHENYLCARBOHYDRAZIDE; PHENYLAZOFORMIC ACID 2-PHENYLHYDRAZIDE COMPOUND WITH 1,5-DIPHENYLCARBAZIDE; PHENYLAZOFORMIC ACID 2-PHENYLHYDRAZIDE WITH 1,5-DIPHENYLCARBAZIDE; S-DIPHENYLCARBAZONE; S-DIPHENYLCARBA |
S-Desethylpiperidino S-[2-Carboxyl-2-oxo-ethyl-(2-aminoethyl)amino] Vardenafil | 448184-56-3 | C21H26N6O7S | 506.54 | Vardenafil Impurity 4; 2-[[2-[[[3-(1,4-Dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]amino]ethyl]amino]-2-oxoacetic Acid; [[2-[[[3-(1,4-Dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyp |
S-Decyanomethyl-S-(1-methyl-1H-tetrazol-5-yl) Cefmetazole | 74228-11-8 | C15H18N10O5S3 | 514.57 | (6R-cis)-7-Methoxy-7-[[[(1-methyl-1H-tetrazol-5-yl)thio]acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt |
SD-282 | 309915-13-7 | C27H30ClFN4O3 | 513.003 | SD-282; SD282; SD 282; SCIO-282 |
SD-254 | 940297-30-3 | C17H18D9NO2 | 286.261 | Venlafaxine-d9; 1-(2-(Bis(trideuteriomethyl)amino)-1-(4-(trideuteriomethoxy)phenyl)ethyl)cyclohexanol |
SD-208 | 627536-09-8 | C17H10ClFN6 | 352.75 | SD 208; ALK5 Inhibitor V; 2-(5-chloro-2-fluorophenyl)-N-pyridin-4-ylpteridin-4-amine |
SD-169 | 1670-87-7 | C9H8N2O | 160.17 | 1H-Indole-5-carboxamide; Indole-5-carboxamide |
SD-06 | 271576-80-8 | C20H20ClN5O2 | 397.86 | 1-[4-[3-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-5-yl]piperidin-1-yl]-2-hydroxyethanone SD 0006 SD-0006 SD0006 |
SD 2590 hydrochloride | 226395-93-3 | C22H25F3N2O7S.HCl | 554.96 | N-Hydroxy-1-(2-methoxyethyl)-4-[4-[4-(trifluoromethoxy)phenoxy]phenyl]sulfonyl]-4-piperidinecarboxamide hydrochloride |
SD 1029 | 118372-34-2 | C25H30Cl2N2O3·2HBr | 639.3 | JAK2 Inhibitor III; Janus-Associated Kinase 2 Inhibitor III; SD1029; SD-1029; 9-(3,4-dichlorophenyl)-2,7-bis[(dimethylamino)methyl]-3,4,5,6,7,9-hexahydro-2H-xanthene-1,8-dione dihydrobromide |
SD 1008 | 960201-81-4 | C18H19NO5 | 329.35 | (1R,5R,6R,7S)-rel-4-Oxo-8-(phenylmethyl)-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid 6,7-dimethyl ester |
Scytonemin | 152075-98-4 | C36H20N2O4 | 544.566 | |
SCYTALONE | 49598-85-8 | C10H10O4 | 194.18 | 3,4-DIHYDRO-3,6,8-TRIHYDROXY-1(2H)-NAPHTHALENONE; SCYTALONE; (R)-3,4-Dihydro-3,6,8-trihydroxynaphthalene-1(2H)-one |
scyllo-Inosose | 488-64-2 | C6H10O6 | 178.14000 | |
scyllo-Inositol | 488-59-5 | C6H12O6 | 180.16 | |
scyllo-Inosamine hydrochloride | 4933-84-0 | C6H13NO4 HCl | 199.63 | 1-Amino-1-deoxy-scyllo-inositol HCl |
scyllo-Inosamine | 16051-25-5 | C6H13NO5 | 179.17 | 1-Amino-1-deoxy-scyllo-inositol |
SCUTIGERAL | 65195-50-8 | C23H32O4 | 372.5 | SCUTIGERAL; 2,3,4-Trihydroxy-6-methyl-5-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl]benzaldehyde; 1-Formyl-3-hydroxyneogrifolin; 2-Methyl-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-4,5,6-trihydroxybenzaldehyde |
Scutellartln | 529-53-3 | C15H10O6 | 286.24 | 5,6,7,4'-Tetrahydroxyflavone; 4',5,6,7-tetrahydroxyflavone; 5,6,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one; |
Scutellarin methylester | 119262-68-9 | C22H20O12 | Scutellarin methylester; 5,6-Dihydroxy-2-(4-Hydroxyphenyl)-4-Oxo-4H-1-Benzopyran-7-Yl Beta-D-Glucopyranosiduronic Acid Methyl Ester; | |
Scutellarin | 27740-01-8 | C21H18O12 | 462.36 | 5,6-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-4-one-7-b-D-glucuronide |
Scutellaric acid | 102919-76-6 | C30H48O4 | 472.7 | 24-hydroxy-3-epi-oleanolic acid |
Scutellaria Baicalensis Root Extract | 94279-99-9 | |||
Scutebata G | 1207181-63-2 | C40H41NO9 | 679.80 | |
Scutebata F | 1207181-62-1 | C30H37NO9 | 555.6 | |
Scutebata E | 1207181-61-0 | C28H40O9 | 520.6 | (3S,4aR,5S,6R,6aR,10R,10aS,10bR)-5,6-Diacetoxy-4a,6a,7,10b-tetram ethyl-5'-oxo-1,2,4',4a,5,5',6,6a,9,10,10a,10b-dodecahydrospiro[be nzo[f]chromene-3,3'-furan]-10-yl 2-methylpropanoate |
Scutebata C | 1207181-59-6 | C28H35NO9 | 529.6 | (1R,2S,3R,4S,4aS,8aR)-4-[(1S)-1-Acetoxy-2-(4-hydroxy-5-oxo-2,5-di hydro-3-furanyl)ethyl]-2,3-dihydroxy-3,4,8,8a-tetramethyl-1,2,3,4 ,4a,5,6,8a-octahydro-1-naphthalenyl nicotinate |
Scutebata B | 1207181-58-5 | C35H39NO10 | 633.7 | |
Scutebata A | 1207181-57-4 | C36H40O10 | 632.70 | [(1R,2S,3R,4S,4aS,8aR)-4-[(1S)-1-acetyloxy-2-(4-hydroxy-5-oxo-2H-furan-3-yl)ethyl]-2-benzoyloxy-3-hydroxy-3,4,8,8a-tetramethyl-2,4a,5,6-tetrahydro-1H-naphthalen-1-yl] benzoate |
Scutebarbatine Z | 1312716-28-1 | C26H33NO5 | 439.55 | 3-Pyridinecarboxylic acid; (1R,2R,3S,4R,4aR,8aR)-4-[2-(2,5-dihydro-5-oxo-3-furanyl)ethyl]-1,2,3,4,4a,5,6,8a-octahydro-2-hydroxy-3,4,8,8a-tetramethyl-1-naphthalenyl ester; [(1R,2R,3S,4R,4aR,8aR)-2-hydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2H-furan-3-yl)ethy |
Scutebarbatine Y | 1312716-27-0 | C33H35NO7 | 557.64 | |
Scutebarbatine X | 1312716-26-9 | C34H38N2O10 | 634.7 | Scutebarbatine X |
Scutebarbatine W | 1312716-25-8 | C33H37NO8 | 575.6 | Scutebarbatine W |
Scutebarbatine B | 905929-95-5 | C33H35NO7 | 557.6 | |
Scutebarbatine A | 176520-13-1 | C32H34N2O7 | 558.6 | (1R,2S,3R,4R,4aS,8aR)-3-Hydroxy-3,4,8,8a-tetramethyl-4-[(E)-2-(5- oxo-2,5-dihydro-3-furanyl)vinyl]-1,2,3,4,4a,5,6,8a-octahydronapht halene-1,2-diyl dinicotinate |
Sculponeatin O | 1169806-00-1 | C28H40O4 | 440.6 | 13,14-dehydro-latanoprost |
Sculponeatin N | 1169805-98-4 | C25H40O4 | 404.6 | |
Sculponeatin K | 477529-70-7 | C20H26O5 | 346.42 | (1s,1's,4r,6's,7r,8r,9s,9'r,11'r)-11'-hydroxy-4-methyl-10'-methylene-3',6,10-trioxaspiro[tricyclo[5.2.1.04,8]decane-9,5'-tricyclo[7.2.1.01,6]dodecan]-2'-one |
Sculponeatic acid | 1169806-02-3 | C30H46O4 | 470.7 | |
SCS | 3232-36-8 | C14H12N2O3 | 256.26 | Salicylidene salicylhydrazide; Chel 180 |
Scriptaid | 287383-59-9 | C18H18N2O4 | 326.35 | GCK 1026 |
SCR7 pyrazine | 14892-97-8 | C18H12N4OS | 332.38 | 2,3-Dihydro-6,7-diphenyl-2-thioxo-4(1H)-pteridinone; 2-mercapto-6,7-diphenylpteridin-4-ol; 6,7-diphenyl-2-sulfanylpteridin-4-ol |
SCR7 | 1533426-72-0 | C18H14N4OS | 334.39 | |
SCR-1481B1 | 1174161-86-4 | C28H29ClF2N5O10P | 699.98 | SCR-1481B1;c-Met inhibitor 2 |
SCORDININE | 37317-75-2 | |||
Scopoletin b-D-glucuronide | 132752-65-9 | C16H16O10 | 368.29 | 6-Methoxy-2-oxo-2H-1-benzopyran-7-yl b-D-glucopyranosiduronic acid |
Scopoletin acetate | 56795-51-8 | C12H10O5 | 234.2 | 6-Methoxy-2-oxo-2H-chromen-7-yl acetate |
Scopoletin | 92-61-5 | C10H8O4 | 192.2 | 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-; 6-Methoxy-7-hydroxycoumarin; 6-Methylesculetin; 6-O-Methylesculetin; 7-hydroxy-6-methoxy-2h-1-benzopyran-2-on; 7-hydroxy-6-methoxy-coumari; beta-Methylesculetin; Buxuletin |
SCH 336 | 447459-51-0 | C23H25NO8S3 | 539.64 | N-[(1S)-1-[4-[[4-Methoxy-2-[(4-methoxyphenyl)sulfonyl]phenyl]sulfonyl]phenyl]ethyl]methanesulfonamide |
SCH 28080 | 76081-98-6 | C17H15N3O | 277.33 | 2-Methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile; Schering compound 28080 |
SCH 23390 hydrochloride | 125941-87-9 | C17H19Cl2NO | 324.24 | (5R)-8-chloro-3-methyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol;hydrochloride |
SCH 221510 | 322473-89-2 | C28H31NO | 397.55 | 3-Endo-8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol |
SCH 202676 hydrobromide | 265980-25-4 | C15H13N3S.HBr | 348.26 | N-(2,3-Diphenyl-1,2,4-thiadiazol-5(2H)-ylidene)methanamine hydrobromide |
Scarlet 808 | 3789-75-1 | C23H17N3O2 | 367.4 | Bronze Red |
S-Carbonyl-L-cysteine | 4033-46-9 | C6H11NO4S | 193.22084 | S-Carbonyl-L-cysteine; S-Carboxyethyl-L-cysteine |
Scandium, tris(h5-2,4-cyclopentadien-1-yl)- | 1298-54-0 | C15H15 Sc | 240.2355 | TRIS(CYCLOPENTADIENYL)SCANDIUM; tris(eta5-cyclopenta-2,4-dien-1-yl)scandium; TRIS(CYCLOPENTADIENYL)SCANDIUM, 99.9%; TRIS(CYCLOPENTADIENYL)SCANDIUM 98+% (99.9%-SC) (REO); 99.9%-sc)(reo); Tris(cyclopentadienyl)scandium,min.98%(99.9%-Sc)(REO); tris(cyclopent |
Scandium, lump, vacuum remelted | 7440-20-2 | Sc | 44.956 | |
Scandium Oxide | 12060-08-1 | Sc2O3 | 137.91 | oxo(oxoscandiooxy)scandium; Scandia; scandiumsesquioxide; scandiumsesquisulfide; AC1NDYJC; SO3c2 |
Scandium oxalate decahydrate | 24670-07-3 | |||
Scandium nitrate hexahydrate | 13465-60-6 | |||
Scandium acetylacetonate | 14284-94-7 | |||
Scandine Nb-oxide | 140701-69-5 | C21H22N2O4 | 366.417 | |
Scandine | 24314-59-8 | C21H22N2O3 | 350.4 | 3-(Methoxycarbonyl)meloscine |
SCA-HCl-13C,15N2 | 1173020-16-0 | Semicarbazide hydrochloride-13C,15N | ||
Scabioside C | 17233-22-6 | C41H66O13 | ||
Scabertopin | 185213-52-9 | C20H22O6 | 358.39 | Scabertopin |
SC-9 | 102649-78-5 | C22H24ClNO2S | 401.95 | 5-Chloro-N-(6-phenylhexyl)-1-naphthalenesulfonamide |
SC79 | 305834-79-1 | C17H17ClN2O5 | 364.78 | SC-79 |
SC75741 | 913822-46-5 | C29H23N7O2S2 | 565.67 | |
SC66 | 871361-88-5 | C18H16N2O | 276.33 | SC66; SC66; SC 66. |
SC58451 | 168433-84-9 | C20H19FO2S | 342.43 | 5-(4-fluorophenyl)-6-(4-methylsulfonylphenyl)spiro[2.4]hept-5-ene |
SC-58125 | 162054-19-5 | C17H12F4N2O2S | 384.3 | 5-(4-fluorophenyl)-1-[4-(methylsulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazole |
SC57666 | 158959-32-1 | C18H17FO2S | 316.39 | 1-fluoro-4-[2-(4-methylsulfonylphenyl)cyclopenten-1-yl]benzene; SC 57666; SC-57666 |
SC-560 | 188817-13-2 | C17H12CIF3N2O | 352.74 | 5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)pyrazole; 5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole; SC 560; SC-560; SC560 |
SC-514 | 354812-17-2 | C9H8N2OS2 | 224.3 | GK 01140 |
SC-51089 | 146033-02-5 | C22H19ClN4O3.HCl | 422.86 | SC 51089; SC-51089; 8-CHLORODIBENZ[B,F][1,4]OXAZEPINE-10(11H)-CARBOXYLIC ACID 2-[1-OXO-3-(4-PYRIDINYL)PROPYL]HYDRAZIDE HYDROCHLORIDE; AC1L31IC |
SC-44463 | 104408-38-0 | C19H29N3O5 | 379.457 | SC44463; SC 44463. |
SC26304 | 41020-79-5 | C26H36O5 | 428.56 | propan-2-yl (7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-carboxylate; SC 26304; SC-26304 |
SC-236 | 170569-86-5 | C16H11ClF3N3O2S | 401.8 | 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide |
SC-144 hydrochloride | 917497-70-2 | C16H12ClFN6O | 358.76 | 2-(7-Fluoropyrrolo[1,2-a]quinoxalin-4-yl)hydrazide-2-pyrazinecarboxylic acid hydrochloride;SC144 hydrochloride;SC-114 HCl;N'-(7-fluoropyrrolo[1,2-a]quinoxalin-4-yl)pyrazine-2-carbohydrazide;hydrochloride |
SC144 | 895158-95-9 | C16H11FN6O | 322.3 | |
SC 51322 | 146032-79-3 | C22H20ClN3O4S | 457.93 | 8-Chloro-2-[3-[(2-furanylmethyl)thio]-1-oxopropyl]-dibenz(Z)[b,f][1,4]oxazepine-10(11H)-carboxylic acid hydrazide |
SC 26196 | 218136-59-5 | C27H29N5 | 423.55 | SC-26196; 2,2-diphenyl-5-[4-[(E)-pyridin-3-ylmethylideneamino]piperazin-1-yl]pentanenitrile |
SC 19220 | 19395-87-0 | C16H14ClN3O3 | 331.76 | 8-Chloro-dibenzo(Z)[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-acetylhydrazide; N'-acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide |
S-Bicalutamide-d4 | 1217769-79-3 | C18H10F4N2O4SD4 | 434.41 | (2S)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl-d4)sulfonyl]-2-hydroxy-2-methylpropanamide; (S)-Casodex-d4 |
S-Bicalutamide | 113299-38-0 | C18H14F4N2O4S | 430.38 | (2S)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide; (S)-Casodex; Propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-, (2S)-; ICI-187556; BicalutaMide S-IsoM |
SB-674042 | 483313-22-0 | C24H21FN4O2S | 448.51 | [5-(2-Fluorophenyl)-2-methyl-4-thiazolyl][2(S)-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl-1-pyrrolidinyl]methanone; |
SB-649868 | 380899-24-1 | C26H24FN3O3S | 477.55 | N-[[(2S)-1-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]piperidin-2-yl]methyl]-1-benzofuran-4-carboxamide; (14C)SB 649868; (14C)SB-649868; (14C)SB649868; N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofuranc |
SB-590885 | 405554-55-4 | C27H27N5O2 | 453.54 | SB590885; SB 590885 |
SB525334 | 356559-20-1 | C21H21N5 | 343.434 | SB-525334; 6-(2-(tert-Butyl)-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)quinoxaline |
SB-505124 hydrochloride | 356559-13-2 | C20H22ClN3O2 | 371.86 | SB 505124 hydrochloride; SB505124 hydrochloride |
SB505124 | 694433-59-5 | C20H21N3O2 | 335.407 | SB-505124; 2-(4-(benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine |
SB431542 | 301836-41-9 | C22H16N4O3 | 384.39 | |
SB415286 | 264218-23-7 | C16H10ClN3O5 | 359.72 | SB-415286; 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione |
SB-408124 (Hydrochloride) | 1431697-90-3 | C19H19ClF2N4O | 392.84 | 1-(6,8-difluoro-2-methylquinolin-4-yl)-3-[4-(dimethylamino)phenyl]urea;hydrochloride SB-408124 (Hydrochloride) 1431697-90-3 C19H18F2N4O.ClH 3024AH CS-1073 HY-76612 W-5807 1-(6,8-Difluoro-2-methylquinolin-4-yl)-3-(4-(dimethylamino)phenyl)urea hydro |
SB408124 | 288150-92-5 | C19H18F2N4O | 356.37 | SB-408124 |
SB-3CT | 292605-14-2 | C15H14O3S2 | 306.394 | MMP-2/MMP-9 Inhibitor IV; 2-((4-phenoxyphenylsulfonyl)methyl)thiirane; SB3CT; IN1250 |
SB-366791 | 472981-92-3 | C16H14ClNO2 | 287.74 | N-(4-Methoxyphenyl)-4-chlorocinnamamide; 3-(4-Chlorophenyl)-N-(3-methoxyphenyl)-2-propenamide; |
SB-334867 | 249889-64-3 | C17H13N5O2 | 319.32 | 1-(2-methyl-1,3-benzoxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea 1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea 1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea hydrochloride SB 334867-A SB 334867A SB-334867 SB-334867-A SB-334867A |
SB334867 | 792173-99-0 | C17H13N5O2 | 319.324 | SB334867A free base; SB334867 free base; SB 334867 free base |
SB-332235 | 276702-15-9 | C13H10Cl3N3O4S | 410.66 | 6-chloro-3-(3-(2,3-dichlorophenyl)ureido)-2-hydroxybenzenesulfonamide; SB-332235; SB 332235; SB332235. |
SB290157 trifluoroacetate | 1140525-25-2 | C24H29F3N4O6 | 526.51 | 5-(diaminomethylideneamino)-2-[[2-(2,2-diphenylethoxy)acetyl]amino]pentanoic acid;2,2,2-trifluoroacetic acid; IN1105 |
Sb-277011 | 215803-78-4 | C28H30N4O | 438.56 | N-[4-[2-(6-cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]cyclohexyl]quinoline-4-carboxamide SB 277011 SB 277011-A SB-277011 SB-277011-A trans-N-(4-(2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)cyclohexyl)-4-quinolinecarboxamide |
SB273005 | 205678-31-5 | C22H24F3N3O4 | 451.44 | |
SB271046 | 209481-20-9 | C20H22ClN3O3S2 | 451.99 | |
SB-269970 hydrochloride | 261901-57-9 | C18H28N2O3S.HCl | 388.95 | SB-269970 hydrochloride |
SB-269970 | 201038-74-6 | C18H28N2O3S | 352.49 | 3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol 3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol SB 269970 SB-269970 |
SB269652 | 215802-15-6 | C27H30N4O | 426.55 | N-[4-[2-(7-cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]cyclohexyl]-1H-indole-2-carboxamide 1H-indole-2-carboxylic acid (4-(2-(cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl)cyclohexyl)amide SB 269,652 SB-269,652 SB269,652 |
SB-242235 | 193746-75-7 | C18H17N5O3 | 353.401 | SB-242235; SB242235 |
SB-242084 HCl salt | 1049747-87-6 | C21H21Cl3N4O2 | 467.78 | SB-242084; SB 242084; SB242084; SB-242084 HCl |
SB239063 | 193551-21-2 | C20H21FN4O2 | 368.412 | SB-239063; SB 239063. |
SB225002 | 182498-32-4 | C13H10BrN3O4 | 352.14 | N-(2-hydroxy-4-nitrophenyl)-N'-(2-bromophenyl)urea; SB 225002; SB-225002 |
SB-218078 | 135897-06-2 | C24H15N3O3 | 393.402 | SB218078. |
SB-216763 | 280744-09-4 | C19H12Cl2N2O2 | 371.217 | SB-216763; 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione |
SB-209670 | 157659-79-5 | C29H28O9 | 520.53 | SCHEMBL4197810; L001486; (1S,2R,3S)-1-(1,3-benzodioxol-5-yl)-3-[2-(carboxymethoxy)-4-methoxyphenyl]-5-propoxy-2,3-dihydro-1H-indene-2-carboxylic acid; SB 209670; SB209670 |
SB-206553 hydrochloride hydrate | 158942-04-2 | C17H16N4O | 328.80 (anhydrous basis) | 5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole hydrochloride hydrate, N-3-Pyridinyl-3,5-dihydro-5-methylbenzo(1,2-b:4,5-b)dipyrrole-1(2H)carboxami |
SB-203580 | 152121-47-6 | C21H16FN3OS | 377.437 | 4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine |
SB202190 | 152121-30-7 | C20H14FN3O | 331.34 | SB-202190; FHPI; 4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]phenol |
Satraplatin | 129580-63-8 | C10H24Cl2N2O4Pt | 500.28 | BMS-182751; JM 216. |
Sativan | 71831-00-0 | C17H18O4 | 286.32 | 3-(2,4-Dimethoxyphenyl)-3,4-dihydro-2H-1-benzopyran-7-ol |
Saterinone | 102669-89-6 | C27H30N4O4 | 0 | Saterinone; 1,2-Dihydro-5-[4-[2-hydroxy-3-[4-(2-methoxyphenyl)piperidino]propoxy]phenyl]-6-methyl-2-oxo-3-pyridinecarbonitrile; BDF-8634 |
S-Atenolol-D7 (Iso-propyl-d7) | 1309283-20-2 | C14H15D7N2O3 | 273.38 | 4-[(2S)-2-Hydroxy-3-[(1-methylethyl-d7)amino]propoxy]benzeneacetamide; Esatenolol-d7; S-(-)-Atenolol-d7 |
Sassafras Oil | 8006-80-2 | 162.13 | SASSAFRAS OIL; SASSAFRAS OIL, IMITATION; oilofcamphorsassafrassy; oilofsassafras; Oils,sassafras; Sasafras oil; Perfume oil; SASSAFRAS OFFICINALE ROOT OIL | |
Sartorypyrone A | 1452396-10-9 | C28H40O5 | 456.6 | 20-O-Acetyl Sartorypyrone D; [(1S,3R)-3-[(3E,7E)-9-(4-hydroxy-6-methyl-2-oxopyran-3-yl)-3,7-dimethylnona-3,7-dienyl]-2,2-dimethyl-4-methylidenecyclohexyl] acetate |
sarsasapogenin | 126-19-2 | C27H44O3 | 416.64 | 5-BETA, 20-ALPHA, 22-BETA, 25L-SPIROSTAN-3-BETA-OL; [25S]-SPIROSTAN-3BETA-OL; (25s)-spirostan-3b-ol; 25S,5ALPHA-SPIROSTAN-3BETA-OL; (25S)-5BETA-SPIROSTAN-3BETA-OL; SASARASAPOGENIN; SARSAPOGENIN; SARSAPOGENINE |
Sarsasapogenin | 82597-74-8 | C27H44O3 | Sarsaponin | |
Sarolaner | 1398609-39-6 | C23H18Cl2F4N2O5S | 581.37 | PF-6450567; (S)-1-(5'-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'H-spiro[azetidine-3,1'-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethan-1-one |
Saroglitazar (Magnesium) | 1639792-20-3 | C50H56MgN2O8S2 | 901.43 | |
Saponin | 8047-15-2 | CCI-187881; CCI 187881; CCI187881 | ||
Saponarin | 20310-89-8 | C27H30O15 | 594.522 | Saponaretin-7-O-glucoside; Isovitexin-7-O-glucoside; Isovitexin-7-O-beta-D-glucopyranoside; 5-hydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-7-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyc |
Sapacitabine | 151823-14-2 | C26H42N4O5 | 490.645 | CS682; CYC682; CYC-682; Sapacitabine |
Santicizer 711 | 39393-37-8 | |||
SANTALYL ACETATE | 1323-00-8 | C34H52O4 | 524.79 | santalyl; FEMA 3007; 2-PENTEN-1-OL, 5-(2,3-DIMETHYL TRICYCLO [2.2.1.0(2,6)] HEPT-3-YL)-2-METHYL:ACETATE; SANTALOL ACETATE; SANTALYL ACETATE; SANTALYL ACETATE FCC; SANTALYLACETATE(ALPHAANDBETA); Santalylacetat |
Santalol | 11031-45-1 | C15H24O | 220.35 | 2-PENTEN-1-OL, 5-(2,3-DIMETHYL TRICYCLO [2.2.1.0(2,6)] HEPT-3-YL)-2-METHYL; A AND B-SANTALOL; FEMA 3006; SANTALOL ALPHA- AND BETA- FCC; D-ALPHA-SANTALOL; CIS-ALPHA-SANTALOL; 2-Methyl-5-((1S,2S,4R)-2-Methyl-3-Methylenebicyclo[2.2.1]heptan-2-yl)pent-2-en-1- |
SANT-2 | 329196-48-7 | C26H26ClN3O4 | 479.96 | N-[3-(1H-Benzimidazol-2-yl)-4-chlorophenyl]-3,4,5-triethoxybenzamide |
SANT-1 | 304909-07-7 | C23H27N5 | 373.49 | Shh Signaling Antagonist V; (E)-N-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenylpyrazol-4-yl)methanimine |
Sanshool | 504-97-2 | C16H25 N O | 247.3758 | |
Sanshodiol | 54854-91-0 | C20H22O6 | 358.39 | Tetrahydro-4-(1,3-benzodioxol-5-ylmethyl)-2-(4-hydroxy-3-methoxyphenyl)-3-furanmethanol;4-(1,3-Benzodioxol-5-ylmethyl)tetrahydro-2-(4-hydroxy-3-methoxyphenyl)-3-furanmethanol |
Sansalvamide A | 227084-43-7 | C32H50N4O6 | 586.76 | |
Sanguisorbigenin | 6812-98-2 | C30H46O3 | 454.68 | 19-Dehydroursolic acid |
SANGUINARINE NITRATE | 4752-86-7 | C20H14N2O7 | 394.33 | PSEUDOCHELERYTHRINE NITRATE; SANGUINARINE NITRATE; SANGUINARIN NITRATE; SANGUINARINE NITRATE(RG) |
Sanguinarine citrate | 132210-34-5 | C21H20O9 | 416.37 | |
Sanguinarine chloride hydrate | 5578-73-4 | C20H14ClNO4 | 367.78 | 13-Methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium Chloride; |
Sanguinarine | 2447-54-3 | C20H14NO4+ | 332.33 | Pseudochelerythrine; Sanguinarin |
Sanguinaria canadensis, ext. | 84929-48-6 | |||
Sanggenone H | 86450-80-8 | C20H18O6 | 354.358 | (2S)-5,7-dihydroxy-2-(5-hydroxy-2,2-dimethylchromen-8-yl)-2,3-dihydrochromen-4-one |
Sanggenone C | 80651-76-9 | C40H36O12 | 2-[(1S,5S,6R)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-1,3,8,10a-tetrahydroxy-5a-(3-methylbut-2-en-1-yl)-5a,10a-dihydro-11H-[1]benzofuro[3,2-b]chromen-11-one | |
Sanggenon N | 92280-12-1 | C25H26O6 | 422.5 | (-)-5,5',7-Trihydroxy-2'-methyl-2'-(4-methyl-3-pentenyl)-2,6'-bi[2H-1-benzopyran]-4(3H)-one |
Sanggenol P | 1351931-30-0 | C30H36O6 | 492.6 | Cathayanon J |
Sanggenol L | 329319-20-2 | C25H26O6 | 422.477 | 5,2'.4'-Trihydroxy-6''-methyl-6''-(4-methylpent-3-enyl)-pyrano[2'',3'':7,8]flavanone; 2-(2,4-dihydroxyphenyl)-5-hydroxy-8-methyl-8-(4-methylpent-3-enyl)-2,3-dihydropyrano[2,3-h]chromen-4-one |
Sanggenol A | 174423-30-4 | C25H28O6 | 424.5 | 5,7,2',4'-Tetrahydroxy-3'-geranylflavanone |
Sanggenofuran B | 1017277-40-5 | C20H20O4 | 324.37 | 5-(6-methoxy-1-benzofuran-2-yl)-2-(3-methylbut-2-enyl)benzene-1,3-diol |
Sandramycin | 100940-65-6 | C60H76N12O16 | 1221.3 | |
Sandenol | 3407-42-9 | C16H28O | 236.39 | 3-(5,5,6-Trimethyl-2-norbornyl)cyclohexanol; 3-(5,5,6-trimethylbicyclo[2.2.1]hept-2-yl)-cyclohexano; 3-(5,5,6-trimethylbicyclo[2.2.1]hept-2-yl)-Cyclohexanol; SANDENOL; 3-[5,5,6-TRIMETHYLBICYCLO[2.2.1]HEPT-2-YL]CYCLOHEXAN-1-OL; INDISAN |
Sancycline hydrochloride | 6625-20-3 | C21H23ClN2O7 | 450.9 | 6-Demethyl-6-deoxytetracycline hydrochloride, NSC 51812 |
SAMS | 125911-68-4 | C74H131N29O18S2 | 1779.15 | H-His-Met-Arg-Ser-Ala-Met-Ser-Gly-Leu-His-Leu-Val-Lys-Arg-Arg-OH; L-histidyl-L-methionyl-L-arginyl-L-seryl-L-alanyl-L-methionyl-L-seryl-glycyl-L-leucyl-L-histidyl-L-leucyl-L-valyl-L-lysyl-L-arginyl-L-arginine; (2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[( |
Sampsone B | 1309125-17-4 | C16H18O7 | 322.315 | |
S-Amlodipine benzenesulfonate | 150566-71-5 | C20H25ClN2O5.C6H6O3S | 567.05 | Levamlodipine Besylate; benzenesulfonic acid 3-O-ethyl 5-O-methyl (4S)-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
S-Amlodipine | 103129-82-4 | C20H25N2O5Cl | 408.88 | (s)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
Samidin | 477-33-8 | C21H22O7 | 386.395 | 3-Methyl-2-butenoic acid (9R,10R)-10-acetoxy-9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b']dipyran-9-yl ester |
Sambutoxin | 160047-56-3 | C28H39NO4 | 453.6 | 3-[(2S,5R,6R)-6-[(E,4R,6S)-4,6-dimethyloct-2-en-2-yl]-5-methyloxan-2-yl]-4-hydroxy-5-(4-hydroxyphenyl)-1-methylpyridin-2-one |
Elderberry Extract | 84603-58-7 | |||
Samarium oxide | 12060-58-1 | Sm2O3 | 348.72 | oxo(oxosamariooxy)samarium; 12060-58-1; SO3m2; AC1N77AL; 228672_ALDRICH; 392537_ALDRICH |
Samarium diiodide | 32248-43-4 | SmI2 | 404.17 | SAMARIUM(II) IODIDE; SAMARIUM IODIDE; SAMARIUM(II) IODIDE SOLUTION, STAB., ~0. 1 M IN THF; SAMARIUM(II) IODIDE, 0.1M SOLUTION IN TE TRAHYDROFURAN; SAMARIUM(II) IODIDE, POWDER, 99.9+%; SAMARIUM (II) IODIDE 0.1M IN THF |
Samarium chloride(SmCl3) | 10361-82-7 | Cl3Sm | 256.70 | SAMARIUMCHLORIDE; Samariumchloride(SmCl3); Samariumtrichloride; EINECS233-797-0; Samarium(III)chloridehexahydrate; NSC84277 |
SAMARIUM BORIDE, 99.9% | 12008-30-9 | B6Sm | 215.22 | |
Samarium acetate, hydrate | 17829-86-6 | |||
Salvisyrianone | 250691-57-7 | C20H24O3 | 312.4 | 3-Oxosaprorthoquinone |
Salvigenin | 19103-54-9 | C18H16O6 | 328.3 | 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)chromen-4-one |
Salviaplebeiaside | 1236273-88-3 | C23H26O10 | 462.45 | [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[2-hydroxy-4-(3-oxobutyl)phenoxy]oxan-2-yl]methyl 4-hydroxybenzoate |
Salvianolicacid D | 142998-47-8 | C20H18O10 | (alphaR)-alpha-[[(2E)-3-[2-(Carboxymethyl)-3,4-dihydroxyphenyl]-1-oxo-2-propen-1-yl]oxy]-3,4-dihydroxybenzenepropanoic acid; Benzenepropanoic acid, a-[[(2E)-3-[2-(carboxymethyl)-3,4-dihydroxyphenyl]-1-oxo-2-propen-1-yl]oxy]-3,4-dihydroxy-,(aR)- | |
Salvianolicacid C | 115841-09-3 | C26H20O10 | (alphaR)-alpha-[[(2E)-3-[2-(3,4-Dihydroxyphenyl)-7-hydroxy-4-benzofuranyl]-1-oxo-2-propen-1-yl]oxy]-3,4-dihydroxybenzenepropanoic acid | |
Salvianolicacid B | 115939-25-8 | C36H30O16 | [2R-[2a,3b-(R*),4[E(R*)]]]-3-Benzofurancarboxylic acid 4-[3-[1-carboxy-2-(3,4-dihydroxy-phenyl) ethoxy]-3-oxo-1-propenyl]-2-(3,4-dihydrophenyl)-2,3-dihydro-7-hydroxyl-3-[1-carboxy-2-(3,4-dihydroxyphenyl) ethyl] ester | |
Salvianolic acid F | 158732-59-3 | C17H14O6 | 314.293 | (E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl]prop-2-enoic acid |
Salvianolic acid B | 121521-90-2 | C36H30O16 | 718.62 | [2R-[2a,3b-(R*),4[E(R*)]]]-3-Benzofurancarboxylic acid 4-[3-[1-carboxy-2-(3,4-dihydroxy-phenyl) ethoxy]-3-oxo-1-propenyl]-2-(3,4-dihydrophenyl)-2,3-dihydro-7-hydroxyl-3-[1-carboxy-2-(3,4-dihydroxyphenyl) ethyl] ester |
Salviaflaside | 178895-25-5 | C24H26O13 | 522.45 | Rosmarinic acid 3'-glucoside |
Salverine | 6376-26-7 | C19H24N2O2 | 312.40606 | |
Salubrinal | 405060-95-9 | C21H17Cl3N4OS | 479.81 | |
Salsolinol-1-carboxylic acid | 57256-34-5 | C11H13NO4 | 223.23 | 1-Carboxysalsolinol; Sal-1-CA; 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid |
SALOR-INT L368741-1EA | 618426-72-5 | C21H25N5OS | 395.521 | |
SALOR-INT L252786-1EA | 324069-34-3 | C15H17Cl3N2O | 347.67 | SALOR-INT L252786-1EA; 3-PHENYL-N-(2,2,2-TRICHLORO-1-(1-PYRROLIDINYL)ETHYL)ACRYLAMIDE |
SALNACEDIN | 87573-01-1 | C12H13NO5S | 283.303 | |
Salmeterol-D3 | 497063-94-2 | C25H34D3NO4 | 418.58 | 4-Hydroxy- - alpha;1[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol-d3; GR-33343X-d3; |
Salmeterol Xinafoate | 94749-08-3 | C36H45NO7 | 603.75 | GR-33343G |
Salmeterol Impurity H (Xinafoate Adduct Impurity) | 1330076-52-2 | C36H43NO6 | 585.75 | 1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid |
Salmeterol Impurity G | 1391051-88-9 | C50H72N2O7 | 813.14 | 1-[4-Hydroxy-3-[[[2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl][6-(4-phenylbutoxy)hexyl]amino]methyl]phenyl]2-[[6-(4-phenylbutoxy)hexyl]amino]ethanol |
Salmeterol Impurity D | 1391052-04-2 | C34H47NO7 | 581.76 | 1-[4-[2-Hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethoxy]-3-(hydroxymethyl)phenyl]-2-[[6-(3-phenylbutoxy)hexyl]amino]ethanol; Salmeterol EP Impurity D; |
Salmeterol Impurity A | 1798014-51-3 | C19H25NO3 | 315.42 | 1-(RS)-1-[4-Hydroxy-3-(Hydroxymethylphenyl]-2-[(4-phenylbutyl)aminoethanol (Salmeterol EP Impurity A) |
Salmefamol | 18910-65-1 | C19H25NO4 | 331.41 | 4-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]-2-(hydroxymethyl)phenol; 1-(4-hydroxy-3-(hydroxymethyl)phenyl)-2-(4-methoxy-alpha-methylphenethylamino)ethanol; AH 3923; AH-3923; salmefamol; salmefamol, sulfate salt |
S-ALLYL-L-CYSTEINE HCL | 60114-85-4 | |||
S-Allyl-D-cysteine | 770742-93-3 | C6H11NO2S | 161.22204 | S-Allyl-D-cysteine |
S-Allyl-d5-L-cysteine | 1217444-21-7 | D2C=CDCD2SCH2CH(NH2)CO2H | 166.25 | (2R)-2-amino-3-(1,1,2,3,3-pentadeuterioprop-2-enylsulfanyl)propanoic acid |
SALITHION | 3811-49-2 | C8H9O3PS | 216.19 | DIOXABENZOFOS; FENPHOSPHORIN; Salibal emulsion; Salibal powder; Salibassa emulsion; Salibassa powder |
Salirasib | 162520-00-5 | C22H30O2S | 358.54 | |
Salinomycin sodium | 55721-31-8 | C42H69NaO11 | 772.99 | Salinomycin sodium salt; Sodium salinomycin; (2R)-2-[(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-me |
Salinomycin | 53003-10-4 | C42H70O11 | 751.01 | Coxistac; Procoxacin; (2R)-2-[(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5 |
Salifungin | 3679-64-9 | C13H9BrClNO2 | 326.57 | Multifungin; Bromosalicylchloranilide; 5-Bromo-4'-chlorosalicylanilide; 5-Bromo-N-(4-chlorophenyl)-2-hydroxybenzamide |
Salidroside | 10338-51-9 | C14H20O7 | 300.30 | Rhodioloside; 2-(4-Hydroxyphenyl)ethyl-b-D-glucopyranoside; Tyrosol glucoside |
salicyloyl chloride | 1441-87-8 | C7H5ClO2 | 156.568 | salicyloyl chloride; 2-Hydroxy-Benzoyl Chloride; Benzoyl chloride, 2-hydroxy- (9CI) |
Salicylic Acid-d4 | 78646-17-0 | C7H2D4O3 | 142.15 | 2-Hydroxybenzoic Acid-d4; 2-Carboxyphenol-d4; 2-Hydroxybenzenecarboxylic Acid-d4; 2-Hydroxybenzoic Acid-d4; o-Carboxyphenol-d4; o-Hydroxybenzoic Acid-d4; Rutranex-d4; Saligel-d4; Salonil-d4; Salvona Nanosal-d4; Stri-Dex-d4; Trans-Ver-Sal-d4; Verrugon-d4; |
Salicylic acid-acyl-b-D-glucuronide | 29315-53-5 | C13H14O9 | 314.24 | |
Salbutamol Impurity N (Albuterol Dimer) | 149222-15-1 | C26H40N2O5 | 460.62 | Albuterol Dimer |
Salbutamol Impurity K | 898542-80-8 | C13H18ClNO3 | 271.75 | 2-(tert-butylamino)-1-(3-chloro-4-hydroxy-5-(hydroxymethyl)phenyl)ethanone. #sthash.IAoj5Vs7.dpuf |
Salbutamol Impurity J | 156547-62-5 | C13H19NO3 | 237.3 | 2-[(1,1-Dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone, |
Salbutamol Impurity H | 132183-64-3 | C13H21NO | 207.32 | 4-[2-[(1,1-Dimethylethyl)amino]ethyl]-2-methylphenol;4-tert-Butylaminoethyl-2-methylphenol;Albuterol impurity H - See more at: https://www.clearsynth.com/en/CST09400.html#sthash.zvmzioIv.dpuf |
Salbutamol Impurity D | 156339-88-7 | 286.33 | 5-[2-[(1,1-Dimethylethyl)amino]-1-hydroxyethyl]-2-hydroxybenzaldehyde Hemisulfate; USP Levalbuterol Related Compound D | |
Retapamulin | 224452-66-8 | C30H47NO4S | 517.76 | [(3-exo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl]thio]acetic Acid; [(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl Ester; Altabax; Altargo; Mutilin ; 14-(exo-8-Methyl-8-azabicyc |
RET Kinase Inhibitor 1 | 1627856-64-7 | C22H21F4N3O4 | 467.4 | GSK3179106; 2-[4-(4-ethoxy-6-oxo-1H-pyridin-3-yl)-2-fluorophenyl]-N-[5-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-3-yl]acetamide |
RET Inhibitor 2667 | 1980023-80-0 | C26H25FN10O | 512.54 | 3-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine |
Resveratrol-3-O-sulfate sodium salt | 858127-11-4 | C14H11O6S·Na | 330.3 | Sodium 3-hydroxy-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenyl sulfate |
Resveratrol-13C6 | 1185247-70-4 | C1813C6H12O3 | 234.18 | 5-[(1E)-2-(4-Hydroxyphenyl-13C6)ethenyl]-1,3-benzenediol; trans-Resveratrol-13C6; (E)-5-(p-Hydroxystyryl)resorcinol-13C6; (E)-Resveratrol-13C6; trans-3,4',5-Trihydroxystilbene-13C6 |
Resveratrol Impurity E | 89946-06-5 | C35H30O3 | 498.63 | 1,3-Bis(phenylmethoxy)-5-[(1E)-2-[4-(phenylmethoxy)phenyl]ethenyl]-benzene; (E)-1,3-Bis(phenylmethoxy)-5-[2-[4-(phenylmethoxy)phenyl]ethenyl]-benzene; (E)-1-[4-(Benzyloxy)phenyl]-2-[3,5-bis(benzyloxy)phenyl]ethene; (E)-(((5-(4-(Benzyloxy)styryl)-1,3-pheny |
Resveratrol Impurity D | 637776-91-1 | C21H18O3 | 318.38 | 5-[(1E)-2-[4-(Phenylmethoxy)phenyl]ethenyl]-1,3-benzenediol; (E)-5-(4-(Benzyloxy)styryl)benzene-1,3-diol; Resveratrol Impurity D |
Resibufogenin | 465-39-4 | C24H32O4 | 384.5 | bufogenin; (3beta,5beta,8xi,9xi,15beta)-3-hydroxy-14,15-epoxybufa-20,22-dienolide; 3-hydroxy-14,15-epoxybufa-20,22-dienolide; (3beta,5beta,15beta)-3-hydroxy-14,15-epoxybufa-20,22-dienolide |
Resibufagin | 20987-24-0 | C24H30O5 | 398.49 | |
Reactive orange 107 | 90597-79-8 | |||
Quetiapine Impurity I (Quetiapine Hydroxy Impurity) | 329216-67-3 | C19H21N3OS | 339.46 | |
Quetiapine Impurity H (Quetiapine-N-Oxide) | 1076199-40-0 | C21H25N3O3S | 399.52 | 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol N-Oxide; Quetiapine EP Impurity H |
Quetiapine Impurity F (Quetiapine Impurity 2) | 848814-27-7 | C21H27N3O3S | 401.53 | 1-[2-[(2-Aminophenyl)thio]benzoyl]-4-[2-(2-hydroxyethoxy)ethyl]-piperazine; [2-[(2-Aminophenyl)thio]phenyl][4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-methanone; 2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol |
Quetiapine Impurity F (11-Chlorodibenzo[b,f][1,4]thiazepine) | 13745-86-3 | C13H8ClNS | 245.73 | |
Quetiapine Impurity E | 1371638-05-9 | C40H44N6O2S2 | 704.96 | 1,2-Bis[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethane |
Quetiapine Impurity D (Quetiapine Dimer Impurity) | 945668-94-0 | C30H24N4S2 | 504.68 | 11,11'-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine; Quetiapine EP Impurity D |
Quetiapine Impurity C | 1798840-31-9 | C40H42N6O3S2 | 718.95 | 2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethyl 2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)acetate;Di(2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl))-2-propoxyethyl Propionate |
Quetiapine Impurity B | 844639-07-2 | C23H27N3O3S | 425.55 | 11-[4-[2-(2-Acetoxyethoxy)ethyl]piperazin-1-yl]dibenzo[b,f][a,4]thiazepine; 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol Acetate; Quetiapine Impurity B; Quetiapine USP-B; |
Quetiapine Impurity 3 | 1011758-06-7 | C23H29N3O2S | 411.57 | |
Pyrrolidine,3-phenoxy-, (3S)- | 931581-76-9 | C10H13 N O | 163.21600 | |
Polygalacic acid | 22338-71-2 | C30H48O6 | 504.708 | (4aR,5R,6aR,6aS,6bR,9R,10R,11S,12aR,14bR)-5,10,11-trihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
Polyethylhydrosiloxane | 24979-95-1 | (C2H6 O Si)n | 0 | POLYETHYLHYDROSILOXANE; POLYETHYLHYDROSILOXANE, TRIETHYLSILOXY TERMINATED; Polyethylhydrosiloxane, viscosity 75-125 cSt.; poly(ethylsiloxane); POLYETHYLHYDROSILOXANE, TRIETHYLSILOXY TERMINATED: VISCOSITY 75-125 CST.; VISCOSITY 75-125 CST.; POLYETHYLHYDROS |
Polyethylenimine, ethylenediamine branched | 25987-06-8 | (C2H8N2.C2H5N)x | 103.16600 | PEI |
Polyethylenglykoldiallylether | 59788-01-1 | |||
Polyethyleneimine, 50% aqueous solution | 26913-06-4 | (C2H8H2)n | 189.30172;g/mol | TETRAETHYLENEPENTAMINE; 112-57-2; Tetren; 1,4,7,10,13-Pentaazatridecane; Tetraethylenepentamine; 1,11-Diamino-3,6,9-triazaundecane |
POLYETHYLENEIMINE | 68307-89-1 | [-CH2CH2NH-]n | 20000 | EPOMINS(R); ETHYLENE IMINE POLYMER; ETHYLENEIMINE RESIN; POLYETHYLENEIMINE ON SILICA BEADS; POLYETHYLENEIMINE, EPICHLOROHYDRIN MODIFIED; POLYETHYLENIMINE P-70; POLYETHYLENIMINE, BRANCHED; POLYETHYLENIMINE, EPICHLOROHYDRIN MODIFIED |
POLYETHYLENEIMINE | 26658-46-8 | N/A | 50000 | Aziridine,polymerwithoxirane; Ethoxylatedpolyethyleneimine; Ethoxylatedpolyethylenepolyamine; PEI; POLYMIN P; POLYETHYLENIMINE P-70; POLYETHYLENIMINE, ETHOXYLATED; POLYETHYLENIMINE, BRANCHED |
Polyethyleneglycol nonylphenyl ether ammonium sulfate | 9051-57-4 | (C2H4 O)n C15 H24 O4 S . H3 N | 917.2866 | PEGnonylphenyletherammoniumsulfate; poly(Ethyleneglycol)nonylphenyletherammoniumsulfate; Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-(nonylphenoxy)-, ammonium salt; AMMONIUM ALPHA-SULFO-OMEGA-(NONYLPHENOXY) POLY(OXY-1,2-ETHANEDIYL); ammonium nonoxynol |
Polyethyleneglycol cetyl/oleyl ether | 68920-66-1 | C20H40O | 0 | Rs-300PolyoxyethyleneOleylCetylEtherSulfosuccinate; Polyethyleneglycolcetyl/oleylether; Alcohols, C16-18 and C18-unsatd., ethoxylated; Fettalkohole, C16-18 und C18 ungesttigt, ethoxyliert (2-EO); ETHOXYLATED OLEYL CETYL ALCOHOL; Polyethyleneglycol alkyl-( |
Polyethyleneglycol Bisphenol A Epichlorohydrin Copolymer | 42617-82-3 | |||
Salbutamol acetate | 1420043-41-9 | C15H25NO5 | 299.36 | 2-(tert-Butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol acetate; Albuterol acetate |
Salazosulfathiazole | 515-58-2 | C16H12N4O5S2 | 404.42028;g/mol | Salazosulfathiazole;UNII-56PE10F2EA;CHEMBL1270562;NSC-114428;515-58-2;Salazosulfathiazole[INN:DCF] |
Salazosulfamide | 139-56-0 | C13H11N3O5S | 321.30854;g/mol | Salazosulfamide;UNII-B6831ORH7W;139-56-0;Salazosulfamida;Lutazol;Oftazol |
Salaspermic acid | 71247-78-4 | C30H48O4 | 472.7 | 5H-3,5a-Methanochryseno[2,1-c]oxepin-12-carboxylic acid, eicosahydro-3-hydroxy-7b,9a,12,13b,15a,16-hexamethyl-, (3S,5aR,7aS,7bR,9aS,12R,13aR,13bS,15aR,15bS,16R)- (1R,4S,5R,8S,11R,13R,14S,17R,18S,21S,24R)-21-Hydroxy-5,8,11,14,17,24-hexamethyl-22-oxahexacy |
Salantel | 36093-47-7 | C20H11Cl2I2NO3 | 638.017 | Salantel; N-[3-Chloro-4-(4-chlorobenzoyl)phenyl]-2-hydroxy-3,5-diiodobenzamide; R-23050 |
SALANNIN(P) | 992-20-1 | C34H44O9 | 596.71 | |
Salannal | 86160-86-3 | C34H44O10 | ||
Salacinol | 200399-47-9 | C9H18O9S2 | 334.37 | 1,4-Dideoxy-1,4-[(S)-[(2S,3S)-2,4-dihydroxy-3-(sulfooxy)butyl]episulfoniumylidene]-D-arabinitol inner salt; (1S,2R,3S,4S)-1-[(2S,3S)-2,4-Dihydroxy-3-(sulfooxy)butyl]tetrahydro-3,4-dihydroxy-2-(hydroxymethyl)thiophenium inner salt |
Sal003 | 1164470-53-4 | C18H15Cl4N3OS | 463.21 | N/A |
Sakuranin | 529-39-5 | C22H24O10 | 448.42 | SAKURANIN;529-39-5;NSC407308;CHEBI:81054;(s)-5-(|A-d-glucopyranosyloxy)-2,3-dihydro-2-(4-hydroxyphenyl)-7-methoxy-4h-1-benzopyran-4-one;NSC407308 |
Sakuranetin | 2957-21-3 | C16H14O5 | 286.3 | |
SAK 3 | 1256269-87-0 | C20H23N3O4 | 369.41 | SAK-3; SAK3; Ethyl 8'-methyl-2',4-dioxo-2-(piperidin-1-yl)-2'H-spiro[cyclopent[2]ene-1,3'-imidazo[1,2-a]pyridine]-3-carboxylate |
Saikosaponin H | 91990-63-5 | C48H78O17 | 927.12 | |
Saikosaponin F | 62687-63-2 | C48H80O17 | ||
Saikosaponin E | 64340-44-9 | C42H68O12 | 764.99 | |
Saikosaponin D | 20874-52-6 | C42H68O13 | 780.98 | (3b,4a,16a)-13,28-Epoxy-16,23-dihydroxyoleana-11-en-3-y16-deoxy-3-O-b-D-glucopyranosyl-b-D-fucoside |
Saikosaponin B4 | 58558-09-1 | C43H72O14 | 813.02 | |
Saikosaponin B3 | 58316-42-0 | C43H72O14 | 813.02 | |
Saikosaponin B2 | 58316-41-9 | C42H68O13 | 780.98 | (3b,4a,16a)-16,23,28-Trihydroxyoleana-11,13(18)-dien-3-yl6-deoxy-3-O-b-D-glucopyranosyl-b-D-fucoside |
Saikosaponin A | 20736-09-8 | C42H68O13 | 780.98 | (3b,4a,16b)-13,28-Epoxy-16,23-dihydroxyolean-11-en-3-y16-deoxy-3-O-b-D-glucopyranosyl-b-D-fucoside |
Saikogenin D | 5573-16-0 | C30H48O4 | 472.71 | |
Saikogenin A | 5092-09-1 | C30H48O4 | 472.7 | |
SAICAR | 3031-95-6 | C13H19N4O12P | 454.3 | Succino-AICAR; Succinyl-5-aminoimidazole-4-carboxamide-1-ribose-5'-phosphate; (2S)-2-[[5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]imidazole-4-carbonyl]amino]butanedioic acid |
SAH-SOS1A | 1652561-87-9 | C100H159N27O28 | 2187.53 | |
SAHM1 | 2050906-89-1 | C94H162N36O23S | 2196.58 | |
SAH-EZH2 | 1453222-26-8 | C155H256N48O40 | 3432.05 | |
Sahandol | 1452398-07-0 | C20H24O2 | 296.4 | (2R)-2,3-Dihydro-4-methyl-8-(1-methylethyl)-2-(2-methyl-1-propen-1-yl)naphtho[1,8-bc]pyran-9-ol;(2R)-Sahandol |
SAHA-d5 | 1132749-48-4 | C14H15D5N2O3 | 269.4 | Suberoylanilide Hydroxamic Acid-d5; Suberoylanilide-d5 Hydroxamic Acid; Vorinostat-d5 |
Sagopilone | 305841-29-6 | C30H41NO6S | 543.719 | DE 03757; ZK 219477; ZK-EPO |
Sagittatoside B | 118525-36-3 | C32H38O14 | 646.64 | 3-[(6-Deoxy-2-O-beta-D-xylopyranosyl-alpha-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one |
Sagittatoside A | 118525-35-2 | C33H40O15 | 676.24 | |
Sageone | 142546-15-4 | C19H24O3 | 300.398 | |
Saccharocarcin A | 158475-32-2 | C67H101NO20 | 1240.5 | |
Saccharin-13C6 | 1286479-01-3 | C13 C6H5NO3S | 189.12 | 1,2-(Benzisothiazol-13C6)-3(2H)-one 1,1-Dioxide; 1,2-Dihydro-2 -ketobenzisosulfonazole-13C6; Benzoic Sulfimide-13C6; o-Benzosulfimide-13C6; Benzosulfimide-13C6; Garantose-13C6; Glucid-13C6; Gluside-13C6; NSC 5349-13C6; Saccharimide-13C6; o-Sulfobenzimide- |
SACCHARIN SODIUM SALT DIHYDRATE | 82385-42-0 | C7H8NNaO5S | 241.2 | SACCHARIN SODIUM SALT DIHYDRATE; SOLUBLE SACCHARIN, DIHYDRATE; SOLUBLE SACCHARIN; SODIUM SACCHARIN; SODIUM SACCHARIN, DIHYDRATE; O-SULFOBENZIMIDE SODIUM SALT DIHYDRATE; O-BENZOIC ACID SULFIMIDE SODIUM SALT DIHYDRATE; O-BENZOIC SULFIMIDE SODIUM SALT DIHYDR |
SACCHARIN SODIUM | 6155-57-3 | C7H8NNaO5S | 241.19 | |
Saccharin hemicalcium salt | 6381-91-5 | C14H10CaN2O7S2 | 467.48 | 2,3-Dihydro-3-oxobenzisosulfonazole, o-Sulfobenzimide |
Saccharin 1-methylimidazole | 482333-74-4 | C7H5NO3S·C4H6N2 | 265.29 | SMI; 1,1-dioxo-1,2-benzothiazol-3-one;1-methylimidazole |
Saccharide isomerate | 100843-69-4 | |||
Sabutoclax | 1228108-65-3 | C42H40N2O8 | 700.78 | BI-97C1 |
SABINENE 98+% | 513-23-5 | C10H18O | 154.24 | |
Sabinene | 3387-41-5 | C10H16 | 136.23 | Sabinen; 4(10)-Thujene; NSC 407278; 4-methylidene-1-propan-2-ylbicyclo[3.1.0]hexane |
Sabcomeline | 159912-53-5 | C10H15N3O | 193.25 | SABCOMELINE; [R-(Z)]-alpha-(Methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitrile; Sabcomeline [inn:ban] |
Sabarubicin | 428506-53-0 | C32H38ClNO13 | 680.1 | BMS-195615; MEN-10755 |
Sabarubicin | 211100-13-9 | C32H37NO13 | 643.64 | (7S,9S)-7-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione; 4-demethoxy-7-O-(2,6-dideoxy-4-O-(2,3,6-trideoxy-3-amino-alpha-L- |
SA-4503 dihydrochloride | 165377-44-6 | C23H34Cl2N2O2 | 441.437 | 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride; SA4503 (dihydrochloride); Cutamesine dihydrochloride |
SA 57 | 1346169-63-8 | C17H23ClN2O3 | 338.83 | 4-[2-(4-Chlorophenyl)ethyl]-1-piperidinecarboxylic acid 2-(methylamino)-2-oxoethyl ester; [2-(methylamino)-2-oxoethyl] 4-[2-(4-chlorophenyl)ethyl]piperidine-1-carboxylate |
SA 47 | 792236-07-8 | C17H26N4O3 | 334.41 | N-[2-[1-(6-Methyl-2-pyridinyl)-4-piperidinyl]ethyl]carbamic acid 2-(methylamino)-2-oxoethyl ester; [2-(methylamino)-2-oxoethyl] N-[2-[1-(6-methylpyridin-2-yl)piperidin-4-yl]ethyl]carbamate |
S-63845 | 1799633-27-4 | C39H37ClF4N6O6S | 829.2646 | (R)-2-((5-(3-chloro-2-methyl-4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)-6-(5-fluorofuran-2-yl)thieno[2,3-d]pyrimidin-4-yl)oxy)-3-(2-((1-(2,2,2-trifluoroethyl)-1H-pyrazol-5-yl)methoxy)phenyl)propanoic acid |
S55746 | 1448584-12-0 | C43H42N4O6 | 710.82 | S-55746; S 55746; S 055746; BCL201 |
S-49076 | 1265965-22-7 | C22H22N4O4S | 438.50 | (Z)-3-((3-((4-(morpholinomethyl)-1H-pyrrol-2-yl)methylene)-2-oxoindolin-5-yl)methyl)thiazolidine-2,4-dione;EBP 883; BMS 790052 |
S-3304 | 193809-34-6 | C24H20N2O4S2 | 464.554 | |
S32826 | 1096770-84-1 | C21H36NO4P | 397.5 | 4-Tetradecanamidobenzylphosphonic acid |
S31-201 | 501919-59-1 | C16H15NO7S | 365.36 | 2-hydroxy-4-(2-(tosyloxy)acetamido)benzoic acid |
S-3,7-DIMETHYL-1-OCTANOL ---OPTICALLY ACTIVE, CLEAR LIQUID, PLEASANT ODOR, D20 0.83--- | 68680-98-8 | C10H22O | 158.29 | |
S-2-N-Cbz-Propane-1,2-diamine hydrochloride | 850033-71-5 | C11H17ClN2O2 | 244.71800 | |
S-2-hydroxy-4-imidazole propionic acid | 14403-45-3 | C6H8N2O3 | 156.14 | S-2-hydroxy-4-imidazole propionic acid; (S)-2-Hydroxy-3-(1H-imidazol-4-yl)propionic acid; L-beta-Imidazolelactic acid; L-beta-Imidazolelactic acid 1-hydrate |
S-2-AMINO-1,2,3,4-TETRAHYDRO-7-METHOXYNAPHTHALENE | 121216-42-0 | C11H15NO | 177.24300 | |
S26948 | 353280-43-0 | C28H25NO7S | 519.57 | [[4-[2-(6-Benzoyl-2-oxo-3(2H)-benzothiazolyl)ethoxy]phenyl]methyl]-1,3-propanedioic acid dimethyl ester |
S-23 | 1010396-29-8 | C18H13ClF4N2O3 | 416.75 | (2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide |
s-2-(4-Aminobenyl)-diethylenetriamine penta-tert-butyl acetate | 205956-41-0 | |||
S-2 methanandamide | 157182-48-4 | C23H39NO2 | 361.6 | (S)-(+)-Arachidonyl-2'-Hydroxy-1'-Propylamide; (5Z,8Z,11Z,14Z)-N-(2-Hydroxypropyl)icosa-5,8,11,14-tetraenamide |
S1RA Hydrochloride | 1265917-14-3 | C20H24ClN3O2 | 373.88 | S1RA hydrochloride; S1RA (hydrochloride); E-52862 hydrochloride; SCHEMBL99116; UNII-18XZ7850YN |
S1RA | 878141-96-9 | C20H23N3O2 | 337.42 | |
S1PR-MO-1 | 1149727-61-6 | C25H29N3O3 | 419.52 | Cyclobutanecarboxylic acid, 3-[[1-[4-[5-[4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl]phenyl]ethyl]amino]- |
S1P1 Agonist III | 1324003-64-6 | C21H16F3N3O3 | 415.37 | S1P1 Agonist III; CHEMBL1938952; 4088AH; BDBM50361891; IN2195 |
S-1-N-CBZ-BUTANE-1,3-DIAMINE | 949916-64-7 | C12H18N2O2 | 222.28 | |
S-1-N-BOC-PROPANE-1,2-DIAMINE-HCL | 121103-15-9 | C8H18N2O2 | 174.24072 | |
S186 | 97759-16-5 | C5H13CaNNaO7P2+3 | 324.17 | |
S-17092 | 176797-26-5 | C22H28N2O2S | 384.54 | S 17092; S-17092; [(2S,3aS,7aS)-2-(1,3-thiazolidine-3-carbonyl)-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-[(1R,2R)-2-phenylcyclopropyl]methanone |
S16961 | 153874-14-7 | C41H71NO6 | 674.01 | 2,3-di(hexadecanoyloxy)propyl pyridine-3-carboxylate; 3-Pyridinecarboxylic acid, 2,3-bis((1-oxohexadecyl)oxy)propyl ester; S-16961; AC1L434K; S-16961-1; S 169611 |
S14161 | 883046-50-2 | C17H14FNO4 | 315.3 | 8-Ethoxy-2-(4-fluorophenyl)-3-nitro-2H-chromene |
S107 | 927871-76-9 | C11H15NOS | 209.31 | 2,3,4,5-Tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine hydrochloride; S107; S-107; S 107. |
S-1,2-Epoxypentane | 123731-68-0 | C5H10O | 86.13 | S-1,2-Epoxypentane; (S)-2-Propyloxirane |
S-1 methanandamide | 157182-50-8 | C23H39NO2 | 361.6 | |
S0859 | 1019331-10-2 | C29H24ClN3O3S | 530.04 | |
S-[2-[3-[[4-[[[5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 2-methylbut-2-enethioate | 6247-62-7 | C26H42N7O17P3S | 849.635 g/mol | |
Ryuvidine | 265312-55-8 | C15H12N2O2S | 284.33 | 2-Methyl-5-[(4-methylphenyl)amino]-4,7-benzothiazoledione; Cdk4 Inhibitor III; Cyclic-dependent Kinase 4 Inhibitor III; SPS812 |
RY785 | 1393748-80-5 | C21H20N4O2S | 392.5 | HY-114608; CS-0063544; 3-(3-methoxyphenyl)-2-methyl-N-(2-(thiazol-4-yl)-1H-benzo[d]imidazol-5-yl)propanamide hydrochloride |
RX-3117 | 865838-26-2 | C10H12FN3O4 | 257.221 | RX3117; RX 3117; TV-1360; TV1360; TV 1360; fluorocyclopentenylcytosine |
RX 821002 hydrochloride | 109544-45-8 | C12H14N2O3.HCl | 270.72 | 2-(2,3-Dihydro-2-methoxy-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole hydrochloride |
RWJ-67657 | 215303-72-3 | C27H24FN3O | 425.507 | RWJ-67657; RWJ-67657; RWJ-67657 |
RWJ 52353 hydrochloride | 245744-13-2 | C11H10N2S·HCl | 238.7 | 5-(6,7-dihydro-1-benzothiophen-4-yl)-1H-imidazole hydrochloride |
RWJ 52353 | 245744-10-9 | C11H10N2S | 202.28 | 5-(6,7-Dihydrobenzo[b]thien-4-yl-1H-imidazole hydrochloride |
RWJ 50271 | 162112-37-0 | C18H17F3N4O2S | 410.41 | N-(3-Hydroxypropyl)-5-methyl-1-[-4-[3-(trifluoromethyl)phenyl)]-2-thiazolyl]-1H-pyrazole-4-carboxamide |
Ruthenium dioxide | 12036-10-1 | RuO2 | 133.07 | rutheniumoxide(ruo2); RUTHENIUM DIOXIDE; RUTHENIUM(IV) DIOXIDE; RUTHENIUM(IV) OXIDE; RUTHENIUM OXIDE; Ruthenium(IV) oxide anhydrous |
Ruthenium acetate | 72196-32-8 | C6H9O6Ru | 278.2 | RUTHENIUM ACETATE; Ruthenium triacetate |
Rutamarin | 14882-94-1 | C21H24O5 | 356.418 | Chalepin acetate; 2-[6-(2-methylbut-3-en-2-yl)-7-oxo-2,3-dihydrofuro[3,2-g]chromen-2-yl]propan-2-yl acetate |
Rutaevin | 33237-37-5 | C26H30O9 | 486.517 | Rutaevine |
Rutaecarpine | 84-26-4 | C18H13N3O | 287.32 | |
Rutacridone | 17948-33-3 | C19H17NO3 | 307.349 | 5-hydroxy-11-methyl-2-prop-1-en-2-yl-1,2-dihydrofuro[2,3-c]acridin-6-one |
RU-SKI 43 hydrochloride | 1782573-67-4 | C22H30N2O2S·HCl | 423 | 2-(2-methylbutylamino)-1-[4-[(3-methylphenoxy)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl]ethanone hydrochloride |
Rupatadine Fumarate | 182349-12-8 | C26H26ClN3.C4H4O4 | 532.03 | 8-Chloro-6,11-dihydro-11-[1-[(5-methyl-3-pyridinyl)methyl]-4-piperidinylidene]-5H-benzo[5,6]cyclohepta[1,2-b]pyridine (2E)-2-Butenedioate |
Rupatadine | 158876-82-5 | C26H26ClN3 | 415.96 | 8-chloro-11-[1-[(5-methylpyridin-3-yl)methyl]piperidin-4-ylidene]-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridine Rupatadine 158876-82-5 Alergoliber Pafinur Rinialer Rupax Rupafin UNII-2AE8M83G3E CHEMBL91397 |
Ruixianglangdusu B | 447454-49-1 | C33H28O10 | 584.57 | (2S,3R)-5,7-dihydroxy-3-[(2S,3R)-5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl]-2-(4-methoxyphenyl)-2,3-dihydrochromen-4-one |
Rugulotrosin A | 685135-81-3 | C32H30O14 | 638.6 | |
Rugulosin ((+) form) | 23537-16-8 | C30H22O10 | 542.5 | Radicalisin |
Rugulosin - form | 21884-45-7 | C30H22O10 | 542.5 | Radicalisin |
Rufloxacin hydroChloride | 106017-08-7 | C17H18FN3O3S.HCl | 399.87 | RUFLOXACIN HCL;RUFLOXACIN HYDROCHLORIDE;7h-pyrido(1,2,3-de)(1,4)benzothiazine-6-carboxylicacid,2,3-dihydro-9-fluoro-1;mf-934;RUFLOXACINHYDROCHLORIDE(SUBJECTTOPATENTFREE);2,3-Dihydro-9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzo |
Rufloxacin | 101363-10-4 | C17H18FN3O3S | 363.411 | AKOS NCG1-0068;8-FLUORO-9-(4-METHYL-PIPERAZIN-1-YL)-6-OXO-2,3-DIHYDRO-6H-1-THIA-3A-AZA-PHENALENE-5-CARBOXYLIC ACID;RUFLOXACIN;9-Fluom-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzothiazine-6-carboxylic acid;ISF-09334;Mones |
Rufinamide-15N-d2 | 1795037-48-7 | C10H6F2N4OD2 | 241.2 | 1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide-15N,d2; CGP 33101-15N,d2; E 2080-15N,d2; Inovelon; RUF 331-15N,d2 |
Rufinamide Impurity 6 | 80819-65-4 | C10H10N4O | 202.22 | 1-(Phenylmethyl)-1H-1,2,3-triazole-4-carboxamide; Rufinamide Impurity 1 |
Rufinamide Impurity 5 | 569501-51-9 | C12H11F2N3O2 | 267.24 | |
Rufinamide Impurity 2 | 166196-11-8 | C10H7F2N3O2 | 239.18 | CGP-47292; CGP 47292; CGP47292; UNII-266244C47B; CGP 47,292; 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid |
Rufinamide Impurity 1 | 217448-86-7 | C11H9F2N3O2 | 253.21 | 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic Acid Methyl Ester; Methyl 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate; USP Rufinamide Related Compound B; |
Rufinamide | 106308-44-5 | C10H8F2N4O | 238.19 | CGP-33101; CGP 33101; CGP33101; E 2080; RUF 331; Inovelon; Banzel; E2080; RUF331; E-2080; RUF-331 |
RuCl[(R,R)-Fsdpen](p-cymene) | 1026995-71-0 | C30H28ClF5N2O2RuS | 712.14 | [(1R,2R)-2-amino-1,2-diphenylethyl]-(2,3,4,5,6-pentafluorophenyl)sulfonylazanide; chlororuthenium(1+); 1-methyl-4-propan-2-ylbenzene; 1026995-71-0; Chloroaminodiphenylethylpentafluorophenylksulfonyl)amido((p-cymene)ruthenium(II)); SCHEMBL1669799 |
Rucaparib Camsylate | 1859053-21-6 | C29H34FN3O5S | 555.665 | Rucaparib (Camsylate); UNII-41AX9SJ8KO; 41AX9SJ8KO; CO-338; Rubraca |
Rucaparib camsylate | 1327258-57-0 | C19H18FN3O·C10H16O4S | 555.66 | 8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2,ef][2]benzazepin-6-one (1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonic acid |
Rucaparib | 283173-50-2 | C19H18FN3O | 323.36 | 8-Fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd)indol-6-one; Rucaparib free base, AG-14447; AG 14447; AG14447; Rubraca |
Rucaparib | 459868-92-9 | C19H21FN3O5P | 421.365 | AG-014699; PF-01367338; AG014699; Rucaparib (phosphate) |
Reactive Blue 74 | 12677-16-6 | C28H23ClN6O9S2.2Na | 0 | C.I.Reactive Blue 74; Cibacron pront Blue 3R; Procion Blue H-4R,P-4R; 2-Anthracenesulfonic acid, 1-amino-4-[[3-[(4-chloro-6-ethoxy-1, 3, 5-triazin-2-yl)amino]-2, 4, 6-trimethyl-5-sulfophenyl]amino]-9, 10-dihydro-9, 10-dioxo, disodium salt; Brilliant Blue |
Reactive blue 59 | 12270-71-2 | |||
Pyroxasulfone | 447399-55-5 | C12H14F5N3O4S | 391.32 | 3-[[[5-(Difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]sulfonyl]-4,5-dihydro-5,5-dimethyl-isoxazole; 3-[5-(Difluoromethoxy)-1-methyl-3-(trifluoromethyl)pyrazol-4-ylmethylsulfonyl]-4,5-dihydro-5,5-dimethyl-1,2-oxazole; KIH 485; Sakura |
Propranolol Hydrochloride | 3506-09-0 | C16H22ClNO2 | 295.8 | 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;hydrochloride; |
Potassium 2-[bis(2-cyanoethyl)phosphine]ethanesulfonate | 86563-95-3 | |||
Pyridine, 2-(diethylboryl)- (9CI) | 385804-67-1 | C9H14BN | 147.02516 | Pyridine, 2-(diethylboryl)- (9CI) |
Prothipendyl | 303-69-5 | C16H19N3S | 285.413 | Prothipendyl; Dominal; Largophren; LG-206; Phrenotropin; Timovan |
Prothionamide-d5 | 1330261-26-1 | C9H7N2SD5 | 185.3 | 2-(Propyl-d5)-4-pyridinecarbothioamide; 2-(Propyl-d5)thioisonicotinamide; 2-(Propyl-d5)isonicotinylthioamide; 9778 R. P.-d5; Ektebin-d5; Prothionamide-d5; Protion-d5; Protionamid-d5; Protionizina-d5; RP 9778-d5; TH 1321-d5; Tebeform-d5; Trevintix-d5; Tube |
Prothionamide | 14222-60-7 | C9H12N2S | 180.27 | Protionamide |
Prothiofos | 34643-46-4 | C11H15Cl2O2PS2 | 345.24 | Bay NTN 8629; bayntn8629; Bideron; dichlorpropaphos; ntn-8629; ntn8629,4541 |
Prothioconazole | 178928-70-6 | C14H15Cl2N3OS | 344.3 | 2-(2-(1-Chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl)-1H-1,2,4-triazole-3(2H)-thione |
Rubrosterone | 19466-41-2 | C19H26O5 | 334.41 | Rubrosterone |
Rubropunctatin | 514-67-0 | C21H22O5 | 354.41 | |
Rubropunctamine | 514-66-9 | C21H23NO4 | 353.42 | Furo[3,2-g]isoquinoline-2,9(7H,9aH)-dione, 9a-methyl-3-(1-oxohexyl)-6-(1-propenyl)-, [R-(E)]-; Furo[3,2-g]isoquinoline-2,9(7H,9aH)-dione, 9a-methyl-3-(1-oxohexyl)-6-(1E)-1-propenyl-, (9aR)- (9CI) |
Rubrene | 517-51-1 | C42H28 | 532.68 | |
RUBRATOXIN B FROM PENICILLIUM RUBRUM | 21794-01-4 | C26H30O11 | 404.42 | |
Rubratoxin A | 22467-31-8 | C26H32O11 | 520.5 | BRN 1633008; HSDB 3532 |
Rubranol | 211126-61-3 | C19H24O5 | 332.4 | Rubral; (R)-1,7-Bis-(3,4-dihydroxyphenyl)-5-hydroxyheptane |
Ruboxistaurin HCl | 169939-93-9 | C28H28N4O3.HCl | 505.01 | Ruboxistaurin Hydrochloride; LY-333531 hydrochloride; Ruboxistaurin (hydrochloride); 169939-93-9; LY 333531 hydrochloride; LY333531 hydrochloride; Ruboxistaurin-d6 Hydrochloride; 169939-94-0 (base); |
Ruboxistaurin | 169939-94-0 | C28H28N4O3 | 468.557 | 13-((dimethylamino)methyl)-10,11,14,15-tetrahydro-4,9:16,21-dimetheno-1H,13H-dibenzo(e,k)pyrrolo(3,4-h)(1,4,13)oxadiazacyclohexadecene-1,3(2H)-dione; Arxxant; LY 333531; LY-333531; ruboxistaurin; ruboxistaurin mesilate hydrate |
Rubitecan | 91421-42-0 | C20H15N3O6 | 393.355 | 9-nitrocamptothecin; 9-nitro-CPT; nitrocamptothecin; RFS 2000; RFS-2000; RFS2000; 9NC; 9-nitro-camptothecin; 9-nitro-CPT; Camptogen; Orathecin |
Rubiprasin B | 125263-66-3 | C32H52O4 | 500.75 | (3beta)-3-(Acetyloxy)-13-hydroxy-oleanan-12-one |
Rubiprasin A | 125263-65-2 | C32H52O5 | 516.75 | (3beta,15alpha)-3-(Acetyloxy)-13,15-dihydroxyoleanan-12-one |
Rubipodanone A | 2170211-22-8 | C27H22O6 | 442.46 | |
Rubioncolin C | 132242-52-5 | C27H22O6 | 442.46 | 1-Hydroxy-3-(3-methyl-2-butenyl)-4-[(1,4-dihydro-1,4-dioxonaphthalen)-2-yl]naphthalene-2-carboxylic acid methyl ester |
RuBi-Nicotine | 1256362-30-7 | C40H44Cl2N8Ru | 808.81 | Bis(2,2'-bipyridine-N,N')bis(S-nicotine-N1) ruthenium(2+) dichloride |
Rubinaphthin A | 448962-05-8 | C17H18O9 | 366.32 | |
RUBIDIUM ACETATE | 563-67-7 | C2H3O2Rb | 144.51 | RUBIDIUM ACETATE; ACETIC ACID, RUBIDIUM SALT; Rubidiumacetatewhitextl; RUBIDIUM ACETATE, 99.8+%; RUBIDIUM ACETATE 98%; RUBIDIUM ACETATE, 99.8% (METALS BASIS) |
RUBIDIUM | 13446-75-8 | RB | 85.46 | |
Rubicordifolin | 849699-55-4 | C33H28O9 | 568.57 | Naphtho[1,2-b]furan-4-carboxylic acid, 5-hydroxy-2-[(2R,3aR,4R)-2,3,3a,6-tetrahydro-7-hydroxy-4-(1-hydroxy-1-methylethyl)-2-methyl-6-oxo-4H-benzo[g]pyrano[4,3,2-de][2]benzopyran-2-yl]-, methyl ester |
RUBICENE | 197-61-5 | C26H14 | 326.39 | BENZO(A)INDENO(1,2,3-HI)ACEANTHRYLENE; RUBICENE; RUBICENE 98%; Rubicene,98% |
Rubiayannone-A | 517978-25-1 | C25H26O14 | 550.47 | |
Rubianthraquinone | 644967-44-2 | C16H12O5 | 284.3 | 2-Methyl-3,6-dihydroxy-1-methoxy-9,10-anthraquinone |
Rubiadin-1-methyl ether | 7460-43-7 | C16H12O4 | 268.26 | 3-Hydroxy-1-methoxy-2-methylanthraquinone |
Rubiadin | 117-02-2 | C15H10O4 | 254.2 | 1,3-DIHYDROXY-2-METHYLANTHRAQUINONE |
RS 45041-190 hydrochloride | 204274-74-8 | C11H12ClN3.HCl | 258.15 | 4-Chloro-2-(imidazolin-2-yl)isoindoline hydrochloride; RS-45041-190 |
RS 39604 hydrochloride | 167710-87-4 | C26H36ClN3O6S.HCl | 590.56 | 1-[4-Amino-5-chloro-2-(3,5-dimethoxyphenyl)methyloxy]-3-[1-[2-methylsulphonylamino]ethyl]piperidin-4-yl]propan-1-one hydrochloride; RS 39604; RS-39604; RS39604; RS 39604 HCl; RS 39604HCl; N-[2-[4-[3-[4-Amino-5-chloro-2-[(3,5-dimethoxyphenyl)methoxy]phenyl |
RS 25344 hydrochloride | 152815-28-6 | C19H13N5O4.HCl | 411.8 | 1-(3-Nitrophenyl)-3-(4-pyridinylmethyl)-pyrido[2,3-d]pyrimidine-2,3-(1H,3H)-dione hydrochloride; RS-25344 HCl; RS 25344 HCl; RS25344 HCl |
RS 23597-190 hydrochloride | 149719-06-2 | C16H23ClN2O3.HCl | 363.28 | 3-(Piperidin-1-yl)propyl 4-amino-5-chloro-2-methoxybenzoate hydrochloride; RS 23597; RS-23,597-190; RS-23597-190; RS-23597; RS23597-190; RS23597 |
RS 16566 dihydrochloride | 1217788-97-0 | C18H23ClN4O.2HCl | 419.78 | (R)-N-1-Azabicyclo[2.2.2]oct-3-yl-6-chloro-1-(1-methylethyl)-1H-benzimidazole-4-carboxamide |
RS 127445 hydrochloride | 199864-86-3 | C17H16FN3.HCl | 317.79 | 4-(4-Fluoro-1-naphthalenyl)-6-(1-methylethyl)-2-pyrimidinamine hydrochloride; 2-Amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine Monohydrochloride; MT 500 Hydrochloride |
RS 127445 | 199864-87-4 | C17H17ClFN3 | 317.79 | 4-(4-fluoronaphthalen-1-yl)-6-propan-2-ylpyrimidin-2-amine 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine MT 500 MT-500 MT500 cpd RS 127445 RS 27354 RS-127445 RS-27354 RS127445 RS27354 |
RS 102895 hydrochloride | 1173022-16-6 | C21H21F3N2O2.HCl | 426.86 | 1'-[2-[4-(trifluoromethyl)phenyl]ethyl]-spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one, monohydrochloride |
RS 102221 hydrochloride | 187397-18-8 | C27H31F3N4O7S.HCl | 649.08 | 8-[5-(2,4-Dimethoxy-5-(4-trifluoromethylphenylsulphonamido)phenyl-5-oxopentyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione hydrochloride; N-[5-[5-(2,4-Dioxo-1,3,8-triazaspiro[4.5]dec-8-yl)-1-oxopentyl]-2,4-dimethoxyphenyl]-4-(trifluoromethyl)-benzenesulfonamid |
RS 100329 hydrochloride | 1215654-26-4 | C20H25F3N4O3.HCl | 462.89 | 5-Methyl-3-[3-[3-[4-[2-(2,2,2,-trifluroethoxy)phenyl]-1-piperazinyl]propyl]-2,4-(1H,3H)-pyrimidinedione hydrochloride |
RS 09 | 1449566-36-2 | C31H49N9O9 | 691.78 | Ala-Pro-Pro-His-Ala-Leu-Ser |
RRX-001 | 925206-65-1 | C5H6BrN3O5 | 268.022 | RRx-001 |
RR-src | 81156-93-6 | C64H106N22O21 | 1519.7 | Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly |
R-Rivaroxaban | 865479-71-6 | C19H18ClN3O5S | 435.88 | (R)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide;5-Chloro-N-({(5R)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide;BAY 59-7939;R-Rivaroxaban;ent-Rivaroxaban |
R-Repaglinide (Repaglinide Impurity E) | 147852-26-4 | C27H36N2O4 | 452.6 | 2-Ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid; (-)-Repaglinide; AG-EE 624ZW; Repaglinide Impurity; |
RQ-00311651 | 1257116-00-9 | C19H18F3N5O2 | 405.38 | (1S'2S)-2-(1H-benzo[d]imidazol-2-yl)-N-((R)-1-(5-(2'2'2-trifluoroethoxy)pyrazin-2-yl)ethyl)cyclopropane-1-carboxamide |
RQ-00203078 | 1254205-52-1 | C21H13ClF6N2O5S | 554.84 | RQ-00203078; RQ 00203078; RQ00203078. |
R-Pregabalin | 148553-51-9 | C8H17NO2 | 159.23 | (3R)-3-(Aminomethyl)-5-methylhexanoic acid; (R)-3-(Aminomethyl)-5-methylhexanoic acid; PD 144550; ent-Pregabalin; |
R-Pralatrexate | 1320211-70-8 | C23H23N7O5 | 477.48 | |
RPR-260243 | 668463-35-2 | C28H25F3N2O4 | 510.51 | (3R,4R)-4-[3-(6-methoxyquinolin-4-yl)-3-oxo-propyl]-1-[3-(2,3,5-trifluoro-phenyl)-prop-2-ynyl]-piperidine-3-carboxylic acid; |
RPR203494 | 218160-26-0 | C26H29FN6O4 | 508.545 | RPR-203494; RPR 203494. |
RPR-200765A Mesylayte | 218162-38-0 | C24H25FN4O4 | 452.48 | [2-[4-(4-fluorophenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]-5-methyl-1,3-dioxan-5-yl]-morpholin-4-ylmethanone; RPR 200765A; RPR-200765 A; 218158-45-3 (RPR-200765, free base) |
RPR-200765A | 218158-45-3 | C24H25FN4O4 | 452.478 | RPR-200765; RPR200765; RPR 200765; RPR-200765A. |
RPL-554 | 298680-25-8 | C26H31N5O4 | 477.56 | [2-[6,7-Dihydro-9,10-dimethoxy-4-oxo-2-[(2,4,6-trimethylphenyl)imino]-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl]ethyl]-urea; UNII-3E3D8T1GIX; LS-193,855; |
RPI-1 | 269730-03-2 | C17H15NO4 | 297.31 | 1,3-dihydro-3-[(4-hydroxyphenyl)methylene]-5,6-dimethoxy-2H-indol-2-one; RPI-1; RPI1; RPI 1. |
Rp-cGMPS | 86562-09-6 | C10H11N5O6PS · Na | 383.3 | Guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
Rp-c-diGMPS | 1259875-32-5 | C20H24N10O13P2S (free acid) | 706.5 (free acid) | Cyclic diguanosine monophosphorothioate, Rp- isomer, sodium salt |
Rp-8-pCPT-cGMPS sodium | 208445-07-2 | C16H14ClN5NaO6PS2 | 525.86 | 8-[(4-Chlorophenyl)thio]-guanosine-cyclic 3',5'-[hydrogen [P(R)]-phosphorothioate] sodium; Rp-8-pCPT-cGMPS |
Rp-8-pCPT-cGMPS | 153660-04-9 | C16H14ClN5O6PS2 · Na | 525.9 | 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
Rp-8-OH-cAMPS | 475084-30-1 | C10H11N5O6PS · Na | 383.3 | 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
Rp-8-CPT-Cyclic AMP sodium salt | 221905-35-7 | C16H14ClN5O5PS2·Na | 509.8 | Rp-8-CPT-cAMP |
Rp-8-CPT-cAMPS | 129735-01-9 | C16H14ClN5O5PS2 · Na | 509.8 | 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
Rp-8-Cl-cAMPS | 142754-27-6 | C10H10ClN5O5PS · Na | 401.7 | 8- Chloroadenosine- 3', 5'- monophosphorothioate, Rp- isomer, sodium salt |
Rp-8-bromo-PET-Cyclic GMPS sodium salt | 185246-32-6 | C18H14BrN5O6PS·Na | 562.27 | Rp-8-Br-PET-cGMPS; Rp-8-bromo-PET-cGMPS |
Rp-8-bromo-Cyclic GMPS sodium salt | 208445-06-1 | C10H10BrN5O6PS·Na | 462.1 | 8-bromo-guanosinecyclic3',5'-[(R)-(hydrogenphosphorothioate)], monosodium salt; Rp-8-Br-cGMPS; Rp-8-bromo-cGMPS |
Rp-8-bromo-Cyclic AMPS sodium salt | 925456-59-3 | C10H10BrN5O5PS·Na | 446.1 | 8-Bromoadenosine 3',5'-cyclic monophosphorothioate, Rp-isomer; Rp-8-Br-cAMPS; Rp-8-bromo-cAMPS |
Rp-8-Br-cGMPS | 150418-07-8 | C10H10BrN5O6PS · Na | 462.2 | 8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
Rp-8-Br-cAMPS | 129735-00-8 | C10H10BrN5O5PS · Na | 446.2 | 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
Rp-8-Br-2'-O-MB-cAMPS | 788807-32-9 | C14H16BrN5O6PS · Na | 516.2 | 8- Bromo- 2'- O- monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
Rp-8-AHA-cAMPS | 214272-02-3 | C16H26N7O5PS | 459.5 | 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer |
Rp-8-AET-cGMPS | 221904-88-7 | C12H17N6O6PS2 | 436.4 | 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer |
Rp-8-AEA-cAMPS | 221904-78-5 | C12H18N7O5PS | 403.4 | 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer |
Rp-6-Phe-cAMPS | 169335-91-5 | C16H15N5O5PS · Na | 443.4 | |
Rp-6-Cl-cPuMPS | 129693-15-8 | C10H9ClN4O5PS · Na | 386.7 | 6- Chloropurine riboside- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
RP-6530 | 1639417-53-0 | C23H18FN5O2 | 415.43 | RP-6530; RP6530; RP 6530; Tenalisib; (S)-2-(1-((7H-purin-6-yl)amino)propyl)-3-(3-fluorophenyl)-4H-chromen-4-one |
Rp-5,6-DCl-cBIMPS | 120912-55-2 | C12H10Cl2N2O5PS · Na | 419.2 | 5, 6- Dichlorobenzimidazole riboside- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
Rp-2-Cl-cAMPS | 124844-92-4 | C10H10ClN5O5PS · Na | 401.7 | 2- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
Rotenone | 83-79-4 | C23H22O6 | 394.42 | (2R,6aS,12aS)-1,2,12,12a-Tetrahydro-8,9-dimethoxy-2-(1-methylethenyl)-[1]benzopyrano[3,4-b]furo[2,3-h][1]benzopyran-6(6aH)-one |
Rosuvastatin-d6 Sodium Salt | 2070009-41-3 | C22H21D6FN3NaO6S | 509.56 | 7-[4-(4-Fluorophenyl)-6-(1-methylethyl-d6)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt |
ROSE OXIDE BRI | 16409-43-1 | C10H18O | 154.24 | 2H-Pyran, tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-, ROSE OXIDE BRI, Tetrahydro-4-methyl-2-(2-methylpropen-1-yl)pyran |
Rose oil | 8007-01-0 | |||
Rose Bengal | 632-69-9 | C20H2Cl4I4Na2O5 | 1017.64 | Rose bengal sodium; Rose bengal disodium salt; 4,5,6,7-Tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one disodium salt |
Rosarin | 84954-93-8 | C20H28O10 | (2E)-3-Phenylprop-2-en-1-yl 6-O-alpha-L-arabinofuranosyl-beta-D-glucopyranoside | |
Rosamultin | 88515-58-6 | C36H58O10 | 650.85 | |
Rosabulin | 501948-05-6 | C22H16N4O2S | 400.456 | STA-5312 |
ROS 234 dioxalate | 184576-87-2 | C13H15N5.2C2H2O4 | 421.37 | N-[3-(1H-Imidazol-4-yl)propyl]-1H-benzimidazol-2-amine dioxalate |
Roridin E | 16891-85-3 | C29H38O8 | 514.61 | Roridine E |
ROR gamma-t-IN-1 | 1426802-50-7 | C23H18Cl2F3NO4S | 532.36 | N-[3,5-dichloro-4-[2-(trifluoromethoxy)phenyl]phenyl]-2-(4-ethylsulfonylphenyl)acetamide ROR gamma-t-IN-1 SCHEMBL14746799 CS-5079 HY-12776 |
ROR gama modulator 1 | 1474110-21-8 | C25H35NO5S | 461.61 | N-(4-ethylphenyl)-3-(hydroxymethyl)-N-(2-methylpropyl)-4-(oxan-4-ylmethoxy)benzenesulfonamide ROR gama modulator 1 SCHEMBL15352875 CS-5449 |
Roquinimex | 84088-42-6 | C18H16N2O3 | 308.33 | FCF89; FCF-89; FCF 89; LS2616; LS-2616; LS 2616; Quinoline-3-carboxamide; CCRIS 7673; Linomide |
Roquefortine E | 871982-52-4 | C27H31N5O2 | 457.6 | |
Roquefortine C | 58735-64-1 | C22H23N5O2 | 389.5 | Roquefortine |
Ropivacaine-d7 | 684647-62-9 | C17H19N2OD7 | 281.45 | |
Ropivacaine Related Compound A | 21436-98-6 | C8H11N . HCl | 157.64 | 2,6-Dimethylbenzenamine Hydrochloride; 2,6-DMA Hydrochloride; 2,6-Xylidine Hydrochloride; 1-Amino-2,6-dimethylbenzene Hydrochloride; 2,6-Dimethylbenzenamine Hydrochloride; 2,6-Dimethylphenylamine Hydrochloride; 2,6-Xylylamine Hydrochloride; 2-Amino-1,3-di |
Ropivacaine mesylate | 854056-07-8 | C18H30N2O4S | 370.51 | |
Ropivacaine hydrochloride | 98717-15-8 | C17H27ClN2O | 310.8621 | |
Ropivacaine HCl.H2O | 132112-35-7 | C17H26N2O.HCl | 310.86 | LEA-103 HCl; LEA 103 HCl; LEA103 HCl |
Ropivacaine | 84057-95-4 | C17H26N2O | 274.4 | |
Ropinirole-d7 HCl | 1261396-31-9 | C16H17N2OD7.HCl | 303.88 | 4-[2-(Propyl-d7-propylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride |
Ropinirole-d14 HCl (di-n-propyl-d14) | 1132746-05-4 | C16H10D14N2O·HCl | 310.92 | 4-[2-(Di-n-propylamino)ethyl]-2-indolinone HCl |
Rolapitant | 552292-08-7 | C25H26F6N2O2 | 500.49 | (5S,8S)-8-(((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro[45]decan-2-one; SCH619734; SCH-619734; SCH 619734; Varubi |
Rokitamycin | 74014-51-0 | C42H69NO15 | 827.999 | ROKITAMYCIN; 3''-Propionylleucomycin A5; Leucomycin V, 4B-butanoate 3B-propanoate (9CI); Ricamycin; TMS 19Q; Leummycin V 4B-bu-tanoate 3 B-propanoate; M-19-Q; Rikamycin |
ROBINETIN | 490-31-3 | C15H10O7 | 3,3',4',5',7-Pentahydroxy-flavon; 3,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-4h-1-benzopyran-4-one; Norkanugin; 5-Hydroxyfisetin | |
Robenidine-D8 hydrochloride | 1173097-77-2 | 1,3-Bis[(4-chloroben- zylidene)amino]guani- dine-D8 hydrochloride | ||
Robenidine hydrochoride | 25875-50-7 | C15H13Cl2N5·HCl | 370.66 | Dexium; Nugatex; Rasexinium; Toraxine; Robenidine HCl; 1,3-bis((4-chlorobenzylidene)amino)guanidine monohydrochloride |
Ro 10-5824 dihydrochloride | 189744-94-3 | C17H22Cl2N4 | 353.29 | 2-methyl-5-[(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methyl]pyrimidin-4-amine;dihydrochloride; Ro 10-5824 (dihydrochloride) |
Ro 08-2750 | 37854-59-4 | C13H10N4O3 | 270.25 | Ro 08-2750; Ro08-2750; Ro-08-2750; Ro 082750; Ro -82750; Ro082750. |
RO 04-6790 hydrochloride | 1197333-95-1 | C12H16N6O2S.2HCl | 381.28 | 4-Amino-N-[2,6-bis(methylamino)-4-pyrimidinyl]benzenesulfonamide Dihydrobromide |
Ro 04-6790 | 202466-68-0 | C12H16N6O2S | 308.36 | 4-Amino-N-[2,6-bis(methylamino)-4-pyrimidinyl]-benzenesulfonamide; Ro 04-6790; Ro04-6790; Ro-04-6790 |
Ro 04-5595 | 64047-73-0 | C19H22ClNO2.HCl | 368.3 | 1-[2-(4-Chlorophenyl)ethyl]-1,2,3,4-tetrahydro-6-methoxy-2-methyl-7-isoquinolinol hydrochloride |
Ro 0437626 | 134362-79-1 | C27H35N5O4S | 525.66 | N-[(1R)-2-[[(1S,2R,3S)-1-(Cyclohexylmethyl)-3-cyclopropyl-2,3-dihydroxypropyl]amino]-2-oxo-1-(4-thiazolylmethyl)ethyl]-1H-benzimidazole-2-carboxamide; Ro 116-6446/008 |
Ro 01-6128 | 302841-86-7 | C17H17NO3 | 283.32 | (Diphenylacetyl)-carbamic acid ethy ester; Ro01-6128; Ro-01-6128; Ro 01-6128 |
RNPA1000 | 359600-10-5 | C23H18BrN3O3 | 464.3 | 4-[3-[(E)-3-(3-bromoanilino)-2-cyano-3-oxoprop-1-enyl]-2,5-dimethylpyrrol-1-yl]benzoic acid; |
R-N-Benzyl-proline | 56080-99-0 | C12H15NO2 | 205.253 | (R)-1-Benzyl-pyrrolidine-2-carboxylicacid; 56080-99-0; (2R)-1-benzylpyrrolidine-2-carboxylicacid; R-N-BENZYL-PROLINE; AC1LE1D1; SCHEMBL2587055 |
R-Naproxen | 23979-41-1 | C14H14O3 | 230.27 | |
RN983 | 1423129-83-2 | C34H37FN8O3 | 624.72 | 6-(tert-butyl)-8-fluoro-2-(3-(hydroxymethyl)-4-(1-methyl-5-((5-(1-methylpiperidin-4-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydropyridazin-3-yl)pyridin-2-yl)phthalazin-1(2H)-one |
RN486 | 1242156-23-5 | C35H35FN6O3 | 606.69 | |
RN-18 | 431980-38-0 | C20H16N2O4S | 380.42 | N-(2-methoxyphenyl)-2-(4-nitrophenyl)sulfanylbenzamide; 2-(4-Nitrophenylthio)-N-(2-methoxyphenyl)benzamide; AC1LQ42R; Ambcb6776439 |
RN-1734 | 946387-07-1 | C14H22Cl2N2O2S | 353.31 | RN 1734;2,4-Dichloro-N-isopropyl-N-(2-isopropylaminoethyl)benzenesulfonamide;2,4-Dichloro-N-propan-2-yl-N-[2-(propan-2-ylamino)ethyl]benzenesulfonamide;2,4-Dichloro-N-(1-methylethyl)-N-[2-[(1-methylethyl)amino]ethyl]benzenesulfonamide |
RN 9893 hydrochloride | 1803003-68-0 | C21H23F3N4O5S.HCl | 536.95 | N-[4-[[4-(1-Methylethyl)-1-piperazinyl]sulfonyl]phenyl]-2-nitro-4-(trifluoromethyl)benzamide hydrochloride; RN9893 HCl; RN-9893 HCl; RN 9893 HCl; RN9893 Hydrochloride; RN-9893 Hydrochloride; RN 9893 Hydrochloride |
RN 1747 | 1024448-59-6 | C17H18ClN3O4S | 395.87 | 1-(4-Chloro-2-nitrophenyl)sulfonyl-4-benzylpiperazine; RN1747; RN 1747; RN-1747 |
RN 1 dihydrochloride | 1781835-13-9 | C23H29N3O2.2HCl | 452.42 | 1-(4-methyl-1-piperazinyl)-2-[[(1R*,2S*)-2-[4-phenylmethoxy)phenyl]cyclopropyl]amino]ethanone dihydrochloride; RN-1, monohydrochloride; RN-1 2HCl |
R-Morinidazole | 898230-59-6 | C11H18N4O4 | 270.29 | (R)-1-(2-Methyl-5-nitro-1H-imidazol-1-yl)-3-morpholinopropan-2-ol;(2R)-1-(2-methyl-5-nitroimidazol-1-yl)-3-morpholin-4-ylpropan-2-ol;Morinidazole R enantiomer |
RMM 46 | 1307896-46-3 | C24H26N4O5 | 450.5 | 2-Cyano-N-(2-hydroxy-1,1-dimethylethyl)-3-[3-(3,4,5-trimethoxyphenyl)-1H-indazol-5-yl]-2-propenamide |
R-Mirtazapine | 61364-37-2 | C17H19N3 | 265.35 | (14bR)-1,2,3,4,10,14b-Hexahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; (R)-1,2,3,4,10,14b-Hexahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; (-)-Mirtazapine; (R)-6-Azamianserin; (R)-Mirtazapine; (R)-Org 3770; Org 44-19; R-(-)-Mir |
RMC-4550 | 2172651-73-7 | C21H26Cl2N4O2 | 437.36 | [3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-6-(2,3-dichlorophenyl)-5-methylpyrazin-2-yl]methanol |
RLLFT-NH | 447408-68-6 | C31H53N9O6 | 647.82 | RLLFT |
R-Licarbazepine | 104746-03-4 | C15H14N2O2 | 254.29 | (10R)-10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide; R-(-)-10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide; (R)-Licarbazepine; CGP 13698; |
R-Lercanidipine-d3 HCl | 1217724-52-1 | C36H39ClD3N3O6 | 651.21 | (4R)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[(3,3-Diphenylpropyl)(methyl-d3)amino]-1,1-dimethylethyl Methyl Ester Hydrochloride |
RKS-262 | 1041469-97-9 | C15H14BrClN2O4S | 433.70 | RKS-262; RKS 262. |
RKI-1447 | 1342278-01-6 | C16H14N4O2S | 326.374 | RKI 1447; 1-(3-Hydroxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea |
RKI-1313 | 1342276-76-9 | C17H16N4O2S | 340.401 | 1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea |
Rivaroxaban Related Compound | 24065-33-6 | C5H3ClO2S | 162.6 | 5-Chloro-2-thiophenecarboxylic acid |
Rivaroxaban Pseudodimer | 1632463-24-1 | C38H36Cl2N6O10S2 | 871.8 | 5-chloro-N-[[(5S)-3-[4-[(5-chlorothiophene-2-carbonyl)-[2-[2-oxo-2-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methylamino]ethoxy]ethyl]amino]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide |
Rivaroxaban Impurity G | 721401-53-2 | C18H20ClN3O4S | 409.89 | 5-Chloro-N-[(2R)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-2-thiophencarboxamide; 5-Chloro-N-[(2R)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-2-thiophenecarboxamide |
Rivaroxaban Impurity A hydrochloride | 931117-61-2 | C19H21Cl2N3O6S | 490.36 | |
Rivaroxaban Impurity 9 | 446292-08-6 | C22H19N3O6 | 421.41 | 2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione; |
Rivaroxaban Impurity 8 | 1365267-36-2 | C36H36N6O10 | 712.72 | |
Rivaroxaban Impurity 4 | 1429334-00-8 | C16H19N3O5 | 333.35 | N-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-acetamide |
Rivaroxaban Amine Impurity | 1151893-81-0 | C24H21Cl2N3O7S2 | 598.48 | 2-[2-[N-(5-Chlorothiophene-2-carbonyl)-4-[(5S)-5-[[(5-chlorothiophene-2-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]anilino]ethoxy]acetic acid |
Rivaroxaban | 366789-02-8 | C19H18ClN3O5S | 435.879 | Xarelto; BAY 59-7939 |
Rituximab | 174722-31-7 | C6416H9874N1688O1987S44 | 143859.7 | Immunoglobulin G1; Hsdb 7455; Immunoglobulin G 1 (human-mouse monoclonal idec-C2B8 gamma1-chain anti-human antigen cd 20), disulfide with human-mouse monoclonal idec-C2B8 kappa-chain, dimer; Mab thera; Mabthera; Rituxan; Unii-4F4X42syq6; Retuxin |
Ritonavir-d6 | 1217720-20-1 | C37H42N6O5S2D6 | 727 | (3S,4S,6S,9S)-4-Hydroxy-12-methyl-9-(1-methylethyl-d6)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-thiazolylmethyl Ester; A 84538-d6; ABT 538-d6; Norvir-d6 |
Ritonavir Impurity O | 1414933-81-5 | C37H48N6O5S2 | 720.96 | Thiazol-5-ylmethyl ((2S,3R,5S)-3-Hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl)carbamate; (3S,4R,6S,9S)-4-Hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo- |
Ritonavir Impurity L | 256328-82-2 | C33H43N5O4S | 605.81 | (2S)-3-Methyl-2-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-N-[(1S)-1-[[(4S,5S)-2-oxo-4-(phenylmethyl)-5-oxazolidinyl]methyl]-2-phenylethyl]-butanamide; |
Ritonavir Impurity H | 1010809-43-4 | C30H32N4O6S | 576.68 | (4S,5S)-4-Benzyl-5-[(2S)-2-((4S)-4-isopropyl-2,5-dioxoimidazolidin-1-yl)-3-phenylpropyl]-2-oxo-1,3-oxazolidine-3-carboxylate thiazol-5-ylmethyl Ester; , (4S,5S)-5-[(2S)-2-[(4S)-4-(1-methylethyl)-2,5-dioxo-1-imidazolidinyl]-3-phenylpropyl]-2-oxo-4-(phenylm |
Ritonavir Impurity E (Hydroxy Ritonavir) | 176655-56-4 | C37H48N6O6S2 | 736.96 | [5S-(5R*,8R*,10R*,11R*)]-10-Hydroxy-1-[2-(1-hydroxy-1-methylethyl)-4-thiazolyl]-2-methyl-5-(1-methylethyl)-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic Acid 5-Thiazolylmethyl Ester; |
Ritonavir impurity B (Monoacyl Valine) Hydrochloride | 165315-97-9 | C30H39N3O4S.HCl | 574.19 | |
Ritonavir Geo-isomer | 959315-21-0 | C37H48N6O5S2 | 720.96 | (S)-(2S,3S,5S)-5-amino-1,6-diphenyl-2-(((thiazol-5-ylmethoxy)carbonyl)amino)hexan-3-yl 2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoate. - See more at: https://www.clearsynth.com/en/CSO14873.html#sthash.XUZUHQfR.dpuf |
Ritonavir EP Impurity F | 1010809-61-6 | C29H34N4O5S | 550.68 | N-[(1S,2S,4S)-2-Hydroxy-4-[(4S)-4-(1-methylethyl)-2,5-dioxo-1-imidazolidinyl]-5-phenyl-1-(phenylmethyl)pentyl]carbamic Acid 5-Thiazolylmethyl Ester; 1,3-Thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-((4S)-4-isopropyl-2,5- dioxoimidazolidin-1-yl)-5 |
R-Indoxacarb | 185608-75-7 | C22H17F3N3O7 | 527.84 | (4aR)-7-Chloro-2,5-dihydro-2-[[(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]amino]carbonyl]-indeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylic Acid Methyl Ester; (R)-7-Chloro-2,5-dihydro-2-[[(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]amino]carbonyl]-inde |
Rimsulfuron-d6 | 122931-48-0 | C14H11N5O7S2D6 | 437.49 | |
Rifabutin EP Impurity E (25-O-Desacetyl Rifabutin) | 100324-63-8 | C44H60N4O10 | 804.99 | 25-O-Deacetyl-1',4-didehydro-1-deoxy-1,4-dihydro-5'-(2-methylpropyl)-1-oxorifamycin XIV; 25-Hydroxy Rifabutin; 25-O-Deacetylrifabutin; 25-O-Desacetylrifabutin; Antibiotic LM 565; LM 565; |
Rifabutin EP Impurity D | 62041-01-4 | C37H47N3O11 | 709.8 | 3-Amino-1,4-dideoxy-1,4-dihydro-4-imino-1-oxorifamycin; 3-Amino-4-iminorifamycin S; 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, Rifamycin Deriv.; 3-Amino-4-deoxo-4-iminorifamycin S; 3-Amino-4-deoxy-4-iminorifamycin S; 3-Amino-1,4-dideoxy-1 |
Rifabutin EP Impurity B (3-Amino Rifamycin S) | 51756-80-0 | C37H46N2O12 | 710.79 | 3-Amino-1,4-dideoxy-1,4-dihydro-1,4-dioxorifamycin; |
Rifabutin | 72559-06-9 | C46H62N4O11 | 847 | Rifabutin; LM-427; LM 427; LM427; Mycobutin; Rifabutina; |
Ridinilazole | 308362-25-6 | C24H16N6 | 388.42 | SMT19969; 2,2'-di(pyridin-4-yl)-1H,1'H-5,5'-bi(benzimidazole); |
Ridaifen-B | 886465-70-9 | C34H42N2O2 | 510.7 | 1-[2-[4-[2-phenyl-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]but-1-enyl]phenoxy]ethyl]pyrrolidine |
Ridaforolimus | 572924-54-0 | C53H84NO14P | 990.222 | Deforolimus; AP23573; MK8669 |
Richenoic acid | 134476-74-7 | C30H48O3 | 456.7 | 3-{(3S,3aR,5aR,6S,7S,9aR,9bR)-7-Isopropenyl-3-[(2S,5S)-5-isoprope nyl-2-methyltetrahydro-2-furanyl]-6,9a,9b-trimethyldodecahydro-1H -cyclopenta[a]naphthalen-6-yl}propanoic acid |
Ribuvaptan | 1245620-47-6 | C23H20ClF6N5O5 | 595.88 | UNII-6004MB8Y0D; 6004MB8Y0D;[(2R)-2-[[2-[3-(4-chlorophenyl)-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hydroxypropyl]-1,2,4-triazol-1-yl]acetyl]amino]-2-[3-(trifluoromethyl)phenyl]ethyl] carbamate |
R-Ibuprofen | 51146-57-7 | C13H18O2 | 206.28 | l-Ibuprofen; Levibuprofen; (R)-(-)-Ibuprofen; (R)-Ibuprofen; |
Ribostamycin sulfate | 53797-35-6 | C17H34N4O10.H2O4S | 552.55 | Vistamycin Sulfate |
Ribonucleic acids,transfer, phenylalanine-specific, Escherichia coli | 92129-41-4 | |||
Ribonucleic acid | 63231-63-0 | pentosenucleicacids; Ribonucleicacids; RIBONUCLEIC ACID-CORE TYPE II-C; RIBONUCLEIC ACID-CORE TYPE XI-C; RIBONUCLEIC ACID TRANSFER, VALINE*SPECIF IC FROM E.; RIBONUCLEIC ACID, TRANSFER*PHENYLALANINE SPECIFIC F; RIBONUCLEIC ACID FROM BAKER'S YEAST; RIBONU | ||
RIBONUCLEASE T2 FROM ASPERGILLUS ORYZAE | 37278-25-4 | |||
Ribavirin 5'-triphosphate | 63142-71- | C8H14N4O14P3 | 484.14 | |
Ribavirin 5'-monophosphate lithium salt | 66983-94-6 | C8H11N4O8P·2Li | 336.1 | Dilithium [5-(3-carbamoyl-1,2,4-triazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
Ribavirin 5'-Diphosphate Lithium Salt | 63142-70-1 | C8H12N4O11P2.2 Li | 416.03 | |
Ribavirin | 36791-04-5 | C8H12N4O5 | 244.20864 | NSC-163039, ICN-1229 ,RTCA, Tribavirin |
Ribaric acid disodium salt | 33012-62-3 | C5H6Na2O7 | 224.08 | Disodium ribarate |
RI-2 | 1417162-36-7 | C21H18Cl2N2O4 | 433.28 | 1-(3,4-dichlorophenyl)-3-(4-methoxyphenyl)-4-morpholin-4-ylpyrrole-2,5-dione RI-2 CHEMBL2316726 1417162-36-7 C21H18Cl2N2O4 SCHEMBL15758872 AOB3500 BDBM50424495 AKOS026750570 HY-16904 B5881 1-(3,4-Dichlorophenyl)-3-morpholino-4-(4-methoxyphenyl) |
RI-1 | 415713-60-9 | C14H11Cl3N2O3 | 361.61 | RAD51 inhibitor 1 |
Rhynchophylline | 76-66-4 | C22H28N2O4 | 384.47 | Mitrinermine;Methyl (E)-2-[(3R,6'R,7'S,8'aS)-6'-ethyl-2-oxospiro[1H-indole-3,1'-3,5,6,7,8,8a-hexahydro-2H-indolizine]-7'-yl]-3-methoxyprop-2-enoate;Corynoxan-16-carboxylicacid, 16,17-didehydro-17-methoxy-2-oxo-, methyl ester, (7b,16E,20a)-;Spiro[3H-indole |
RHODIUM(II) HEPTAFLUOROBUTYRATE DIMER | 73755-28-9 | C16F28O8Rh2 | 1057.93 | |
Rhodium(1+),bis(2,2'-bipyridine-kN1,kN1')dichloro-, chloride (9CI) | 14551-15-6 | C20H16 Cl2 N4 Rh . Cl | 521.6323 | cis-Bis(2,2'-bipyridine)dichlororhodiumchloride; cis-Dichlorobis(2,2'-bipyridine-N,N')rhodiumchloride; (OC-6-22)-Bis(2,2'-bipyridine-N,N')dichlororhodiumchloride; Rhodium(1+),bis(2,2'-bipyridine)dichloro-,chloride,(Z)-; 14551-15-6; 2-pyridin-2-ylpyridine |
Rhodium tris(isononanoate) | 93963-87-2 | C27H51O6Rh | 574.59600 | |
Rhodium (II) octanoate dimer | 73482-96-9 | C32H60O8Rh2 | 778.63 | RHODIUM(III)OCTANOATE DIMER; RHODIUM (II) OCTANOATE DIMER; RHODIUM OCTANOATE DIMER; Rhodiumoctanoatedimergreenpowder; Rhodium(II)octanoatedimer,98%; Rhodium(II)octanoate |
Rhodium (II) acetate dimer dihydrate | 5503-41-3 | 2(C4H6O4).2Rh.2H2O | 478.02 | |
Rhodionin | 85571-15-9 | C21H20O11 | Herbacetin 7-O-a-rhamnopyranoside | |
Rhodiolin | 86831-53-0 | C25H20O10 | 480.42 | rel-(2R,3R)-2,3-Dihydro-6,8-dihydroxy-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-9-(4-hydroxyphenyl)-7H-pyrano[2,3-f]-1,4-benzodioxin-7-one; 2,3-Dihydro-6,8-dihydroxy-3beta-(4-hydroxy-3-methoxyphenyl)-2alpha-(hydroxymethyl)-9-(4-hydroxyphenyl)-7H-pyr |
Rhodiocyanoside A | 168433-86-1 | C11H17NO6 | 259.258 | (2Z)-4-(beta-D-glucopyranosyloxy)-2-methylbut-2-enenitrile; (2Z)-2-methyl-4-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}but-2-enenitrile |
Rhenium pentabromide | 30937-53-2 | Br5Re | 585.727 | |
Rhenium hexafluoride | 10049-17-9 | ReF6 | 300.2 | (oc-6-11)-rheniumfluoride(ref6; ReF6; Rhenium fluoride (ReF6), (OC-6-11)-; RHENIUM(VI) FLUORIDE; RHENIUM HEXAFLUORIDE; RHENIUM FLUORIDE |
Rhein-13C4 | 1189928-10-6 | C15H8O6 | 288.18 | |
Rhein 8-b-D-glucuronide | 70793-10-1 | C21H16O12 | 460.34 | |
Rhein 1-D-glucuronide | 71938-10-8 | |||
Rheediaxanthone A | 77181-97-6 | C23H20O6 | 392.407 | |
RHC 80267 | 83654-05-1 | C20H34N4O4 | 394.51 | O,O'-[1,6-Hexanediylbis(iminocarbonyl)]dioxime cyclohexanone |
Rhapontisterone | 137476-71-2 | C27H44O8 | 496.63 | Punisterone |
Rhapontigenin 3'-O-glucoside | 94356-22-6 | C21H24O9 | 420.4 | |
Rhapontigenin | 500-65-2 | C15H14O4 | 258.3 | Protigenin; (E)-5-(3-Hydroxy-4-methoxystyryl)benzene-1,3-diol; 5-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]benzene-1,3-diol |
Rhaponticin 6''-gallate | 94356-23-7 | C28H28O13 | 572.51 | Rhaponticin 6''-O-gallate |
Rhaponticin 2''-gallate | 94356-24-8 | C28H28O13 | 572.51 | Rhaponticin 2''-O-gallate |
Rhaponticin | 155-58-8 | C21H24O9 | 420.41 | Rhapontin 4-Methoxy-3,3,5-stilbenetriol-3-glucoside |
Retigabine | 150812-12-7 | C16H18FN3O2 | 303.33 | Ezogabine; Potiga; ethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate |
Reticulol | 26246-41-3 | C11H10O5 | 222.2 | 6,8-Dihydroxy-7-methoxy-3-methylisocoumarin |
Reticuline | 485-19-8 | C19H23NO4 | 329.4 | (S)-1,2,3,4-tetrahydro-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methylisoquinolin-7-ol |
RETF-4NA | 1160928-63-1 | C32H43N9O10 | 713.75 | acetyl-L-Arg-Glu-Thr-Phe-4-nitroanilide |
Retaspimycin Hydrochloride | 857402-63-2 | C31H48ClN3O8 | 626.17 | |
Retaspimycin | 857402-23-4 | C31H45N3O8 | 587.70 | IPI-504 |
Retapamulin Impurity 7 | 35136-87-9 | C10H18O3S | 218.32 | |
Reserpine hydrochloride | 16994-56-2 | C33H41ClN2O9 | 645.14 | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;hydrochloride Reserpine hydrochloride Reserpine (hydrochloride) 16994-56-2 Reserpine HCl UNII-GWN3C4FT |
Reserpine | 50-55-5 | C33H40N2O9 | 608.68 | |
Reserpic | 83-60-3 | C22H28N2O5.HCl | 436.91 | |
Resatorvid | 243984-11-4 | C15H17ClFNO4S | 361.82 | TAK-242; TAK 242; TAK242; Resatorvid; UNII-H2MZ648C31; ethyl (6R)-6-[(2-chloro-4-fluorophenyl)sulfamoyl]cyclohexene-1-carboxylate |
Reposal | 3625-25-0 | C14H18N2O3 | 0 | Reposal; 5-Ethyl-5-(bicyclo[3.2.1]oct-2-en-3-yl)pyrimidine-2,4,6(1H,3H,5H)-trione; Reposal Novo; Reposamal; WT-161; 5-(3-bicyclo[3.2.1]oct-3-enyl)-5-ethyl-1,3-diazinane-2,4,6-trione; 5-(3-bicyclo[3.2.1]oct-3-enyl)-5-ethyl-barbituric acid |
Repirinast | 73080-51-0 | C20H21NO5 | 355.39 | 4H-Pyrano[3,2-c]quinoline-2-carboxylic acid, 5,6-dihydro-7,8-dimethyl-4,5-dioxo-, 3-methylbutyl Ester; MY 5116; Romet; |
Reparixin L-lysine salt | 266359-93-7 | C20H35N3O5S | 429.57 | Repertaxin L-lysine salt |
Reparixin | 266359-83-5 | C14H21NO3S | 283.39 | (R)-2-(4-isobutylphenyl)propionylmethanesulfonamide; 2-(4-isobutylphenyl)propionylmethanesulfonamide; repertaxin |
Repaglinide-ethyl-d5 | 1217709-85-7 | C27H31N2O4D5 | 457.63 | 2-(Ethoxy-d5)-4-[2-[[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid; AG-EE-623-d5; Novonorm-d5; Prandin-d5 |
Repaglinide Impurity IV | 646054-50-4 | C23H37N3O | 371.57 | |
Repaglinide Impurity A | 220438-80-2 | C11H12O5 | 224.22 | 4-Carboxy-3-ethoxybenzeneacetic Acid; Repaglinide EP Impurity A |
Repaglinide Impurity 2 | 219921-93-4 | C16H26N2 | 246.4 | |
Repaglinide impurity (R-Repaglinide Ethyl Ester) | 147770-08-9 | C29H40N2O4 | 480.65 | 2-Ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid Ethyl Ester |
Repaglinide | 135062-02-1 | C27H36N2O4 | 452.59 | Repaglinide; AG-EE 388 ZW; AG-EE388 ZW; AG-EE-388 ZW; AG-EE 623 ZW, AG-EE623 ZW, AG-EE-623 ZW, Prandin, GlucoNorm, Surepost, NovoNorm |
REP 3123 dihydrochloride | 1013915-99-5 | C19H19Br2N3O2S.2HCl | 586.17 | 5-[(3-{[(4R)-6,8-Dibromo-3,4-dihydro-2H-chromen-4-yl]amino}propyl)amino]thieno[3,2-b]pyridin-7(4H)-one dihydrochloride |
Reomet 39 | 94270-86-7 | |||
Renzapride hydrochloride | 109872-41-5 | C16H23Cl2N3O2 | 323.83 | |
RENNIN FROM CALF STOMACH ACTIVITY: 20 UNITS MG | 9001-98-3 | |||
Rediocide A | 280565-85-7 | C44H58O13 | 794.92 | |
Redaporfin | 1224104-08-8 | C48H38F8N8O8S4 | 1135.11 | 3,3',3'',3'''-(7H,8H,17H,18H-porphyrin-5,10,15,20-tetrayl)tetrakis(2,4-difluoro-N-methylbenzenesulfonamide |
Red Ferric Oxide | 1309-37-1 | Fe2O3 | 159.69 | Iron(III) Oxide |
Recoflavone | 203191-10-0 | C20H18O8 | 386.356 | 2-[2-(3,4-dimethoxyphenyl)-5-methoxy-4-oxochromen-7-yl]oxyacetic acid; 7-carboxymethoxyloxy-3',4',5-trimethoxyflavone; DA 6034; DA-6034; recoflavone |
Recilisib | 334969-03-8 | C16H13ClO4S | 336.786 | ON 01210.Na; ON 01210; ON01210; ON-01210 |
Recaldent | 691364-49-5 | |||
Recainam | 74738-24-2 | C15H25N3O | 263.379 g/mol | |
Rec 15/2615 dihydrochloride | 173059-17-1 | C26H33N5O5.2HCl | 568.49 | 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[[2-methoxy-6-(1-methylethyl)phenoxy]acetyl]piperazine dihydrochloride; REC-2615; Rec-15; 2615; REC2615; Rec15; REC 2615; Rec 15 |
Reboxetine mesylate | 71620-89-8 | C19H23NO3.CH3SO3H | 409.50 | (2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine; methanesulfonic acid; 2-((2-ethoxyphenoxy)benzyl)morpholine methanesulfonate; reboxetine; reboxetine mesylate; Vestra; 98769-84-7; Reboxetine mesilate; Reboxetine (mesylate); Edronax; PNU 155950E; FCE |
Reboxetine Mesylate | 98769-84-7 | C19H23NO3·CH4O3S | 409.5 | PNU 155950E |
Reboxetine | 98769-81-4 | C19H23NO3.CH4O3S | 313.39 | (2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine; 2-((2-ethoxyphenoxy)benzyl)morpholine methanesulfonate; reboxetine; reboxetine mesylate; Vestra; Reboxetine; Edronax (TN); AC1L2RJ0; Vestra; Reboxetine (INN); D08472; 98769-81-4; (2R)-2-[(R)-(2-ethoxy |
Rebimastat | 259188-38-0 | C23H41N5O5S | 499.671 | BMS-275291 |
Rebeccamycin | 93908-02-2 | C27H21Cl2N3O7 | 570.4 | |
Rebaudioside O | 1220616-48-7 | C62H100O37 | 1437.44 | 13-[(O-b-D-Glucopyranosyl-(1,2)-O-[b-D-glucopyranosyl-(1,3)]-b-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid (4)-O-b-D-glucopyranosyl-(1,3)-O-6- deoxy-L-mannopyranosyl-(1,2)-O-[b-D-glucopyranosyl-(1,3)]-b-D-glucopyranosyl ester; Reb O |
Rebaudioside N | 1220616-46-5 | C56H90O32 | 1275.29 | 13-[(O-b-D-Glucopyranosyl-(1,2)-O-[b-D-glucopyranosyl-(1,3)]-b-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid (4)-O-6-deoxy-L-mannopyranosyl-(1,2)-O-[b-D-glucopyranosyl-(1,3)]-b-D-glucopyranosyl ester; Reb N |
Rebaudioside M | 1220616-44-3 | C56H90O33 | 1291.29 | 13-[(O-b-D-Glucopyranosyl-(1,2)-O-[b-D-glucopyranosyl-(1,3)]-b-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid (4)-O-b-D-glucopyranosyl-(1,2)-O-[b-D-glucopyranosyl-(1,3)]-b-D-glucopyranosyl ester; Reb M; Reb X |
Rebaudioside I | 1220616-34-1 | C50H80O28 | 1129.15 | |
Reactive Red 23 | 12769-07-2 | 0 | C.I. Reactive Red 23; Reactive red 23 (C.I. 16202) | |
Reactive Red 180 | 72828-03-6 | C29H19N3O17S5.4Na | 0 | Adizol Red 3B; Dinazol Red F3B; Dyetron Red ME3BN; Hostalan Red F3B; Kemactive Red CE3B; Lamafix Red F3B; Pamarrex Red R5B; Reactive Red F3B |
reactive orange 14 practical grade | 12225-86-4 | C19H12Cl2N8O9S2 | 631.37 | REACTIVE ORANGE 14; reactive orange 14 practical grade; REACTIVEORANGENO14; Reactive orange 14 (C.I. 19138); C.I. Reactive Orange 14; 1H-Pyrazole-3-carboxylic acid, 4-[[4-[(4, 6-dichloro-1, 3, 5-triazin-2-yl)amino]-2-sulfophenyl]azo]-4, 5-dihydro-5-oxo-1- |
Reactive Blue 4 | 13324-20-4 | C23H14Cl2N6O8S2 | 637.43 | 1-AMINO-4-[3-(4,6-DICHLOROTRIAZIN-2-YLAMINO)-4-SULFOPHENYLAMINO] ANTHRAQUINONE-2-SULFONIC ACID; CI NO 61205; CI 61205; PROCION BLUE MX-R; PROCION BLUE MX-R(R); PROCION BRILLIANT BLUE MR |
Reactive blue 2 (C.I. 61211) | 12236-82-7 | C29H17ClN7Na3O11S3 | 774.1574 | BASILEN BLUE E-3G; CI NO 61211; CI 61211; CIBACRON BLUE F3GA; CIBACRON BLUE 3G-A; 1-AMINO-4-[[4-[[4-CHLORO-6-[[3 (OR 4)-SULFOPHENYL]AMINO]-1,3,5-TRIAZIN-2-YL]AMINO]-3-SULFOPHENYL]AMINO]-9,10-DIHYDRO-9,10-DIOXO-2-ANTHRACENESULFONIC ACID |
Reactive Blue 19 | 2580-78-1 | C22H16N2Na2O11S3 | 626.54 | 2-anthracenesulfonicacid,1-amino-9,10-dihydro-4-(m-((2-hydroxyethyl)sulfonyl); 2-anthracenesulfonicacid,1-amino-9,10-dihydro-9,10-dioxo-4-((3-((2-(sulfooxy); 2-anthracenesulfonicacid,1-amino-9,10-dihydro-9,10-dioxo-4-[[3-[[2-(sulfooxy); anilino)-9,10-diox |
Reactive Black 31 | 12731-63-4 | 0 | Reactive Black 31; Britasol Black N; C.I.Reaction Black 31; Dinazol Black RL; Indofix Black VRI; Navictive Black RL; Reaction Black RL; Reactofix Supra Black HRL | |
RBI 257 maleate | 911378-38-6 | C21H28IN3O·C4H4O4 | 581.4 | (Z)-But-2-enedioic acid; N-[1-[(4-iodophenyl)methyl]piperidin-4-yl]-N-methyl-3-propan-2-yloxypyridin-2-amine |
RBC8 | 361185-42-4 | C25H20N4O3 | 424.45 | |
Ramosetron Hydrochloride | 132907-72-3 | C17H17N3O.HCl | 315.80 | Ramosetron hydrochloride; Nasea; Ramosetron HCl; (R)-(1-Methyl-1H-indol-3-yl)(4,5,6,7-tetrahydro-1H-benzo[d]imidazol-6-yl)methanone hydrochloride; YM 060 |
Ramoplanin complex | 76168-82-6 | C119H154ClN21O40 (for A2) | 2554.1 | |
R-Amlodipine | 103129-81-3 | C20H25ClN2O5 | 408.89 | (R)-Amlodipine; (R)-(+)-Amlodipine; (R)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
Radalbuvir | 1314795-11-3 | C30H41NO6S | 543.72 | GS-9669;5-(3,3-dimethyl-1-butyn-1-yl)-3-((cis-4-hydroxy-4-((((3S)-tetrahydro-3-furanyl)oxy)methyl)cyclohexyl)(((1R)-4-methyl-3-cyclohexen-1-yl)carbonyl)amino)- 2-Thiophenecarboxylic acid |
Radafaxine Hydrochloride | 106083-71-0 | C13H19Cl2NO2 | 292.20 | Radafaxine hydrochloride; Radafaxine (hydrochloride); UNII-SYD411HZ3S; (2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol hydrochloride; SS-hydroxybupropion hydrochloride |
RAD1901 HCl salt | 1349723-93-8 | C30H40Cl2N2O2 | 531.56 | (R)-6-(2-(ethyl(4-(2-(ethylamino)ethyl)benzyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol dihydrochloride; RAD1901; RAD-1901; RAD 1901; RAD1901 HCl salt; Elacestrant dihydrochloride |
rac-Benidipine HCl | 91599-74-5 | C28H31N3O6·HCl | 542.02 | KW-3049; KW 3049; KW3049 |
rac-Astaxanthin | 7542-45-2 | C40H52O4 | 596.852 | 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; Astaxanthin |
Racanisodamine | 17659-49-3 | C17H23NO4 | Anisodamine | |
R-932348 | 916742-11-5 | C23H22FN5O4S | 483.52 | Propanamide, N-[[5-[[5-fluoro-4-[[4-(2-propyn-1-yloxy)phenyl]amino]-2-pyrimidinyl]amino]-2-methylphenyl]sulfonyl]- |
R916562 | 1037798-41-6 | C26H30ClN9S | 536.09 | |
R-59-949 | 120166-69-0 | C28H25F2N3OS | 489.6 | Diacylglycerol Kinase Inhibitor II; DKGI-II; R 59949; R 59 949 |
R547 | 741713-40-6 | C18H21F2N5O4S | 441.45 | Ro4584820; R 547 |
R406 | 841290-81-1 | C28H29FN6O8S | 628.63 | |
R406 | 841290-80-0 | C22H23FN6O5 | 470.45 | R 406; R-406 |
R306465 | 604769-01-9 | C19H19N5O4S | 413.452 | R 306465; JNJ-16241199; JNJ16241199; JNJ 16241199 |
R-268712 | 879487-87-3 | C20H18FN5O | 363.39 | R 268712 |
R18 | 211364-78-2 | C101H157N27O29S3 | 2309.69 | L-Prolyl-L-histidyl-L-cysteinyl-L-valyl-L-prolyl-L-arginyl-L-a-aspartyl-L-leucyl-L-seryl-L-tryptophyl-L-leucyl-L-a-aspartyl-L-leucyl-L-a-glutamyl-L-alanyl-L-asparaginyl-L-methionyl-L-cysteinyl-L-leucyl-L-proline trifluoroacetate; PHCVPRDLSWLDLEANMCLP trif |
R162 | 64302-87-0 | C17H12O3 | 264.28 | 1-hydroxy-2-prop-2-enylanthracene-9,10-dione; 2-allyl-1-hydroxy-anthraquinone; 2-allyl-1-hydroxyanthra-9,10-quinone; 1-hydroxy-2-prop-2-enylanthracene-9,10-dione; AC1N9MGY |
R1530 | 882531-87-5 | C18H14ClFN4O | 356.78136 | R-1530; R 1530 |
R1487 HCl | 449808-64-4 | C19H19ClF2N4O3 | 424.83 | R1487 ; R 1487 ; R-1487 ; R1487 HCl. |
R-1479 | 478182-28-4 | C9H12N6O5 | 284.23 | 4'-Azidocytidine |
R-130823 | 321344-32-5 | C28H26FN3 | 423.535 | R-130823; R130823; R 130823 |
R-121919 | 195055-03-9 | C22H32N6 | 380.53 | R-121,919;3-(6-(DIMETHYLAMINO)-4-METHYLPYRIDIN-3-YL)-2,5-DIMETHYL-N,N-DIPROPYLPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE; 3-[6-(Dimethylamino)-4-methyl-3-pyridinyl]-2,5-dimethyl-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-amine |
R112 | 575474-82-7 | C16H13FN4O2 | 312.3 | R112 |
R-106583-d3 (Prasugrel Metabolite) | 1795133-28-6 | C19H19FNO3SD3 | 366.47 | 2-[1-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-(methyl-d3-thio)-3-piperidinylidene]acetic Acid; R 106583-d3; Prasugrel Metabolite M5-d3 |
R-1,1'-BINAPHTHALENE-2,2'-DIIODO | 86688-06-4 | C20H12I2 | 506.115 | R-1,1'-BINAPHTHALENE-2,2'-DIIODO; (R)-1,1''-BINAPHTHALENE-2,2''-DIIODO ((R)-2,2''-DIIODO-1''1-BINAPHTHYL) |
R-1 methanandamide | 157182-49-5 | C23H39NO2 | 361.6 | (R)-methanandamide; R(+)-Methanandamide; R-(+)-methanandamide; AM-356; AM 356; AM356; (R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide |
R,S-Flurbiprofen-acyl-b-D-glucuronide | 91683-37-3 | C21H21FO8 | 420.39 | |
R,S-Equol 7-b-D-glucuronide sodium salt | 38482-82-5 | C21H21NaO9 | 440.38 | 3,4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-yl-b-D-glucuronide |
R,S-cis-3,5-Dimethyl-morpholine | 45597-00-0 | C6H13NO | 115.18 | |
R,S-Ambrisentan-acyl-b-D-glucuronide | 1106685-82-8 | C28H30N2O10 | 554.55 | |
R-(3)-Hydroxymyristic acid | 28715-21-1 | C14H28O3 | 244.37 | DL-BETA-HYDROXYMYRISTIC ACID; HYDROXYMYRISTIC ACID, 3-; (+/-)-3-HYDROXYTETRADECANOIC ACID; 3-HYDROXYTETRADECANOIC ACID; 3-HYDROXY C14:0 ACID; 3-HYDROXYMYRISTIC ACID |
R(+)-SULPIRIDE | 23756-79-8 | C15H23N3O4S | 341.43 | Sulpiride CP2000 JP13; Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-, (R)-; Benzamide, 5-(aminosulfonyl)-N-[[(2R)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy- (9CI); d-Sulpiride |
R(+)-IAA-94 | 54197-31-8 | C17H18Cl2O4 | 357.23 | Indanyloxyacetic acid; 2-[[(2S)-6,7-dichloro-2-cyclopentyl-2-methyl-1-oxo-3H-inden-5-yl]oxy]acetic acid; (R)-[(6,7-Dichloro-2-cyclopentyl-2,3-dihydro-2-methyl-1-oxo-1H-inden-5-yl)oxy]acetic Acid; |
R(+)-Gomisin M1 | 82467-50-3 | C22H26O6 | 386.4 | Gomisin M |
R-(+)-Carvedilol | 95093-99-5 | C24H26N2O4 | 406.49 | (+)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol; (+)-Carvedilol; (R)-Carvedilol; |
R(+)Bay K 8644 | 98791-67-4 | C16H15F3N2O4 | 356.31 | |
R(+)-7-HYDROXY-2-DIPROPYLAMINO TETRALIN& | 82730-72-1 | C16H25NO | 247.3758 | |
R-(+)-6,6'-BIS(DIPHENYLPHOSPHINO)-1,1'-BIPHENYL-2,2'-DIYLBIS(CYCLOHEXYLCARBOXYLATE), 99% (R)-CYCLOHEXYL SONIPHOS | 398128-03-5 | C50H48O4P2 | 774.88 | |
R-(-)-O-Desmethyl-Venlafaxine-d6 | 1062609-96-4 | C16H19D6NO2 | 269.37 | (R)-4-(2-(bis(methyl-d3)amino)-1-(1-hydroxycyclohexyl)ethyl)pheno |
R-(-)-O-Desmethyl-Venlafaxine | 142761-11-3 | C16H25NO2 | 263.38 | (R)-(-)-4-[2-(Dimethylamino)-1-(1-hydroxycyclo-hexyl)ethyl]phenol; (-)-O-Desmethylvenlafaxine; (R)-(-)-O-Desmethylvenlafaxine |
R(-)-N-Propylnorapomorphine hydrobromide | 85199-01-5 | C19H21NO2.HBr | 376.29 | |
R(-)-Norapomorphine hydrobromide | 115017-61-3 | C16H15NO2.HBr | 334.21 | (R)-5,6,6a,7-Tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol hydrobromide |
R(-)-N-Ethylnorapomorphine hydrochloride | 123240-93-7 | C18H19NO2.HBr | 362.26 | (6aR)-6-ethyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol hydrobromide |
(R)-Mevalonolactone | 19115-49-2 | C6H10O3 | 130.14 | (-)-Mevalonolactone; (4R)-Tetrahydro-4-hydroxy-4-methyl-2H-Pyran-2-one; (-)-(R)-Mevalonic Acid Lactone; (-)-(R)-Mevalonolactone |
R-(-)-Manidipine-d4 | 1217718-54-1 | C35H34N4O6D4 | 614.72 | (4R)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[4-(Diphenylmethyl)-1-piperazinyl]ethyl-d4 Methyl Ester; (-)-Manidipine-d4 |
R-(-)-Manidipine | 133082-19-6 | C35H38N4O6 | 610.7 | (4R)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[4-(Diphenylmethyl)-1-piperazinyl]ethyl Methyl Ester; (-)-Manidipine |
R(-)-GAMMA-VINYL GABA | 77162-51-7 | C6H11NO2 | 129.158 | |
R-(-)-Flecainide | 99495-90-6 | C17H20F6N2O3 | 414.35 | N-[(2R)-2-Piperidinylmethyl]-2,5-bis(2,2,2-trifluoroethoxy)benzamide; (R)-Flecainide; (-)-Flecainide; |
R-(-)-Arundic Acid | 185517-21-9 | C11H22O2 | 186.29 | (2R)-2-propyloctanoic acid; (R)-(-)-2-propyloctanoic acid; arundic acid; ONO-2506; ONO2506 |
R(-)-2 10 11-TRIHYDROXYAPORPHINE | 77630-01-4 | C17H17N1O3 | 364.23 | |
R 892 | 229030-05-1 | C58H83N13O12 | 1154.37 | (1Z,4Z,6S,7Z,9S,10Z,12R,13Z,15S)-1-((S)-1-((S)-1-((S)-2-((Z)-((S)-6-amino-1-hydroxy-2-((Z)-(1-hydroxyethylidene)amino)hexylidene)amino)-5-guanidinopentanoyl)pyrrolidine-2-carbonyl)pyrrolidin-2-yl)-6-benzyl-15-((S)-sec-butyl)-1,4,7,10,13-pentahydroxy-9-(hy |
R 715 | 185052-09-9 | C57H81N13O12 | 1140.35 | |
R 59-022 | 93076-89-2 | C27H26FN3OS | 459.58 | 6-[2-[4-[(4-Fluorophenyl)phenylmethylene]-1-piperidinyl]ethyl]-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one; Diacylglycerol Kinase Inhibitor I |
R 568 hydrochloride | 177172-49-5 | C18H22ClNO.HCl | 340.29 | 2-Chloro-N-[(1R)-1-(3-methoxyphenyl)ethyl]-benzenepropanamine hydrochloride; 2-Chloro-N-[(1R)-1-(3-methoxyphenyl)ethyl]-benzenepropanamine Hydrochloride (9CI); (R)-2-Chloro-N-[(1R)-1-(3-methoxyphenyl)ethyl]-benzenepropanamine Hydrochloride; KRN 568; NPS-R |
Quinoline-4-carbonitrile | 2973-27-5 | C10H6N2 | 154.17 | 4-CYANOQUINOLINE; QUINOLINE-4-CARBONITRILE; cinchoninonitrile |
Quinoline,6-bromo-1,2-dihydro-2,2,4-trimethyl- | 91720-32-0 | C12H14 Br N | ||
Quinoline,3-bromo-7-chloro- | 84973-05-7 | C9H5 Br Cl N | 242.50000 | |
Quinoline,2-bromo-6-methoxy- | 476161-59-8 | C10H8 Br N O | 238.08062 | 2-BROMO-6-METHOXYQUINOLINE |
Quinoline,2-(chloromethyl)-6-methyl- | 22989-38-4 | C11H10 Cl N | 191.6568 | 2-(CHLOROMETHYL)-6-METHYL QUINOLINE; Quinoline,2-(chloromethyl)-6-methyl- |
Quinoline Blue | 523-42-2 | C29H35IN2 | 538.51 | (4E)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline; iodide; QuinolineBlue; 523-42-2; (4E)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinolineiodide; 1-(3-Methylbutyl)-4-((1-(3-methylbutyl)-4( |
Quinolin-2-ylmethanol | 1780-17-2 | C10H9NO | 159.18456;g/mol | quinolin-2-ylmethanol; 2-Quinolinylmethanol; 1780-17-2; 2-Quinolinemethanol; 2-(Hydroxymethyl)quinoline; 2-Quinolylmethanol |
Quinolactacin A1 | 815576-68-2 | C16H18N2O2 | 270.3 | |
Quinocetone | 81810-66-4 | C18H14N2O3 | 306.32 | QUINOCETONE; 1-(3-Methyl-1,4-dioxido-2-quinoxalinyl)-3-phenyl-2-propen-1-one; 1-(3-Methyl-2-quinoxalinyl)-3-phenyl-2-propen-1-one N,N'-dioxide |
Quininib | 143816-42-6 | C17H13NO | 247.29 | 2-[(E)-2-(quinolin-2-yl)ethenyl]phenol; (E)-2-(2-(quinolin-2-yl)vinyl)phenol; AC1Q791J |
Quinazolin-8-ylamine | 101421-74-3 | C8H7N3 | 145.16100 | |
QUINAPYRAMINE SULPHATE | 23609-66-7 | |||
QUINAPYRAMINE | 20493-41-8 | C17H22N6+2 | 310.4 | QUINAPYRAMINE |
Quinaldopeptin | 130743-07-6 | C62H78N14O14 | 1243.4 | BMY 28662, BU 3845T |
Quetiapine Impurity S (Quetiapine Sulfoxide) | 329216-63-9 | C21H25N3O3S | 399.51 | ETHANOL, 2-[2-[4-(5-OXIDODIBENZO[B,F][1,4]THIAZEPIN-11-YL)-1-PIPERAZINYL]ETHOXY]-;2-[2-[4-(5-Oxidodibenzo[b,f][1,4]Thiazepin-11-Yl)-1-Piperazinyl]ethoxy] Ethanol;Quetiapine Sulfoxide;11-yl)-1-piperazinyl]ethoxy]-;Ethanol, 2-[2-[4-(5-oxidodibenzo[b,f][1,4 |
Quetiapine Impurity N | 1800291-86-4 | C29H41N5O3S | 539.73 | 2-(2-(4-(2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethyl)piperazin-1-yl)ethoxy)ethanol; Quetiapine EP Impurity N; |
Quetiapine Impurity L | 1371638-11-7 | C21H24ClN3O2S | 417.96 | 2-[2-[4-(9-Chlorodibenzo[b,f][1,4]thiazepin-11-yl)-1-piperazinyl]ethoxy]ethanol;9-Chloro Quetiapine |
Quetiapine Impurity 1 | 1011758-00-1 | C22H25N3O4S | 427.53 | 4-Dibenzothiazepin-11-yl-1-piperazinecarboxylic Acid 2-(2-Hydroxyethoxy)ethyl Ester; Quetiapine Carboxylate Impurity |
Quetiapine Hemifumarate | 111974-72-2 | C46H54N6O8S2 | 883.09 | ICI-204636; ICI 204636; ICI204636 |
Quetiapine D4 fumarate | 1287376-15-1 | C25H25D4N3O6S | 503.60 | Seroquel D4 |
Quetiapine | 111974-69-7 | C21H25N3O2S | 383.51 | QUETIAPINE-D4 FUMARATE;QUETIAPIN;2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol;Quetiapine;11-[4-[2-(2-Hydroxyethoxy)ethyl]piperazino]dibenzo[b,f][1,4]thiazepine;2-[2-[4-[Dibenzo[b,f][1,4]thiazepin-11-yl]piperazin-1-yl]ethoxy]etha |
Questiomycin A | 1916-59-2 | C12H8N2O2 | 212.2 | 2-Amino-3H-phenoxazin-3-one, 2-Aminophenoxazone, AV Toxin C, NSC 94945 |
Questinol | 35688-09-6 | C16H12O6 | 300.26 | 1,6-Dihydroxy-3-(hydroxymethyl)-8-methoxy-9,10-anthracenedione; 9,10-Anthracenedione, 1,6-dihydroxy-3-(hydroxymethyl)-8-methoxy-; Omega-Hydroxymethylemodin |
Questin | 3774-64-9 | C16H12O5 | 284.26 | 1,6-Dihydroxy-3-methyl-8-methoxy-9,10-anthraquinone; Emodin-8-methyl ether; 1,6-Dihydroxy-8-methoxy-3-methylanthracene-9,10-dione |
Quercitrin | 522-12-3 | C21H20O11 | 448.38 | Quercitrin; 3-[(-6-Deoxy-a-L-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one |
Quercetin 3-O-neohesperidoside | 32453-36-4 | C27H30O16 | 610.5 | Calendoflavobioside; Quercetin 3-neohesperidoside |
Quercetin 3-O-glucoside-7-O-rhamnoside | 18016-58-5 | C27H30O16 | 610.521 | Vincetoxicoside A; 2-(3,4-dihydroxyphenyl)-5-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one |
Quercetin 3-O-(6''-galloyl)-beta-D-galactopyranoside | 53171-28-1 | C28H24O16 | 616.5 | Hyperin 6''-gallate; Quercetin 3-(6-O-galloylgalactoside) |
Quercetin 3-Methyl Ether 7-Glucuronide | 98751-52-1 | C22H20O13 | 492.4 | |
Quaternaryammonium compounds, dimethylditallow alkyl, chlorides | 68783-78-8 | |||
Quaternaryammonium compounds, coco alkylethyldimethyl, Etsulfates | 68308-64-5 | 0 | Quaternary ammonium compounds, coco alkylethyldimethyl, Et sulfates; COCO-ETHYLDIMONIUM ETHOSULFATE; Catafor F; Quaternare Ammoniumverbindungen, Kokos-alkylethyldimethyl-, Ethylsulfate; Cocodimethylammonium diethyl sulfate; N-Coco-N,N-dimethyl-N-ethylammo | |
Quaternaryammonium compounds, benzyl(hydrogenated tallow alkyl)dimethyl, chlorides | 61789-72-8 | |||
Quaternary ammoniumcompounds, coco alkylbis(hydroxyethyl)methyl, ethoxylated, chlorides | 61791-10-4 | |||
Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides | 68424-95-3 | C32H66Cl2+4 | 521.77244 | Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides; DICAPRYL/DICAPRYLYL DIMONIUM CHLORIDE; di-C8-10-alkyldimethylammonium chloride; Bardac(R) 2050; Mixed Dialkyl Dimethyl Ammonium Chloride; N,N-Dialkyl(C8-10)-N,N-dimethyl Ammonium chloride ( |
Quaternary ammonium compounds, C12-18-alkyl(hydroxyethyl)dimethyl, chlorides | 85736-63-6 | |||
Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides | 85409-23-0 | 0 | Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides; Alkyl(C12-C14) dimethylethylbenzyl ammonium chloride; C12-C14ALKYLDIMETHYL(ETHYLBENZYL)AMMONIUMCHLORIDE; C12-14-Alkyldimethyl(ethylbenzyl)ammonium chloride; C12-14-Alkyld | |
Quassin | 76-78-8 | C22H28O6 | 388.5 | 11,16-trione,2,12-dimethoxy-picrasa-12-diene-1;(3aS,6aR,7aS,8S,11aS,11bS,11cS)-1,3a,4,5,6a,7,7a,8,11,11a,11b,11c-dodecahydro-2,10-dimethoxy-3,8,11a;Picrasa-2,12-diene-1,11,16-trione, 2,12-dimethoxy- |
Quassidine B | 1207862-37-0 | C27H24N4O3 | 452.514 | Dihydropicrasidine A; 3-(4,8-dimethoxy-9H-pyrido[3,4-b]indol-1-yl)-1-(9H-pyrido[3,4-b]indol-1-yl)propan-1-ol |
Quassia extract | 68915-32-2 | 0 | QUASSIA WOOD FLUID EXTRACT; Quassia, ext.; Quassia axtract | |
Quarfloxin | 865311-47-3 | C35H33FN6O3 | 604.686 | CX 3543; CX3543; CX-3543; Quarfloxacin |
Quadrosilan | 33204-76-1 | C18H28O4Si4 | 420.759 | quadrosilan; Cyclotetrasiloxane, 2,2,4,6,6,8-hexamethyl-4,8-diphenyl-, cis-; 2,4,6,6,8-hexamethyl-4,8-diphenyl- cis-cyclotetrasiloxan; 2,6-cis-diphenylhexamethylcyclotetrasiloxane; 2,6-diphenylhexamethyl-, Z-Cyclotetrasiloxane; 6-diphenylhexamethyl- z-cyc |
Quadrone | 66550-08-1 | C15H20O3 | 248.3 | (-)-Quadrone |
QUAB 342 | 41892-01-7 | |||
Q-Switch 5 | 61010-01-03 | 775.32 | 8-[[3-[(6,7-dihydro-2,4-diphenyl-5H-1-benzopyran-8-yl)methylene]-1-cyclohexen-1-yl]methylene]-5,6,7,8-tetrahydro-2,4-diphenyl-1-benzopyrylium perchlorate | |
QO 58 | 1259536-62-3 | C18H8Cl2F4N4O | 443.18 | 5-(2,6-Dichloro-5-fluoro-3-pyridinyl)-3-phenyl-2-(trifluoromethyl)-pyrazolo[1,5-a]pyrimidin-7(4H)-one |
QNZ46 | 1237744-13-6 | C24H17N3O6 | 443.41 | Qnz 46; 1237744-13-6; QNZ46; CHEMBL1215292; C24H17N3O6; (E)-4-(6-Methoxy-2-(3-nitrostyryl)-4-oxoquinazolin-3(4H)-yl)benzoic acid |
QNZ | 545380-34-5 | C22H20N4O | 356.42 | EVP4593 |
QL-IX-55 | 1223002-54-7 | C24H14F4N4O | 450.39 | QL-IX-55 |
Pyrrolo[1,2-b]pyridazin-2(1H)-one,4-hydroxy- | 270902-36-8 | C7H6N2O2 | 150.13474 | Pyrrolo[1,2-b]pyridazin-2(1H)-one,4-hydroxy-; Pyrrolo[1,2-b]pyridazin-2(1H)-one, 4-hydroxy- (9CI) |
Pyrrolo[1,2-a]quinoxalin-2-ol, 1,2,3,3a,4,5-hexahydro-, (2S,3aR)- (9CI) | 214143-87-0 | C11H14N2O | 190.24166 | (2S,3aR)-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinoxalin-2-ol; Pyrrolo[1,2-a]quinoxalin-2-ol,1,2,3,3a,4,5-hexahydro-,(2S,3aR)-(9CI); 214143-87-0; ZINC95923009; HE041015; (2S,3AR)-1,2,3,3A,4,5-HEXAHYDRO-PYRROLO[1,2-A]QUINOXALIN-2-OL |
Pyrrolo[1,2-a]quinoxalin-2-ol, 1,2,3,3a,4,5-hexahydro-, (2R,3aS)- (9CI) | 214143-85-8 | C11H14N2O | 190.24166 | (2R,3aS)-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinoxalin-2-ol; Pyrrolo[1,2-a]quinoxalin-2-ol,1,2,3,3a,4,5-hexahydro-,(2R,3aS)-(9CI); 214143-85-8; SCHEMBL7968489; ZECIZWFKUHNOHM-DTWKUNHWSA-N; ZINC59199334 |
Pyrrolo[1,2-a]quinoxalin-2-ol, 1,2,3,3a,4,5-hexahydro-, (2R,3aR)- (9CI) | 214143-86-9 | C11H14N2O | 190.24166 | (2R,3aR)-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinoxalin-2-ol; 214143-86-9; Pyrrolo[1,2-a]quinoxalin-2-ol,1,2,3,3a,4,5-hexahydro-,(2R,3aR)-(9CI); SCHEMBL7980116; ZECIZWFKUHNOHM-RKDXNWHRSA-N; ZINC82390364 |
Pyrrolo[1,2-a]pyrazine-2(1H)-ethanol, hexahydro- (9CI) | 39186-51-1 | C9H16N2O | 168.23614 | |
Pyrrolo[1,2-a]pyrazine-1-carboxylic acid, octahydro-, methyl ester, (1S,8aS)- (9CI) | 273223-56-6 | C9H16N2O2 | 184.23554 | methyl(1S,8aS)-1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine-1-carboxylate; 273223-56-6; ZINC39114485; Pyrrolo[1,2-a]pyrazine-1-carboxylicacid,octahydro-,methylester,-; Pyrrolo[1,2-a]pyrazine-1-carboxylicacid,octahydro-,methylester,(1S,8aS)-(9CI) |
Pyrrolo[1,2-a]pyrazin-1(2H)-one, hexahydro-2-methyl- (9CI) | 88327-86-0 | C8H14N2O | 154.20956 | |
Pyrrolnitrin | 1018-71-9 | C10H6Cl2N2O2 | 257.07 | Pyrrolnitrine; Pyroace |
PYRROLIDINYL DIAMINOPYRIMIDINE OXIDE | 55921-65-8 | C8H13N5O | 195.22172 | 3-hydroxy-2-imino-5-pyrrolidin-1-ylpyrimidin-4-amine; SCHEMBL432266; PYRROLIDINYLDIAMINOPYRIMIDINEOXIDE |
Pyrrolidinedithiocarbamate Ammonium | 5108-96-3 | C5H9NS2.NH3 | 164.29 | 1-Pyrrolidinecarbodithioic Acid, Ammonium Salt; Ammonium 1-Pyrrolidinecarbodithioat; |
PYRROLIDINE-2,2,3,3,4,4,5,5-D8 | 212625-79-1 | C4HD8N | 79.17 | PYRROLIDINE-2,2,3,3,4,4,5,5-D8; PYRROLIDINE-2,2,3,3,4,4,5,5-D8, 98 ATOM % D; Pyrrole-2,2,3,3,4,4,5,5-D8 |
Pyrrolidine,2-(1,1-dimethylethyl)- | 180258-82-6 | C8H17 N | 127.22728;g/mol | 2-tert-butylpyrrolidine;Pyrrolidine,2-(1,1-dimethylethyl)-;180258-82-6;AC1N7QKM;AC1Q1MGG;2-tert-Butyl-pyrrolidine |
Pyrrolidine, 2-ethynyl- | 853304-19-5 | C6H9 N | 95.14240 | |
Pyrrolidine, 2-ethyl- | 1003-28-7 | C6H13 N | 135.64 | 2-ethylpyrrolidine; 1003-28-7; Pyrrolidine,2-ethyl-; JFZLDRUSMYBXRI-UHFFFAOYSA-N; 2-Ethyl-pyrrolidine; Pyrrolidine,2-ethyl |
Pyrrolidin-3-yl-acetic acid tert-butyl ester | 783301-96-2 | C10H19NO2 | 185.26300 | |
PYRROLIDIN-2-YL-ACETIC ACID TERT-BUTYL ESTER, | 754177-25-8 | C10H19NO2 | 185.26300 | |
Pyroxamide | 382180-17-8 | C13H19N3O3 | 265.313 | Suberoyl-3-aminopyridineamide Hydroxamic Acid |
Pyrotinib | 1269662-73-8 | C32H31ClN6O3 | 582.21 | (R,E)-N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)acrylamide; Pyrotinib; SHR-1258; SHR1258; SHR 1258; Pyrotinib maleate |
PYROQUILON | 57369-32-1 | C11H11NO | 173.21 | PYROQUILON; 2,1-ij)quinolin-4-one,1,2,5,6-tetrahydro-4h-pyrrolo(; cga49104; fongoren; fongorene; lilolidone; pyroquilone; 1,2,5,6-TETRAHYDROPYRROL[3,2,1-IJ]QUINOLINE-4-ON |
Pyrophyllite(AlH(SiO3)2) (9CI) | 12269-78-2 | Al. 2 H2 O3 Si | 0 | PYRAX HS; PYRAX MP; PYRAX(R) A; PYRAX(R) B; PYRAX RG 1/4''; PYRAX RG 140 |
Pyrophosphatase, Nucleotide from Crotalus adamanteus venom | 9032-64-8 | Dinucleotide nucleotidohydrolase | ||
Pyronaridine Tetraphosphate | 76748-86-2 | C29H44ClN5O18P4 | 910.033 | Pyranoridine phosphate; Pyronaridine phosphate; 4-[(7-chloro-2-methoxy-1,5-dihydrobenzo[b][1,5]naphthyridin-10-yl)imino]-2,6-bis(pyrrolidin-1-ylmethyl)cyclohexa-2,5-dien-1-one;phosphoric acid |
Pyronaridine | 74847-35-1 | C29H32ClN5O2 | 518.06 | 2-Methoxy-7-chloro-10-(3',5'-bis(pyrrolin-1-ylmethyl)-4'-hydroxyphenylamino)benzo(b)-1,5-naphthyridine;76748-86-2(Pyronaridine tetraphosphate) |
Pyromeconic acid | 496-63-9 | C5H4O3 | 112.08 | 3-hydroxypyran-4-one |
PYROLIGNEOUS ACID | 8030-97-5 | 0 | Pyroligneousacids; woodvinegar; FEMA 2967; PYROLIGNEOUS ACID; WOODTARS; WOODTAR; Wood vineger; Biopirol | |
PYRIMIDINE-2-BORONIC ACID PINACOL ESTER | 937593-41-4 | C10H15BN2O2 | 206.05 | PYRIMIDINE-2-BORONIC ACID PINACOL ESTER; 2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIMIDINE |
Pyrimidine-2-boronic acid | 851199-85-4 | C4H5BN2O2 | 123.91 | PYRIMIDINE-2-BORONIC ACID; PYRIMIDIN-2-YLBORONIC ACID |
Pyrimidine-2,4-dicarboxylic acid | 37645-41-3 | C6H4N2O4 | 168.10696 | pyrimidine-2,4-dicarboxylicacid;37645-41-3;2,4-PYRIMIDINEDICARBOXYLICACID;2,4-Pyrimidinedicarboxylicacid;SCHEMBL87765;AMMD00032 |
Pyrimidine,2,4-bis[(trimethylsilyl)oxy]- | 10457-14-4 | C10H20 N2 O2 Si2 | 256.449 | BIS(O-TRIMETHYLSILYL)URACIL; 2,4-BIS-TRIMETHYLSILANYLOXY-PYRIMIDINE; O,O'-BIS(TRIMETHYLSILYL)URACIL; O,O-BIS(TRIMETHYLSILYL)URACIL; 2,4-Bis(trimethylsiloxy)pyrimidine; 2,4-Bis(trimethylsilyl)uracil; 2,4-Bis(trimethylsilyloxy)pyrimidine; 2,4-O-Bis(trimethy |
5-Ethynylpyrimidine | 153286-94-3 | C6H4N2 | 104.11 | Pyrimidine, 5-ethynyl-(9CI) |
Pyrimidine, 5-bromo-2-chloro-4-(phenylmethoxy)- | 205672-19-1 | C11H8 Br Cl N2 O | 299.55 | 4-BENZYLOXY-5-BROMO-2-CHLOROPYRIMIDINE; 5-bromo-2-chloro-4-(phenylmethoxy)- Pyrimidine |
Pyrimidine, 4-ethenyl- (9CI) | 45588-69-0 | C6H6N2 | 106.12524 | Pyrimidine, 4-ethenyl- (9CI) |
Pyrimidine, 4-chloro-6-[(phenylmethoxy)methyl]- | 914802-11-2 | C12H11 Cl N2 O | 234.68154 | 4-BENZYLOXYMETHYL-6-CHLORO-PYRIMIDINE |
Pyrimidine, 4-(chloromethyl)- | 54198-81-1 | C5H5ClN2 | 128.5596;g/mol | 4-(chloromethyl)pyrimidine; 4-(Chloromethyl)pyrimidine; 54198-81-1; PYRIMIDINE,4-(CHLOROMETHYL)-; 4-Chloromethylpyrimidine; 4-chloromethyl-pyrimidine |
Pyridazine, 4-bromo- (9CI) | 115514-66-4 | C4H3BrN2 | 158.98402;g/mol | 4-bromopyridazine; 4-BROMOPYRIDAZINE; 115514-66-4; 4-BROMO-PYRIDAZINE; Pyridazine,4-bromo-; Pyridazine,4-bromo-(9CI) |
POLYACRYLAMIDOMETHYL BENZYLIDENE CAMPHOR | 113783-61-2 | |||
Pyridine methanesulfonate | 39879-60-2 | C6H9NO3S | 175.2 | PYRIDINE METHANESULFONATE; Pyridine mesylate |
PYRIDINE 1 | 87004-02-2 | C19H23ClN2O4 | 378.85 | PYRIDINE 1; LDS 698; 1-ETHYL-2-[-4-(4-DIMETHYLAMINOPHENYL)-1,3-BUTADIEN-1-YL]PYRIDINIUM PERCHLORATE; 1-Ethyl-2-[-4-(4-dimethylaminophenyl)-1,3-butadien)-1-yl]pyridinium perchloroate; Pyridine 1,99% |
P-XYLENE-D10 | 41051-88-1 | C8D10 | 116.23 | 1,4-Di(methyl-d3)benzene-d4; Benzene-1,2,4,5-d4-, 3,6-di(methyl-d3)-; Benzene-1,2,4,5-d4,3,6-di(methyl-d3)-; P-XYLENE-D10; (2H10)-p-xylene; P-XYLENE-D10, 99 ATOM % D |
PXS 4728A | 1478364-68-9 | C15H21FN2O2.HCl | 316.8 | BI-1467335 HCl; (E)-4-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-(tert-butyl)benzamide hydrochloride |
PX-866-17OH | 1012327-63-7 | C29H37NO8 | 527.6 | [(1S,3aR,6E,9S,9aR,10R,11aS)-6-[[bis(prop-2-enyl)amino]methylidene]-1,5-dihydroxy-9-(methoxymethyl)-9a,11a-dimethyl-4,7-dioxo-2,3,3a,9,10,11-hexahydro-1H-indeno[4,5-h]isochromen-10-yl] acetate |
PX-866 | 502632-66-8 | C29H35NO8 | 525.598 | PX-866; PX866; PX 866 |
PX-478 dihydrochloride | 685898-44-6 | C13H18Cl2N2O3.2HCl | 394.1 | PX-478 2HCl; PX-478 hydrochloride; Melphalan N-Oxide Impurity HCl; Melphalan N-Oxide Impurity hydrochloride; L-Phenylalanine, 4-[bis(2-chloroethyl)oxidoamino]-, dihydrochloride; L-Phenylalanine, 4-[bis(2-chloroethyl)oxidoamino]-, hydrochloride (1:2) |
Ptelatoside B | 90852-99-6 | C20H28O10 | 428.4 | 4-Ethenylphenyl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside |
Protostemotinine | 169534-85-4 | C23H29NO6 | 415.48 | |
Protosappanin B | 102036-29-3 | C16H16O6 | 304.30 | (7S)-3,7,10,11-Tetrahydroxy-7,8-dihydro-6H-dibenzo[b,d]oxocin-7-methanol |
Protosappanin A dimethyl acetal | 868405-37-2 | C17H18O6 | 318.32 | Protosappaninadimethylacetal |
protosappanin A | 102036-28-2 | C15H12O5 | 272.25 | |
Protopseudohypericin | 54328-09-5 | C30H18O9 | 522.46 | |
Protoporphyrin IX | 553-12-8 | C34H34N4O4 | 562.66 | Protoporphyrin; 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid; |
Protoplumericin A | 80396-57-2 | C36H42O19 | 778.72 | Protoplumericin |
Propranolol N-Formyl Impurity | 77252-67-0 | C17H21NO3 | 287.36 | |
Propranolol N-Acetyl Impurity | 2007-11-6 | C18H23NO3 | 301.39 | |
Propranolol impurity C, bis-ether derivative | 17216-10-3 | C23H20O3 | 344.4 | 1,3-Bis(1-naphthoxy)-2-propanol; 1,3-Bis(1-naphthalenyloxy)-2-propanol |
Propranolol Impurity B | 83314-78-7 | C29H33NO4 | 459.58 | 1,1'-[(1-Methylethyl)imino]bis[3-(1-naphthalenyloxy)-2-propanol |
Potassium 2,5-dichlorophenolate | 68938-81-8 | C6H4 Cl2 O . K | 163.0014 | |
Potassium 2,4-di-tert-butylphenolate | 37408-22-3 | C14H21KO | 244.41424;g/mol | potassium; 2,4-ditert-butylphenolate; Potassium2,4-di-tert-butylphenolate; 37408-22-3; SCHEMBL7746261; CTK4H8110 |
Poly[trifluoropropyl(methyl)siloxane] | 63148-56-1 | (C4H7F3OSi)n | 0 | fluorosiliconeoil; poly(trifluoropropyl(methyl)siloxane)àreclasser; SiloxanesandSilicones,Me3,3,3-trifluoropropyl; DOW CORNING FS CHEMICALLY INERT FLUID; POLY[TRIFLUOROPROPYL(METHYL)SILOXANE]; POLY[3,3,3-TRIFLUOROPROPYL(METHYL)SILOXANE], TMS END CAPPED; S |
Poly[oxy(methyl-1,2-ethanediyl)],a-octadecyl-w-hydroxy- | 25231-21-4 | C21H43OX2 | 311.57 | 1-octadecoxypropan-2-ol; 25231-21-4; Polyoxypropylene15stearylether; Prostearyl15; Polypropyleneglycolmonostearylether; PPG-11Stearylether |
Poly[oxy(methyl-1,2-ethanediyl)],a-hydro-w-hydroxy-, ether with methyl b-D-glucopyranoside (4:1) | 61849-72-7 | (C3H6 O)n (C3 H6 O)n (C3 H6 O)n (C3 H6 O)n C7 H14 O6 | 730.8767 | 2-ethanediyl)],alpha-hydro-omega-hydroxy-poly[oxy(methyl-etherwithmethylbeta-d-glucopyranoside(4:1); Poly[oxy(methyl-1,2-ethanediyl)],.alpha.-hydro-.omega.-hydroxy-,etherwithmethyl.beta.-D-glucopyranoside(4:1); ylbeta-d-glucopyranoside(4:1); GLUCAM P-10/2 |
Poly[oxy(methyl-1,2-ethanediyl)],a-hexadecyl-w-hydroxy- | 9035-85-2 | (C3H6 O)n C16 H34 O | ||
Poly[oxy(1-oxo-1,2-ethanediyl)] | 26009-03-0 | C6H6O5X2 | 158.11 | POLY(2-HYDROXYACETIC ACID); POLYGLYCOLIC ACID; POLYGLYCOLIDE |
Poly[nitrilomethanetetraylnitrilo[2,4,6-tris(1-methylethyl)-1,3-phenylene]] | 29117-01-9 | (C16H22 N2)n | 0 | STABILIZER 11000; Poly[nitrilomethane tetraylnitrilo[2,4,6-tris(1-methylethyl)-1,3-phenylene]] |
Poly[nitrilo(dichlorophosphoranylidyne)] | 26085-02-9 | (Cl2N P)n | 115.88600 | |
Poly[methylene(polyphenyl isocyanate)] | 9016-87-9 | |||
Poly[imino-1,6-hexanediylimino(1,9-dioxo-1,9-nonanediyl)] | 28757-63-3 | (C15H28 N2 O2)n | ||
Poly[imino-1,4-butanediylimino(1,6-dioxo-1,6-hexanediyl)] | 50327-22-5 | C14H20N6O2 | 304.3476;g/mol | (2S)-2-amino-4-{6-[(3-methylbut-2-en-1-yl)amino]-3H-purin-3-yl}butanoicacid;AC1L97MH;3-(3-Amino-3-carboxypropyl)-N6-(delta2-isopentenyl)-adenine;SCHEMBL5327063;CHEBI:15955;HE111509 |
Poly[ethyl acrylate-co-methacrylic acid-co-3-(1-isocyanato-1-methylethyl)--methylstyrene], adduct with ethoxylated nonylphenol solution | 96828-31-8 | |||
Poly[di(ethylene glycol) adipate] | 9010-89-3 | C10H17O6 | 233.23800 | |
Poly[bis(2-chloroethyl) ether-alt-1,3-bis[3-(dimethylamino)propyl]urea] quaternized, solution | 68555-36-2 | Polyquaternium-2 | ||
Pyrimidine Related Compound 1 | 1402452-15-6 | C27H28ClN7O3S | 566.09 | 2-Chloro-N,N-diethyl-5-[[4-[2-[4-[[(methylamino)carbonyl]amino]phenyl]-4-pyridinyl]-2-pyrimidinyl]amino]benzenesulfonamide |
Pyrimidifen | 105779-78-0 | C20H28ClN3O2 | 377.91 | -4-amine; 4-pyrimidinamine,5-chloro-n-(2-(4-(2-ethoxyethyl)-2,3-dimethylphenoxy)ethyl)-6; 5-chloro-n-(2-(4-(2-ethoxyethyl)-2,3-dimethylphenoxy)ethyl)-6-ethylpyrimidin; PYRIMIDIFEN; SU-9118; MITECLEAN |
Pyrimethamine-D3 | 1189936-99-9 | C12H10ClN4D3 | 251.74 | 5-(4-Chlorophenyl)-6-ethyl-d3-2,4-pyrimidinediamine; 2,4-Diamino-5-(4-chlorophenyl)-6-ethyl-d3-pyrimidine; Chloridin-d3; Chloridine-d3; Malocide-d3; Pirimecidan-d3; Pirimetamin-d3; NSC 3061-d3; RP 4753-d3 |
Pyrimethamine | 58-14-0 | C12H13ClN4 | 248.71 | Pirimecidan; Pirimetamin; RP 4753 |
Pyrilamine maleate salt | 59-33-6 | C21H27N3O5 | 401.46 | N1-(4-Methoxybenzyl)-N2,N2-dimethyl-N1-(pyridin-2-yl)ethane-1,2-diamine fumarate;Diaminide maleate;(Z)-but-2-enedioic acid;N-[(4-Methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl- 1,2-ethanediamine (2Z)-2-Butenedioate;Paraminyl Maleate |
Pyrilamine | 91-84-9 | C17H23N3O | 285.38 | 1,2-Ethanediamine, N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl-; 1,2-Ethanediamine, N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridyl-; 2-((2-(dimethylamino)ethyl)(p-methoxybenzyl)amino)-pyridin; 2-((2-(dimethylamino)ethyl)-(p-methoxyben |
Pyridyl Urazol | 1076199-39-7 | C7H6N4O2 | 178.15 | 4-(3-Pyridyl)-1,2,4-triazolidine-3,5-dione |
pyridoxine tripalmitate | 4372-46-7 | C56H101NO6 | 884.40424 | PYRIDOXINETRIPALMITATE; VitaminB6tripalmitate; UNII-KXS58JW4OT; Pyridoxol,tripalmiate(ester); 4372-46-7; EINECS224-470-3 |
Pyridoxine Impurity B HCl | 148-51-6 | C8H11NO2. HCl | 189.64 | 2,4-Dimethyl-3-hydroxy-5-hydroxymethylpyridine Hydrochloride; 4-Deoxypyridoxine Hydrochloride; 3-Hydroxy-5-hydroxymethyl-2,4-dimethylpyridine Hydrochloride; 4-Deoxypyridoxol Hydrochloride; 5-Hydroxy-4,6-dimethyl-3-pyridinemethanol Hydrochloride; 4-Desoxya |
Pyridoxine Impurity A HCl | 1006-21-9 | C8H9NO2. HCl | 187.63 | Pyridoxine Cyclic Ether Impurity Hydrochloride Salt; 1,3-Dihydro-6-methylfuro[3,4-c]pyridin-7-ol Hydrochloride; |
Pyridoxine Hydrochloride | 58-56-0 | C8H11NO3.HCl | 205.46 | 5-Hydroxy-6-methyl-3,4-pyridinedimethanol Hydrochloride; Pyridoxol Hydrochloride; Aderomine Hydrochloride; Aderoxin; Hexobion; Pyridox; Pyridoxine Hydrogen Chloride; Pyridoxine Monohydrochloride; Pyridoxinium Chloride; Vitamin B6 Hydrochloride |
Pyrido[2,3-e]pyrrolo[1,2-a]pyrazin-6(4H)-one (9CI) | 104149-51-1 | C10H7N3O | 185.18208 | Pyrido[2,3-e]pyrrolo[1,2-a]pyrazin-6(4H)-one (9CI); PYRIDO[2,3-E]PYRROLO[1,2-A]PYRAZIN-6(5H)-ONE |
Pyrido[2,3-d]pyrimidine, 4-chloro-1,5,6,7-tetrahydro- | 3771-95-7 | C7H8ClN3 | 169.61152 | |
Pyrido[1,2-a]benzimidazole-2,8-diamine (9CI) | 152403-50-4 | C11H10N4 | 198.2239 | Pyrido[1,2-a]benzimidazole-2,8-diamine (9CI) |
Pyridine, 4-(bromomethyl)- (9CI) | 54751-01-8 | C6H6BrN | 172.02254 | Pyridine, 4-(bromomethyl)- (9CI) |
Pyridine, 2-(triethoxysilyl)- (9CI) | 213602-91-6 | C11H19NO3Si | 241.35896 | Pyridine, 2-(triethoxysilyl)- (9CI); 2-PYRIDYLTRIETHOXYSILANE |
Protein hydrolyzates, yeast | 100684-36-4 | C29H29N3O3S | 499.62386;g/mol | 3',6'-bis(diethylamino)-6-isothiocyanato-3h-spiro[2-benzofuran-1,9'-xanthen]-3-one; 3',6'-BIS(DIETHYLAMINO)-6-ISOTHIOCYANATO-3H-SPIRO[2-BENZOFURAN-1,9'-XANTHENE]-3-ONE; RhodamineB-5(or6)-isothiocyanate; AC1Q7EVJ; AC1L3B4G; AR-1E9925 |
Potassium oxalate | 583-52-8 | K2C2O4 | 166.20 | DI-POTASSIUM OXALATE; dipotassiumethanedioate; Ethanedioicacid,dipotassiumsalt; oxalicacid,dipotassiumsalt; potassiumneutraloxalate; potassiumoxalate(k2c2o4) |
Potassium o-tert-butylphenolate | 41769-06-6 | C10H13KO | 188.30792;g/mol | potassium; 2-tert-butylphenolate; Potassiumo-tert-butylphenolate; 41769-06-6; Potassiumt-butylphenoxide; potassiumo-tert-butylphenolate |
Potassium osmate(VI) 2-hydrate | 19718-36-6 | K2OsO4.H2O | 876.90996 | potassium(VI) osmiate dihydrate; Potassium osmate dihydrate, 99+%; PotassiumOsmium(VI)OxideHydrate; ( beta-4)-osmate; 2-dipotassium; POTASSIUM OSMATE(VI)) |
Potassium Chloride | 7447-40-7 | KCl | 74.548 | Acronitol |
POLY(VINYLPHOSPHONIC ACID) | 27754-99-0 | C2H5O3P | 108.0331 | POLYETHENYLPHOSPHONIC ACID; POLYVINLYPHOSPHONIC ACID; POLY(VINYLPHOSPHONIC ACID); PVPA; ethenyl-phosphonicacihomopolymer; Phosphonicacid,ethenyl-,homopolymer |
Poly(vinylidene chloride-co-acrylonitrile-co-methyl methacrylate) | 25214-39-5 | C10H13Cl2NO2 | 250.12172;g/mol | 1,1-dichloroethylene; methyl2-methylprop-2-enoate; prop-2-enenitrile; 25214-39-5; 2-Propenoicacid,2-methyl-,methylester,polymerwith1,1-dichloroetheneand2-propenenitrile; 208728-30-7 |
POLY(VINYLBENZYL TRIMETHYL AMMONIUM CHLORIDE) | 9017-80-5 | 0 | POLY(VINYLBENZYL TRIMETHYL AMMONIUM CHLORIDE); Benzenemethanaminium,.alpha.-ethenyl-N,N,N-trimethyl-,chloride,homopolymer; benzenemethanaminium,ar-ethenyl-n,n,n-trimethyl-,chloride,homopolymer; polytrimethyl; polytrimethylvinylbenzylammonium; polytrimethy | |
POLY(METHYLENE-CO-GUANIDINE), HYDROCHLORIDE | 55295-98-2 | 0 | POLY(METHYLENE-CO-GUANIDINE), HYDROCHLORIDE; cyano-guanidinpolymerwithammoniumchloride((nh4)cl)andformaldehyde; Dicyandiamide,ammoniumchloride,formaldehydecondensate; Dicyandiamide,ammoniumchloride,formaldehydepolymer; Dicyandiamide,formaldehyde,ammoniumc | |
Poly(methyl vinyl ether-alt-maleic anhydride), cross-linked with 1,9-decadiene | 136392-67-1 | maleated copolymer, maleated polymer, maleic copolymer | ||
Poly(methyl vinyl ether-alt-maleic anhydride) | 9011-16-9 | C21H24O12X2 | 468.41 | POLY(METHYL VINYL ETHER-ALT-MALEIC ANHYDRIDE); (Malricanhydride-methylvinylether)copolymer; 2,5-Furandione,polymerwithmethoxyethene; GANTREZ AN-139; METHYL VINYL ETHER/MALEIC ANHYDRIDE; METHYL VINYL ETHER/MALEIC ANHYDRIDE COPOLYMER; PVM/MA COPOLYMER; POLY |
POLY(METHYL METHACRYLATE-CO-BUTYL METHACRYLATE) | 25608-33-7 | [CH2C(CH3)[CO2(CH2)3CH3]]X[CH2C(CH3)(CO2CH3)]Y | 0 | 2-Propenoicacid,2-methyl-,butylester,polymerwithmethyl2-methyl-2-propenoate; Butylmethacrylate,methylmethacrylatepolymer; POLY(METHYL METHACRYLATE-CO-BUTYL METHACRYLATE); EUKITT(R) QUICK-HARDENING MOUNTING ME-DI UM, F. MICROSCOPY; POLY(BUTYL METHACRYLATE- |
Poly(methyl methacrylate) | 9011-14-7 | (C5H8O2)x | 99.1083 | METHYL METHACRYLATE POLYMER; METHYL METHACRYLATE, POLYMERIZED; METHYL METHACRYLATE RESIN; METHACRYLIC ACID METHYL ESTER POLYMER; LUCITE; POLY(METHYL METHACRYLATE-CO-ETHYL ACRYLATE); POLY(METHYL METHACRYLATE), ISOTACTIC; POLY(METHYL METHACRYLATE) |
Poly(methyl hydrogen siloxane) | 26403-67-8 | C7H21O2Si3 | 0 | POLY(METHYL HYDROGEN SILOXANE); PMHS; Polyoxy(methylsilylene), .alpha.-(trimethylsilyl)-.omega.-(trimethylsilyl)oxy- |
Pyridin-2-ylmethanesulfonyl chloride | 540523-41-9 | C6H6ClNO2S | 191.64 | PYRIDIN-2-YL-METHANESULFONYL CHLORIDE; 2-PYRIDINEMETHANESULFONYL CHLORIDE |
PYRIDAZOMYCIN | 115920-43-9 | C10H16ClN4O3+ | 275.71 | |
Pyridazinediones-derivative-1 | 147493-44-5 | C11H6ClN3O3 | 263.64 | Pyridazino[4,5-b]quinoline-1,4-dione, 7-chloro-2,3-dihydro-10-hydroxy-; 7-chloro-3,5-dihydro-2H-pyridazino[4,5-b]quinoline-1,4,10-trione |
Pyribenzoxim | 168088-61-7 | C32H27N5O8 | 609.59 | pyribenzoxim; Pyanchor; O-(2,6-Bis(4,6-dimethoxypyrimidin-2-yloxy)benzoyl)oxime benzophenone; Benzophenone O-[2,6-bis[(4,6-dimethoxy-2- pyrimidyl)oxy]benzoyl]oxime; benzophenone-O-[2,6-dimethoxy-2-pyrimidinyl) oxy] benzoyl oxime; LGC 40863 |
PYR-GLN-OH | 109481-23-4 | C10H15N3O5 | 257.24 | PYR-GLN-OH |
Pyrenophorol | 22248-41-5 | C16H24O6 | 312.4 | (-)-Pyrenophorol, Helmidiol |
Pyrene-1,2,3,4,5,6,7,9,10-d9,8-nitro- | 93487-20-8 | C16D9 N O2 | 256.3 | 1-NITROPYRENE-D9 |
Pyrene, 1-ethenyl- | 17088-21-0 | C18H12 | 228.2 | 1-ethenylpyrene;1-Ethenylpyrene;1-Vinylpyrene;Pyrene,1-ethenyl-;3-Vinylpyrene;Pyrene,3-vinyl- |
Pyrene, 1-butyl- | 35980-18-8 | C20H18 | 258.36 | 1-N-BUTYLPYRENE |
Pyrazolone | 39455-90-8 | C3H2N2O | 82.06 | |
Pyrazolo[1,5-a]pyridine-2-carboxamide | 885275-08-1 | C8H7N3O | 161.16 | PYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID AMIDE; Pyrazolo[1,5-a]pyridine-2-carboxamide |
Pyrazolo[1,5-A]Pyridine-2-Carbaldehyde | 885275-10-5 | C8H6N2O | 146.15 | |
PYRAZOLO[1,5-A]PYRIDIN-7-YL-METHANOL | 885275-64-9 | C8H8N2O | 148.16 | PYRAZOLO[1,5-A]PYRIDIN-7-YL-METHANOL |
PYRAZOLO[1,5-A]PYRIDIN-5-OL | 156969-42-5 | C7H6N2O | 134.14 | PYRAZOLO[1,5-A]PYRIDIN-5-OL |
Pyrazolo[1,5-a]pyridin-3-ylmethylamine | 118054-99-2 | C8H9N3 | 147.18 | C-PYRAZOLO[1,5-A]PYRIDIN-3-YL-METHYLAMINE; Pyrazolo[1,5-a]pyridin-3-yl-methylamine dihydrochloride; Pyrazolo[1,5-a]pyridin-3-ylmethylamine |
Pyrazolo[1,5-a]-1,3,5-triazine-2,4(1H,3H)-dione | 34683-40-4 | C5H4N4O2 | 152.11086;g/mol | 6H-pyrazolo[1,5-a][1,3,5]triazine-2,4-dione;34683-40-4;Pyrazolo[1,5-a]-1,3,5-triazine-2,4(1H,3H)-dione;pyrazolo[1,5-a][1,3,5]triazine-2,4-diol;Pyrazolo[1,5-a][1,3,5]triazine-2,4(1H,3H)-dione;PubChem20885 |
Pyrazolo[1,5-a]-1,3,5-triazin-4(3H)-one | 54346-27-9 | C5H4N4O | 136.11146;g/mol | 54346-27-9; Pyrazolo[1,5-a][1,3,5]triazin-4(3H)-one; Pyrazolo[1,5-a]-1,3,5-triazin-4(3H)-one; 6H-pyrazolo[1,5-a][1,3,5]triazin-4-one; NSC168461; AC1L6RHM |
Pyrazole N-Desmethyl Sildenafil | 139755-95-6 | C21H28N6O4S | 460.55 | 1-[[3-(4,7-Dihydroxy-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methyl-piperazine; Desmethylsildenafil; |
Pyrazofurin | 30868-30-5 | C9H13N3O6 | 259.08 | |
Pyrazino[1,2-a]indole, 9-fluoro-1,2,3,4-tetrahydro- (9CI) | 256930-21-9 | C11H11FN2 | 190.2168432 | 9-fluoro-1,2,3,4-tetrahydropyrazino[1,2-a]indole; 256930-21-9; Pyrazino[1,2-a]indole,9-fluoro-1,2,3,4-tetrahydro-(9CI); SCHEMBL4705657; CTK8H8611; ZINC39115401 |
Pyrazino[1,2-a]indole, 1,2,3,4-tetrahydro-9-methyl- (9CI) | 796069-32-4 | C12H14N2 | 186.25296 | |
Pyrazino[1,2-a]benzimidazole, 1,2,3,4-tetrahydro- (6CI,8CI,9CI) | 4744-53-0 | C10H11N3 | 173.21444;g/mol | 1,2,3,4-tetrahydropyrazino[1,2-a]benzimidazole; CHEMBL6503; 4744-53-0; 1,2,3,4-Tetrahydro-benzo[4,5]imidazo[1,2-a]pyrazine; NSC700996; AC1L9BD9 |
Pyrazinecarbonitrile, 3-amino-6-propyl-, 4-oxide (9CI) | 50627-14-0 | C8H10N4O | 178.1912 | 4-hydroxy-3-imino-6-propylpyrazine-2-carbonitrile;50627-14-0;Pyrazinecarbonitrile,3-amino-6-propyl-,4-oxide(9CI);CTK4J2908;ZINC39114145;HE346492 |
Pyrazine-2-boronic acid pinacol ester | 1083179-99-0 | C10H15BN2O2 | ||
Pyrazine-2,6-Dicarboxylic Acid | 940-07-8 | C6H4N2O4 | 168.10696 | AKOS 90649; PYRAZINE-2,6-DICARBOXYLIC ACID |
Pyrazine,2-methoxy-6-methyl- | 2882-21-5 | C6H8 N2 O | 124.14052 | 2-methoxy-6-methylpyrazine; Pyrazine, 2-methoxy-6-methyl-; 2-METHOXYL-6-METHYLPYRAZINE |
Pyrazine,2-methoxy-5-methyl- | 2882-22-6 | C6H8 N2 O | 124.14052 | 2-methoxy-5-methylpyrazine; Pyrazine, 2-methoxy-5-methyl-; METHOXY-3-METHYLPYRAZINE |
Pyrazine,2-ethyl-6-methyl- | 13925-03-6 | C7H10 N2 | 122.1677 | 2-ethyl-6-methylpyrazine; Pyrazine, 2-ethyl-6-methyl-; 2-Ehtyl-6-methylpirazine; 2-Methyl-6-ethylpyrazine |
Pyrazine,2-bromo-5-methyl- | 98006-90-7 | C5H5 Br N2 | 0 | |
pyrazine ethanethiol | 35250-53-4 | C6H8N2S | 140.21 | BETA-MERCAPTOETHYL PYRAZINE; FEMA 3230; FEMA NUMBER 3230; MERCAPTOETHYLPYRAZINE; 2-PYRAZINE ETHANETHIOL; 2-PYRAZINYLETHANETHIOL |
Pyrazinamide-d3 | 1432059-16-9 | C5H2N3OD3 | 126.13 | |
Pyrazinamide | 98-96-4 | C5H5N3O | 123.11 | Pyrazinecarboxamide; Pyrazinoic acid amide |
Pyranthrene | 191-13-9 | C30H16 | 376.45 | benzo[c]naphtho[3,2,1,8,7-rstuv]pentaphene; tribenzo[ghi,m,pqr]picene; PYRANTHRENE; Pyranthrene(Rri7526) |
Pyrantel tartrate | 33401-94-4 | C15H20N2O6S | 356.39 | 1-Methyl-2-(2-[2-thienyl]ethenyl)-1,4,5,6-tetrahydropyrimidine |
Pyrantel pamoate | 22204-24-6 | C34H30N2O6S | 594.68 | Pyrantel embonate; Antiminth; Cobantril |
Pyrantel Impurity A | 36700-38-6 | C11H14N2S | 206.31 | |
PYRANTEL CITRATE | 5685-86-9 | C17H22N2O7S | 398.43 | 1-METHYL-2-[2-(2-THIENYL)ETHENYL]-1,4,5,6-TETRAHYDROPYRIMIDINE CITRATE SALT; PYRANTEL CITRATE; PYRANTEL CITRATE SALT; (E)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine citrate (1:1); 1-methyl-2-(2-[2-thienyl]ethenyl)-1,4,5,6-tetrahydropyrim |
Pyrantel | 15686-83-6 | C11H14N2S | 206.31 | |
Pyranojacareubin | 78343-62-1 | C23H20O6 | 392.407 | 5,12-dihydroxy-2,2,10,10-tetramethyl-2H,6H,10H-dipyrano[3,2-b:2',3'-i]xanthen-6-one |
Pyran-3,5-dione | 61363-56-2 | C5H6O3 | 114.099 | |
Pyracrenic acid | 80832-44-6 | C39H54O6 | 618.855 | |
Pyraclonil | 158353-15-2 | C15H15ClN6 | 314.77 | Pyraclonil |
PYR8535 | 62618-53-5 | C18H19NO5 | 329.35 | 1H-Pyrrole-3-propanoic acid, 5-formyl-4-methyl-2-[(phenylmethoxy)carbonyl]-, methyl ester;PYR-8535;Benzyl 5-formyl-3-(3-methoxy-3-oxopropyl)-4-methyl-1H-pyrrole-2-carboxylate |
PYR-7911 | 124307-91-1 | C16H17NO4 | 287.31 | benzyl 5-(acetoxymethyl)-3-methyl-1H-pyrrole-2-carboxylate |
PYR-6921 | 31896-92-1 | C13H21NO2 | 223.15 | 1H-Pyrrole-2-carboxylic acid, 4-ethyl-3,5-dimethyl-, 1,1-dimethylethylester; |
PYR-6502 | 27226-50-2 | C8H11NO | 137.18 | 3,4,5-trimethyl-1H-pyrrole-2-carbaldehyde; PYR-6502; PYR 6502; PYR6502 |
Pyr6 | 245747-08-4 | C17H9F7N4O | 418.27 | N-[4-[3,5-bis(trifluoromethyl)pyrazol-1-yl]phenyl]-3-fluoropyridine-4-carboxamide PYR6 C17H9F7N4O CHEMBL101896 SCHEMBL7325729 N-(4-(3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)-3-fluoroisonicotinamide N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazole-1 |
PYR5120 | 59435-12-0 | C12H17NO3 | 223.27 | PYR-5120;Tert-butyl 5-formyl-3,4-dimethyl-1H-pyrrole-2-carboxylate;1H-Pyrrole-2-carboxylic acid, 5-formyl-3,4-dimethyl-, 1,1-dimethylethylester |
PYR5084 | 59435-08-4 | C15H15NO3 | 257.29 | 1H-Pyrrole-2-carboxylic acid, 5-formyl-3,4-dimethyl-, phenylmethyl ester;PYR-5084;Benzyl 5-formyl-3,4-dimethyl-1H-pyrrole-2-carboxylate |
PYR4897 | 60024-89-7 | C15H23NO4 | 281.35 | Tert-butyl 4-(2-methoxycarbonylethyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate;PYR-4897 |
PYR-41 | 418805-02-4 | C17H13N3O7 | 371.305 | PYR-41; PYR 41; PYR41 |
Pyr3 | 1160514-60-2 | C16H11Cl3F3N3O3 | 456.63 | 1-[4-[(2,3,3-Trichloro-1-oxo-2-propen-1-yl)amino]phenyl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid |
Pyr10 | 1315323-00-2 | C18H13F6N3O2S | 449.37 | N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-4-methyl-benzenesulfonamide |
PYR-0503 | 16200-50-3 | C12H19NO2 | 209.28 | 3,4-Diethyl-2-ethoxycarbonyl-5-methylpyrrole;Ethyl 3,4-diethyl-5-methyl-1H-pyrrole-2-carboxylate |
PYR-0222 | 4030-22-2 | C6H9NO | 111.14 | 3,4-Dimethyl-3-pyrrolin-2-one; 1,5-Dihydro-3,4-dimethyl-2H-pyrrol-2-one |
Pyoluteorin | 25683-07-2 | C11H7Cl2NO3 | 272.1 | |
Pyocyanin | 85-66-5 | C13H10N2O | 210.2 | Sanasin; Sanazin; Pyocyanine; 5-methylphenazin-1-one |
Pymetrozine | 123312-89-0 | C10H11N5O | 217.23 | Pymetrozine; Pymetrozin; 123312-89-0; Endeavor; Fulfill; Plenum |
PYCNOGENOL | 174882-69-0 | |||
PyBlue Hydrazide | 137182-38-8 | C18H11N2Na3O11s3 | 596.44 | |
PyBlue ethylenediamine trisodium salt | 138039-52-8 | C20H15N2Na3O11S3 | 624.5 | |
PX-316 | 253440-95-8 | C28H57O10P | 584.728 | PX-316; PX 316; PX316; 1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol; 1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol. |
PX-13-17OH | 884539-95-1 | C29H42N2O8 | 546.7 | WAY-266176; (1E,4S,4aR,5R,6aS,7S,9aR)-5-(acetyloxy)-1-[[[3-(dimethylamino)propyl]methylamino]methylene]-4a,5,6,6a,7,8,9,9a-octahydro-cyclopenta[5,6]naphtho[1,2-c]pyran-2,10(1H,4H)-dione |
PX-12 | 141400-58-0 | C7H12N2S2 | 188.31 | PX 12 |
PX-102 | 1268244-85-4 | C29H22Cl3NO4 | 554.848 | PX-20606; CHEMBL3822773; UNII-378SU5NO8S; 378SU5NO8S; SCHEMBL17087854; 4-[(1S,2S)-2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid |
PX 20350 | 1198085-23-2 | C28H22Cl2F3N3O4 | 592.39 | PX 20350 - FXR agonist Cpd 22; 4-[[[6-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]-2-(trifluoromethyl)pyridin-3-yl]-methylamino]methyl]benzoic acid |
PX 102 | 1268245-19-7 | C29H22Cl3NO4 | 554.85 | UNII-378SU5NO8S; 378SU5NO8S; SCHEMBL17087854; Px-102; PX20606;4-[(1S,2S)-2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid |
PWZ-029 | 164025-33-6 | C14H14ClN3O2 | 291.74 | PWZ-029; SCHEMBL6847260; BDBM50034820; 3-Methoxymethyl-5-methyl-8-chloro-4,5-dihydro-6H-imidazo[1,5-a][1,4]benzodiazepin-6-one; 8-Chloro-3-methoxymethyl-5-methyl-4,5-dihydro-2,5,10b-triaza-benzo[e]azulen-6-one |
PVK | 25067-59-8 | |||
PV-10 | 11121-48-5 | C20H2Cl4I4Na2O5 | 1017.64 | Rose Bengal |
PU-WS13 | 1454619-14-7 | C17H20Cl2N6S | 411.35 | 8-((3,5-dichlorophenyl)thio)-9-(3-(isopropylamino)propyl)-9H-purin-6-amine |
PUTRESCINE DIHYDROCHLORIDE, [2,3-3H(N)] | 92915-83-8 | C4H10Cl2N2T4 | 169.11 | PUTRESCINE [2,3-3H(N)] DIHYDROCHLORIDE; PUTRESCINE DIHYDROCHLORIDE, [2,3-3H(N)] |
Putraflavone | 23624-21-7 | C32H22O10 | 566.5 | Podocarpusflavone B; 2-(4-Methoxyphenyl)-5,7-dihydroxy-8-[2-hydroxy-5-(4-oxo-5-hydroxy-7-methoxy-4H-1-benzopyran-2-yl)phenyl]-4H-1-benzopyran-4-one |
PuTP | 23197-96-8 | C10H15N4O13P3 (free acid) | 492.2 (free acid) | Purine riboside- 5'- O- triphosphate, sodium salt |
Pustulan | 37331-28-5 | |||
Purvalanol B | 212844-54-7 | C20H25ClN6O3 | 432.9 | NG 95; NG95; NG-95 |
Purvalanol A | 212844-53-6 | C19H25ClN6O | 388.89 | Purvalanol A |
Purpuromycin | 53969-01-0 | C26H18O13 | 538.41 | |
Purpurogallincarboxylic acid | 5146-12-3 | C12H8O7 | 264.19 | Purpurogallin carboxylic acid; 2,3,4,5-tetrahydroxy-6-oxobenzo[7]annulene-8-carboxylic acid |
Purpurogallin | 569-77-7 | C11H8O5 | 220.18 | Purpurogallin |
Purpurin 18 | 25465-77-4 | C33H32N4O5 | 564.63 | Purpurin 18; (17S-trans)-18-(2-Carboxyethyl)-12-ethenyl-7-ethyl-17,18-dihydro-3,8,13,17-tetramethyl-21H,23H-porphine-2,20-dicarboxylic acid cyclic 2,20-anhydride; (17S,18S)-18-(2-Carboxyethyl)-12-vinyl-7-ethyl-17,18-dihydro-3,8,13,17-tetramethyl-21H,23H-p |
Purpurin | 81-54-9 | C14H8O5 | 256.21 | 1,2,4-Trihydroxy-9,10-anthraquinone; 1,2,4-Trihydroxyanthraquinone; Hydroxylizaric acid; NSC 10447; Purpurine; SmokeBrown G; Verantin |
Purpureaside C | 108648-07-3 | C35H46O20 | 786.7 | |
Puromycin dihydrochloride | 58-58-2 | C22H31Cl2N7O5 | 544.4 | Stylomycin dihydrochloride, CL 13900 dihydrochloride, CL16536, NSC 3055, P638 dihydrochloride |
Puromycin aminonucleoside | 58-60-6 | C12H18N6O3 | 294.31 | 3'-Amino-3'-deoxy-N6,N6-dimethyladenosine |
Puromycin | 53-79-2 | C22H29N7O5 | 471.5 | Achromycin, Stillomycin, Stylomycin, CL 13900, 3123L, P638, Bacterenomycin |
Purmorphamine | 483367-10-8 | C31H32N6O2 | 520.60 | 9-cyclohexyl-N-(4-morpholin-4-ylphenyl)-2-naphthalen-1-yloxypurin-6-amine; purmorphamine; Purmorphamine; 483367-10-8; 2-(1-Naphthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine; UNII-PB12M2F8KY; Shh Signaling Antagonist VI; PB12M2F8KY; CHEMBL1221984; CHEB |
pTp | 2863-04-9 | C10H16N2O11P2 | 402.2 | Thymidine- 3', 5'- O- bisphosphate, sodium salt |
p-Topolin-9-glucoside | 1046433-04-8 | C18H21N5O6 | 403.39 | 6-(4-hydroxybenzylamino)-9-b-D-glucopyranosylpurine |
p-Tolyl--D-glucuronide | 17680-99-8 | C13H16O7 | 284.26 | p-Tolyl--D-glucuronic acid |
P-TOLUIDINE-D3 (METHYL-D3) | 23346-25-0 | C7H6D3N | 110.17 | P-TOLUIDINE-D3 (METHYL-D3) |
PTOEP | 31248-39-2 | C36H44N4Pt | 727.84 | RARECHEM AS SA 0081; PT(II) OCTAETHYLPORPHINE; PT(II) OCTAETHYLPORPHINE(PTOEP)2,3,7,8,12,13,17,18-OCTAETHYL-21H,23H-PORPHINE PLATINUM(II); PTOEP; PLATINUM OCTAETHYLPORPHYRIN; Platin(II)octaethylporphine; Pt(II) Octaethylporphine (PtOEP); PtOEP, Platinum( |
PTIQ | 1032822-42-6 | C13H17NO3 | 235.28 | 1-(3,4-Dihydro-7-hydroxy-6-methoxy-2(1H)-isoquinolinyl)-1-propanone |
p-tert-Butoxycarbonyloxystyrene | 87188-51-0 | C13H16O3 | 220.26 | 1,1-dimethylethyl4-ethenylphenylcarbonate; 4-boc-styrene; c-1566; carbonicacid,1,1-dimethylethyl4-ethenylphenylester; p-tert-butoxycarbonyloxystyrenemonomer; tbsm; p-tert-Butoxycarbonyloxystyrene; TERT-BUTYL 4-VINYLPHENYL CARBONATE |
Pteroyltriglutamic | 89-38-3 | C29H35N9O10 | 669.648 | |
Pterostilbene | 537-42-8 | C16H16O3 | 256.3 | trans-pterostilbene; 4-(3,5-Dimethoxystyryl)phenol; (E)-4-(3,5-dimethoxystyryl)phenol |
Pterosin Z | 34169-69-2 | C15H20O2 | 232.3 | 2,3-Dihydro-6-(2-hydroxyethyl)-2,2,5,7-tetramethyl-1H-inden-1-one; |
Pterosin D 3-O-glucoside | 84299-80-9 | C21H30O8 | 410.46 | (R)-3-(beta-D-Glucopyranosyloxy)-2,3-dihydro-6-(2-hydroxyethyl)-2,2,5,7-tetramethyl-1H-inden-1-one |
Pterosin D | 34169-70-5 | C15H20O3 | 248.3 | [R,(-)]-2,3-Dihydro-3-hydroxy-6-(2-hydroxyethyl)-2,2,5,7-tetramethyl-1H-indene-1-one |
Pterosin C | 35938-43-3 | C14H18O3 | 234.295 | (2S,3S)-3-hydroxy-6-(2-hydroxyethyl)-2,5,7-trimethyl-1-indanone |
Pterosin B | 34175-96-7 | C14H18O2 | 218.29 | (2R)-Pterosin B;6-(2-Hydroxyethyl)-2,5,7-trimethyl-1-indanone |
Pterolactone A | 74730-10-2 | C15H16O4 | 260.289 | (8R)-8-hydroxy-5,7,7-trimethyl-4,8-dihydro-3H-cyclopenta[g]isochromene-1,6-dione |
Pterolactam | 38072-88-7 | C5H9NO2 | 115.1 | 5-Methoxy-2-pyrrolidinone |
Pterokaurene L3 | 77658-38-9 | C20H30O3 | 318.46 | 9beta-Hydroxy-ent-kaur-16-en-oic acid |
Pterodontic acid | 185845-89-0 | C15H22O2 | 234.3 | 5,11(13)-eudesmadien-12-oic acid; 2-[(2R,4aR,8S)-4a,8-Dimethyl-2,3,4,4a,5,6,7,8-octahydro-2-naphtha lenyl]acrylic acid |
Pterodondiol | 60132-35-6 | C15H28O2 | 240.4 | |
Pterocarpadiol D | 2055882-23-8 | C16H16O6 | 304.298 | |
Pterocarpadiol C | 2055882-22-7 | C16H14O7 | 318.28 | |
Pterocarpadiol B | 2055882-20-5 | C16H14O6 | 302.282 | Kushecarpin D |
Pterocarpadiol A | 2055882-21-6 | C16H12O7 | 316.265 | |
Pterisolic acid F | 1401419-90-6 | C20H30O6 | 366.5 | (4alpha,16alpha)-9,16,17-Trihydroxy-15-oxokauran-18-oic acid |
Pterisolic acid E | 1401419-89-3 | C20H30O5 | 350.50 | (4alpha,12beta)-9,12-Dihydroxy-15-oxokauran-18-oic acid |
Pterisolic acid D | 1401419-88-2 | C20H30O5 | 350.5 | (4alpha,6beta)-6,9-Dihydroxy-15-oxokauran-18-oic acid |
Pterisolic acid C | 1401419-87-1 | C20H26O4 | 330.4 | (4alpha)-13-Hydroxy-15-oxokaura-9(11),16-dien-18-oic acid |
Pterisolic acid B | 1401419-86-0 | C20H26O4 | 330.42 | |
Pterisolic acid A | 1401419-85-9 | C20H26O5 | 346.4 | (4alpha,6alpha)-6,13-Dihydroxy-15-oxokaura-9(11),16-dien-18-oic acid |
Protopine | 130-86-9 | C20H19NO5 | 353.40 | 7,13a-Secoberbin-13a-one, 7-methyl-2,3:9,10-bis(methylenedioxy)-;7-Methyl-6,8,9,16-tetrahydrodi[1,3]benzodioxolo[4,5-c:5,6-g]azecin-15(7H)-one;Biflorine;Bis[1,3]benzodioxolo[4,5-c:5',6'-g]azecin-13(5H)-one, 4,6,7,14-tetrahydro-5-methyl-;Corydinine;Hyperco |